,Approval,Class,Drug Class,Drug Name,EntryName,Gene,YearIuphar,Year FDA,INDEX,Indication(s),LigandType,Phase,Status,Subfamily,Target class,Target_novelty,Trial name,Uniprot
0,0,Class B1 (Secretin),small molecule,561679,crfr1_human,CRHR1,-,-,543,Anti-depressant,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,crf-1 antagonist,P34998
1,0,Class B1 (Secretin),small molecule,768974,pth1r_human,PTH1R,-,-,10,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"768974, parathyroid hormone analog",Q03431
2,2003,Class A (Rhodopsin),peptide,abarelix,gnrhr_human,GNRHR,2003,2003,19,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"abarelix, plenaxis",P30968
3,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r1_human,PTGER1,-,-,29,dental ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P34995
4,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r2_human,PTGER2,-,-,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43116
5,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r3_human,PTGER3,-,-,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43115
6,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r4_human,PTGER4,-,-,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P35408
7,2004,Class C (Glutamate) ,small molecule,acamprosate,grm5_human,GRM5,2004,2004,34,Antineoplastic,Amino acid ,,approved,Metabotropic glutamate receptors,GPCR;Glutamate,established,"acamprosate,campral",P41594
8,1984,Class A (Rhodopsin),small molecule,acebutolol,adrb1_human,ADRB1,1984,1984,NRDD001,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
9,0,Class A (Rhodopsin),small molecule,aceprometazine,hrh1_human,HRH1,-,-,NRDD003,Hypnotics and Sedatives,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
10,1961,Class A (Rhodopsin),small molecule,acetophenazine,drd1_human,DRD1,-,1961,NRDD006,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
11,1961,Class A (Rhodopsin),small molecule,acetophenazine,drd2_human,DRD2,-,1961,NRDD006,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
12,2012,Class A (Rhodopsin),small molecule,aclidinium,acm1_human,CHRM1,2012,2012,44,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P11229
13,2012,Class A (Rhodopsin),small molecule,aclidinium,acm2_human,CHRM2,2012,2012,44,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08172
14,2012,Class A (Rhodopsin),small molecule,aclidinium,acm3_human,CHRM3,2012,2012,44,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P20309
15,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,2012,2012,44,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08173
16,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,2012,2012,44,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08912
17,2012,Class A (Rhodopsin),small molecule,aclidinium,acm2_human,CHRM2,2012,2012,MMAmay2016_0039,Chronic obstructive pulmonary disease (copd),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08172
18,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,2012,2012,MMAmay2016_0040,Chronic obstructive pulmonary disease (copd),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08173
19,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,2012,2012,MMAmay2016_0041,Chronic obstructive pulmonary disease (copd),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P08912
20,2012,Class A (Rhodopsin),small molecule,aclidinium,acm1_human,CHRM1,2012,2012,MMAmay2016_0042,Chronic obstructive pulmonary disease (copd),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P11229
21,2012,Class A (Rhodopsin),small molecule,aclidinium,acm3_human,CHRM3,2012,2012,MMAmay2016_0043,Chronic obstructive pulmonary disease (copd),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium bromide + formoterol fumarate,P20309
22,0,Class A (Rhodopsin),small molecule,acp-104,acm1_human,CHRM1,-,-,47,schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acp-104,P11229
23,0,Class A (Rhodopsin),small molecule,acp-104,drd2_human,DRD2,-,-,47,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acp-104,P14416
24,0,Class A (Rhodopsin),small molecule,acp-104,drd3_human,DRD3,-,-,47,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acp-104,P35462
25,0,Class A (Rhodopsin),small molecule,acp-104,5ht2a_human,HTR2A,-,-,47,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,acp-104,P28223
26,2015,Class A (Rhodopsin),small molecule,selexipag,pi2r_human,PTGIR,2015,-,MMAmay2016_0747,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,selixipag,P43119
27,1989,Class A (Rhodopsin),small molecule,adenosine,aa1r_human,ADORA1,1989,1989,2267,Analgesics,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P30542
28,1989,Class A (Rhodopsin),small molecule,adenosine,aa2ar_human,ADORA2A,1989,1989,2267,Analgesics,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P29274
29,1989,Class A (Rhodopsin),small molecule,adenosine,aa2br_human,ADORA2B,1989,1989,2267,Analgesics,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P29275
30,1989,Class A (Rhodopsin),small molecule,adenosine,aa3r_human,ADORA3,1989,1989,2267,Analgesics,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P0DMS8
31,0,Class A (Rhodopsin),small molecule,adl5747,oprd_human,OPRD1,-,-,55,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,adl5747,P41143
32,0,Class A (Rhodopsin),small molecule,adl5859,oprd_human,OPRD1,-,-,56,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"adl5859, pf-04856880",P41143
33,0,Class A (Rhodopsin),small molecule,adl5945,oprm_human,OPRM1,-,-,57,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,adl5945,P35372
34,0,Class A (Rhodopsin),small molecule,adl7445,oprm_human,OPRM1,-,-,58,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,adl7445,P35372
35,0,Class C (Glutamate) ,small molecule,adx10059,grm5_human,GRM5,-,-,62,Anti-migraine ; gastroesophageal reflux disease,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,adx10059,P41594
36,0,Class A (Rhodopsin),small molecule,adx415,ada2a_human,ADRA2A,-,-,63,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,adx415,P08913
37,0,Class C (Glutamate) ,small molecule,adx-48621,grm5_human,GRM5,-,-,2472,Antiparkinson,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,adx-48621,P41594
38,0,Class C (Glutamate) ,small molecule,adx-71149,grm2_human,GRM2,-,-,64,Antipsychotic ; Anti-depressant; anxiolytic,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,adx-71149,Q14416
39,0,Class C (Glutamate) ,small molecule,adx71441,gabr1_human,GABBR1,-,-,MMAmay2016_0243,neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,Q9UBS5
40,0,Class C (Glutamate) ,small molecule,adx71441,gabr2_human,GABBR2,-,-,MMAmay2016_0244,neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,O75899
41,0,Class A (Rhodopsin),small molecule,afamelanotide,mshr_human,MC1R,-,-,73,dermatological,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,afamelanotide,Q01726
42,0,Class A (Rhodopsin),small molecule,agn-214868,ada1a_human,ADRA1A,-,-,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P35348
43,0,Class A (Rhodopsin),small molecule,agn-214868,ada1b_human,ADRA1B,-,-,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P35368
44,0,Class A (Rhodopsin),small molecule,agn-214868,ada1d_human,ADRA1D,-,-,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P25100
45,0,Class A (Rhodopsin),small molecule,agn-214868,ada2a_human,ADRA2A,-,-,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P08913
46,0,Class A (Rhodopsin),small molecule,agn-214868,ada2b_human,ADRA2B,-,-,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P18089
47,0,Class A (Rhodopsin),small molecule,agn-214868,ada2c_human,ADRA2C,-,-,85,Analgesics; neuralgia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,agn-214868,P18825
48,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1b_human,MTNR1B,2009,-,86,Anti-depressant,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine , ago178c, s-20098,valdoxan, thymanax",P49286
49,2009,Class A (Rhodopsin),small molecule,agomelatine,5ht2b_human,HTR2B,2009,-,87,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P41595
50,2009,Class A (Rhodopsin),small molecule,agomelatine,5ht2c_human,HTR2C,2009,-,87,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P28335
51,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1a_human,MTNR1A,2009,-,87,Anti-depressant,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P48039
52,0,Class A (Rhodopsin),small molecule,aiko-150,oprm_human,OPRM1,-,-,92,opioid antagonist,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,aiko-150,P35372
53,0,Class A (Rhodopsin),small molecule,ajulemic acid,cnr1_human,CNR1,-,-,2361,Analgesics;neuropathic pain,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P21554
54,0,Class A (Rhodopsin),small molecule,ajulemic acid,cnr2_human,CNR2,-,-,2361,Analgesics;neuropathic pain,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P34972
55,0,Class A (Rhodopsin),small molecule,ajulemic acid,cnr2_human,CNR2,-,-,MMA2016_0031,Anti-inflammatory ; systemic schlerosis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,resunab,P34972
56,0,Class B1 (Secretin),small molecule,akl-0707,ghrhr_human,GHRH,-,-,96,hormone replacement,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"akl-0707, ghrh analog",Q02643
57,0,Class A (Rhodopsin),small molecule,akp-11,s1pr1_human,S1PR1,-,-,MMA2016_0028,psoriasis,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,akp-11,P21453
58,0,Class A (Rhodopsin),small molecule,alb-127158(a),mshr_human,MC1R,-,-,100,Anti-obesity,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,alb-127158(a),Q01726
59,0,Class B1 (Secretin),protein,albiglutide,glp1r_human,GLP1R,2014,2014,101,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,"albiglutide, gsk716155,syncria",P43220
60,2010,Class A (Rhodopsin),small molecule,alcaftadine,hrh1_human,HRH1,2010,2010,NRDD011,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
61,1986,Class A (Rhodopsin),small molecule,alfentanil,oprm_human,OPRM1,1986,1986,NRDD015,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
62,1986,Class A (Rhodopsin),small molecule,alfentanil,oprm_human,OPRM1,1986,1986,MMAmay2016_0108,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox51,  sublingual alfentanil",P35372
63,2003,Class A (Rhodopsin),small molecule,alfuzosin,ada1a_human,ADRA1A,2003,2003,107,benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P35348
64,2003,Class A (Rhodopsin),small molecule,alfuzosin,ada1b_human,ADRA1B,2003,2003,107,benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P35368
65,2003,Class A (Rhodopsin),small molecule,alfuzosin,ada1d_human,ADRA1D,2003,2003,107,benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alfuzosin,uroxatral",P25100
66,0,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,-,-,115,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 29,P41143
67,0,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,-,-,115,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 29,P41145
68,0,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,-,-,115,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 29,P35372
69,0,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,-,-,116,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 33,P41143
70,0,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,-,-,116,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 33,P41145
71,0,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,-,-,116,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 33,P35372
72,0,Class A (Rhodopsin),small molecule,alks 33,oprd_human,OPRD1,-,-,118,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41143
73,0,Class A (Rhodopsin),small molecule,alks 33,oprk_human,OPRK1,-,-,118,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41145
74,0,Class A (Rhodopsin),small molecule,alks 33,oprm_human,OPRM1,-,-,118,alcohol dependance; Anti-depressant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P35372
75,0,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprd_human,OPRD1,-,-,MMAmay2016_0184,Anti-obesity ; for antipsychotic-related metabolic weight gain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P41143
76,0,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprk_human,OPRK1,-,-,MMAmay2016_0184,Anti-obesity ; for antipsychotic-related metabolic weight gain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P41145
77,0,Class A (Rhodopsin),small molecule,"alks 33, samidorphan",oprm_human,OPRM1,-,-,MMAmay2016_0184,Anti-obesity ; for antipsychotic-related metabolic weight gain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35372
78,0,Class A (Rhodopsin),small molecule,alks 37,oprd_human,OPRD1,-,-,117,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P41143
79,0,Class A (Rhodopsin),small molecule,alks 37,oprk_human,OPRK1,-,-,117,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P41145
80,0,Class A (Rhodopsin),small molecule,alks 37,oprm_human,OPRM1,-,-,117,motilitant,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 37,P35372
81,0,Class A (Rhodopsin),small molecule,almorexant,ox1r_human,HCRTR1,-,-,119,sleep disorder treatment,Peptide ,,in trial,Orexin receptors,GPCR;Rhodopsin,established,"almorexant, act-078573",O43613
82,0,Class A (Rhodopsin),small molecule,almorexant,ox2r_human,HCRTR2,-,-,119,sleep disorder treatment,Peptide ,,in trial,Orexin receptors,GPCR;Rhodopsin,established,"almorexant, act-078573",O43614
83,2001,Class A (Rhodopsin),small molecule,almotriptan,5ht1b_human,HTR1B,2001,2001,120,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"almotriptan,axert, almogran, amignul",P28222
84,2001,Class A (Rhodopsin),small molecule,almotriptan,5ht1d_human,HTR1D,2001,2001,120,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"almotriptan,axert, almogran, amignul",P28221
85,0,Class A (Rhodopsin),small molecule,alprenolol,adrb1_human,ADRB1,,-,NRDD019,Anti-Arrhythmia ; Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
86,0,Class A (Rhodopsin),small molecule,alprenolol,adrb2_human,ADRB2,,-,NRDD019,Anti-Arrhythmia ; Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
87,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,-,1981,128,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,alista",P34995
88,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,-,1981,128,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,alista",P43116
89,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,-,1981,129,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,femprox",P34995
90,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,-,1981,129,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,femprox",P43116
91,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,-,1981,130,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,topiglan",P34995
92,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,-,1981,130,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"alprostadil,topiglan",P43116
93,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,-,1981,MMAapril2016_0157,Raynaud's Disease,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"rayva, alprostadil + ddaip.hcl",P34995
94,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,-,1981,MMAapril2016_0158,Raynaud's Disease,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"rayva, alprostadil + ddaip.hcl",P43116
95,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r1_human,PTGER1,-,1981,2039,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"topical alprostadil cream,alprox-td, befar, vitaros",P34995
96,1981,Class A (Rhodopsin),small molecule,alprostadil,pe2r2_human,PTGER2,-,1981,2039,sexual dysfunction,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"topical alprostadil cream,alprox-td, befar, vitaros",P43116
97,2008,Class A (Rhodopsin),small molecule,alvimopan,oprm_human,OPRM1,2008,2008,NRDD021,Opiate Antagonists,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
98,2008,Class A (Rhodopsin),small molecule,alvimopan,oprm_human,MOR,2008,2008,2549,opioid-induced bowel dysfunction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,entereg,P35372
99,0,Class A (Rhodopsin),antibody,"alx- 0651, biparatopic nanobody",cxcr4_human,CXCR4,-,-,MMAmay2016_0267,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"alx- 0651, biparatopic nanobody",P61073
100,0,Class B1 (Secretin),protein,alx1-11,pth1r_human,PTH1R,-,-,1646,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,Q03431
101,0,Class B1 (Secretin),protein,alx1-11,pth2r_human,PTH2R,-,-,1646,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,P49190
102,0,Class A (Rhodopsin),small molecule,am1030,5ht2b_human,HTR2B,-,-,MMAmar2016_0116,Anti-inflammatory ; atopic dermatitis,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,am1030,P41595
103,0,Class A (Rhodopsin),small molecule,am-152,lpar1_human,LPAR1,-,-,144,Anti-inflammatory ; antifibrotic,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,am-152,Q92633
104,0,Class A (Rhodopsin),small molecule,am-211,pd2r2_human,GPR44,-,-,145,Anti-inflammatory ; antiallergy,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,am-211,Q9Y5Y4
105,0,Class A (Rhodopsin),small molecule,am-461,pd2r_human,PTGDR,-,-,146,Anti-inflammatory,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,am-461,Q13258
106,0,Class A (Rhodopsin),small molecule,am-831,acm1_human,CHRM1,-,-,MMAmay2016_0047,Antipsychotic ; schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,am-831,P11229
107,0,Class A (Rhodopsin),small molecule,am-831,drd2_human,DRD2,-,-,MMAmay2016_0048,Antipsychotic ; schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,am-831,P14416
108,0,Class A (Rhodopsin),small molecule,am-831,5ht2a_human,HTR2A,-,-,MMAmay2016_0049,Antipsychotic ; schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,am-831,P28223
109,0,Class A (Rhodopsin),small molecule,amantadine hcl,drd2_human,DRD2,-,-,MMAmay2016_0242, for levodopa-induced dyskinesia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"ads-5102, amantadine hcl extended release",P14416
110,0,Class A (Rhodopsin),small molecule,amap102,5ht2b_human,HTR2B,-,-,148,Anti-inflammatory ; DMARD,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,amap102,P41595
111,0,Class A (Rhodopsin),small molecule,amap102,5ht2c_human,HTR2C,-,-,148,Anti-inflammatory ; DMARD,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,amap102,P28335
112,2007,Class A (Rhodopsin),small molecule,ambrisentan,ednra_human,EDNRA,20072008,2007,1111,Antihypertensive,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,letairis,P25101
113,2007,Class A (Rhodopsin),small molecule,ambrisentan,ednrb_human,EDNRB,20072008,2007,1111,Antihypertensive,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,letairis,P24530
114,0,Class A (Rhodopsin),small molecule,amd-070,cxcr4_human,CXCR4,-,-,150,antiviral ; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,amd-070,P61073
115,0,Class B1 (Secretin),antibody,amg 334,calrl_human,CALCRL,-,-,MMAapril2016_0116,Anti-migraine,Peptide ,,in trial,Calcitonin receptors,GPCR;Secretin,not established,amg 334,Q16602
116,0,Class A (Rhodopsin),small molecule,amibegron,adrb3_human,ADRB3,-,-,158,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"amibegron, sr 58611",P13945
117,1985,Class A (Rhodopsin),small molecule,amiodarone,ada1a_human,ADRA1A,1985,1985,160,Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"amiodarone hcl,amio-aqueous iv",P35348
118,1985,Class A (Rhodopsin),small molecule,amiodarone,adrb1_human,ADRB1,1985,1985,160,Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"amiodarone hcl,amio-aqueous iv",P08588
119,0,Class A (Rhodopsin),small molecule,amisulpride,drd2_human,DRD2,,-,161,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"amisulpride,solian",P14416
120,0,Class A (Rhodopsin),small molecule,amisulpride,drd3_human,DRD3,,-,161,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"amisulpride,solian",P35462
121,0,Class A (Rhodopsin),small molecule,amisulpride,drd2_human,DRD2,,-,MMAmay2016_0704,Antiemetics,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,apd403,P14416
122,0,Class A (Rhodopsin),small molecule,amisulpride,drd3_human,DRD3,,-,MMAmay2016_0705,Antiemetics,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,apd403,P35462
123,1961,Class A (Rhodopsin),small molecule,amitriptyline,5ht2a_human,HTR2A,1961,1961,1491,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,oms-103hp,P28223
124,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,1976,-,413,cognitive dysfunction; ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"c105, levo-amphetamine sulfate",Q96RJ0
125,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,1976,-,MMAmay2016_0357,cognitive dysfunction; ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,d-amphetamine transdermal system (d-ats),Q96RJ0
126,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,1976,-,MMAmay2016_0658,cognitive dysfunction; ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"hld-100, reformulated amphetamine",Q96RJ0
127,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,1976,-,1862,cognitive dysfunction; ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"sli 381, spd 465,adderall, adderall xr, adderall ir",Q96RJ0
128,0,Class A (Rhodopsin),small molecule,anamorelin,ghsr_human,GHSR,-,-,175,Appetite stimulant,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"anamorelin, rc-1291",Q92847
129,0,Class A (Rhodopsin),small molecule,anatibant,bkrb2_human,BDKRB2,-,-,177,traumatic brain injury,Peptide ,,in trial,Bradykinin receptors,GPCR;Rhodopsin,established,anatibant,P30411
130,0,Class A (Rhodopsin),small molecule,anileridine,oprm_human,OPRM1,,-,NRDD027,Analgesics; Narcotics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
131,0,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm1_human,CHRM1,-,-,NRDD029,Antispasmodics; Anti-ulcer,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
132,0,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm2_human,CHRM2,-,-,NRDD029,Antispasmodics; Anti-ulcer,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
133,0,Class A (Rhodopsin),small molecule,anisotropine methylbromide,acm3_human,CHRM3,-,-,NRDD029,Antispasmodics; Anti-ulcer,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
134,0,Class A (Rhodopsin),small molecule,ap-1034,mshr_human,MC1R,-,-,189,Anti-obesity,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,Q01726
135,0,Class A (Rhodopsin),small molecule,ap-1034,mc4r_human,MC4R,-,-,189,Anti-obesity,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,P32245
136,0,Class A (Rhodopsin),peptide,ap214,mshr_human,MC1R,-,-,2538,post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,Q01726
137,0,Class A (Rhodopsin),peptide,ap214,mc3r_human,MC3R,-,-,2538,post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P41968
138,0,Class A (Rhodopsin),peptide,ap214,mc4r_human,MC4R,-,-,2538,post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P32245
139,0,Class A (Rhodopsin),peptide,ap214,mc5r_human,MC5R,-,-,2538,post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P33032
140,0,Class A (Rhodopsin),small molecule,apd125,5ht2a_human,HTR2A,-,-,192,insomnia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,apd125,P28223
141,0,Class A (Rhodopsin),small molecule,apd334,s1pr1_human,S1PR1,-,-,MMAmay2016_0282,for autoimmune disorders,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,apd334,P21453
142,0,Class A (Rhodopsin),small molecule,apd421,drd2_human,DRD2,-,-,193,Antiemetics,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,apd421,P14416
143,0,Class A (Rhodopsin),small molecule,apd597,gp119_human,GPR119,-,-,2469,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,apd597,Q8TDV5
144,0,Class A (Rhodopsin),small molecule,apd668,gp119_human,GPR119,-,-,194,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,apd668,Q8TDV5
145,0,Class A (Rhodopsin),small molecule,apd791,5ht2a_human,HTR2A,-,-,195,antithrombotic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,apd791,P28223
146,0,Class A (Rhodopsin),small molecule,apd811,pi2r_human,PTGIR,-,-,MMAmay2016_0283,Antihypertensive,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,apd811,P43119
147,0,Class A (Rhodopsin),small molecule,apd916,hrh3_human,HRH3,-,-,196,sleep disorders; narcolepsy,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,apd916,Q9Y5N1
148,0,Class A (Rhodopsin),peptide,apelin,apj_human,APLNR,-,-,MMAjun2016_0045,Cardiovascular disorders; Insulin sensitivity,Peptide ,,in trial,Apelin receptors,GPCR;Rhodopsin,not established,apelin,P35414
149,0,Class A (Rhodopsin),small molecule,"api246,  srx246",v1ar_human,AVPR1A,-,-,MMAjun2016_0005,Treatment of affective and anger disorders,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"api246,  srx246",P37288
150,0,Class A (Rhodopsin),small molecule,aplindore,drd2_human,DRD2,-,-,203,Antiparkinson ; restlegs legs syndrome,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"aplindore, dab-452",P14416
151,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,20012004,2004,206,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P14416
152,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,20012004,2004,206,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P35462
153,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,20012004,2004,206,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hcl,uprima, ixense",P21917
154,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,20012004,2004,207,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P14416
155,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,20012004,2004,207,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P35462
156,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,20012004,2004,207,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"apomorphine hydrochloride,apokyn, apo-go",P21917
157,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,20012004,2004,976,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P14416
158,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,20012004,2004,976,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P35462
159,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,20012004,2004,976,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",P21917
160,2001,Class A (Rhodopsin),small molecule,apomorphine,drd2_human,DRD2,20012004,2004,1009,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P14416
161,2001,Class A (Rhodopsin),small molecule,apomorphine,drd3_human,DRD3,20012004,2004,1009,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P35462
162,2001,Class A (Rhodopsin),small molecule,apomorphine,drd4_human,DRD4,20012004,2004,1009,sexual dysfunction in women; erectile dysfunction; Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,intranasal apomorphine,P21917
163,1987,Class A (Rhodopsin),small molecule,apraclonidine,ada2a_human,ADRA2A,1987,1987,NRDD032,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
164,2003,Class A (Rhodopsin),small molecule,aprepitant,nk1r_human,TACR1,2003,2003,209,Antiemetics,Peptide ,,approved,Tachykinin receptors,GPCR;Rhodopsin,established,"aprepitant, mk-869, fosaprepitant dimeglumine, mk-0517,emend",P25103
165,0,Class C (Glutamate) ,small molecule,arbaclofen,gabr1_human,GABBR1,-,-,216,Fragile X syndrome,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,arbaclofen,Q9UBS5
166,0,Class C (Glutamate) ,small molecule,arbaclofen,gabr2_human,GABBR2,-,-,216,Fragile X syndrome,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,arbaclofen,O75899
167,1997,Class A (Rhodopsin),small molecule,arbutamine,adrb1_human,ADRB1,-,1997,NRDD034,Cardiotonic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
168,2006,Class A (Rhodopsin),small molecule,arformoterol,adrb2_human,ADRB2,2006,-,NRDD036,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
169,2006,Class A (Rhodopsin),small molecule,arformoterol,adrb2_human,ADRB2,2006,-,2276,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,brovana,P07550
170,0,Class A (Rhodopsin),small molecule,ari-3037mo,hcar2_human,HCAR2,-,-,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,Q8TDS4
171,0,Class A (Rhodopsin),small molecule,ari-3037mo,hcar3_human,HCAR3,-,-,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,P49019
172,2002,Class A (Rhodopsin),small molecule,aripiprazole,drd2_human,DRD2,2002,2002,22,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,abilify,P14416
173,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht1a_human,HTR1A,2002,2002,22,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,abilify,P08908
174,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht2a_human,HTR2A,2002,2002,22,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,abilify,P28223
175,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht1a_human,HTR1A,2002,2002,MMAmay2016_0260,Antipsychotic ; schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 9070,P08908
176,2002,Class A (Rhodopsin),small molecule,aripiprazole,drd2_human,DRD2,2002,2002,MMAmay2016_0261,Antipsychotic ; schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 9070,P14416
177,2002,Class A (Rhodopsin),small molecule,aripiprazole,5ht2a_human,HTR2A,2002,2002,MMAmay2016_0262,Antipsychotic ; schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 9070,P28223
178,0,Class A (Rhodopsin),small molecule,arry-502,pd2r2_human,GPR44,-,-,MMAapril2016_0314,Anti-Allergic,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,arry-502,Q9Y5Y4
179,2009,Class A (Rhodopsin),small molecule,asenapine,ada1a_human,ADRA1A,20092010,2009,250,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P35348
180,2009,Class A (Rhodopsin),small molecule,asenapine,ada2a_human,ADRA2A,20092010,2009,250,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P08913
181,2009,Class A (Rhodopsin),small molecule,asenapine,ada2b_human,ADRA2B,20092010,2009,250,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P18089
182,2009,Class A (Rhodopsin),small molecule,asenapine,ada2c_human,ADRA2C,20092010,2009,250,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,asenapine,P18825
183,2009,Class A (Rhodopsin),small molecule,asenapine,drd1_human,DRD1,20092010,2009,250,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P21728
184,2009,Class A (Rhodopsin),small molecule,asenapine,drd2_human,DRD2,20092010,2009,250,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P14416
185,2009,Class A (Rhodopsin),small molecule,asenapine,drd3_human,DRD3,20092010,2009,250,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P35462
186,2009,Class A (Rhodopsin),small molecule,asenapine,drd4_human,DRD4,20092010,2009,250,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,asenapine,P21917
187,2009,Class A (Rhodopsin),small molecule,asenapine,hrh1_human,HRH1,20092010,2009,250,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,asenapine,P35367
188,2009,Class A (Rhodopsin),small molecule,asenapine,hrh2_human,HRH2,20092010,2009,250,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,asenapine,P25021
189,2009,Class A (Rhodopsin),small molecule,asenapine,5ht1a_human,HTR1A,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P08908
190,2009,Class A (Rhodopsin),small molecule,asenapine,5ht1b_human,HTR1B,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28222
191,2009,Class A (Rhodopsin),small molecule,asenapine,5ht2a_human,HTR2A,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28223
192,2009,Class A (Rhodopsin),small molecule,asenapine,5ht2b_human,HTR2B,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P41595
193,2009,Class A (Rhodopsin),small molecule,asenapine,5ht2c_human,HTR2C,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P28335
194,2009,Class A (Rhodopsin),small molecule,asenapine,5ht5a_human,HTR5A,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P47898
195,2009,Class A (Rhodopsin),small molecule,asenapine,5ht6r_human,HTR6,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P50406
196,2009,Class A (Rhodopsin),small molecule,asenapine,5ht7r_human,HTR7,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P34969
197,0,Class A (Rhodopsin),small molecule,asimadoline,oprk_human,OPRK1,-,-,253,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,asimadoline,P41145
198,0,Class A (Rhodopsin),small molecule,asm-024,adrb2_human,ADRB2,-,-,MMAmay2016_0687,Anti-Asthmatic ; COPD,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,asm-024,P07550
199,1988,Class A (Rhodopsin),small molecule,astemizole,hrh1_human,HRH1,,-,NRDD037,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
200,1981,Class A (Rhodopsin),small molecule,atenolol,adrb1_human,ADRB1,1981,1981,NRDD038,Anti-Arrhythmia ; Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
201,0,Class A (Rhodopsin),small molecule,athx-105,5ht2c_human,HTR2C,-,-,263,Anti-obesity,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,athx-105,P28335
202,0,Class A (Rhodopsin),small molecule,ati-7505,5ht4r_human,HTR4,-,-,265,Parasympathomimetic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ati-7505,Q13639
203,0,Class A (Rhodopsin),small molecule,ati-9242,drd2_human,DRD2,-,-,2423,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ati-9242,P14416
204,0,Class A (Rhodopsin),small molecule,ati-9242,5ht2a_human,HTR2A,-,-,2423,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ati-9242,P28223
205,0,Class A (Rhodopsin),small molecule,atrasentan,ednra_human,EDNRA,-,-,270,Antineoplastic,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"atrasentan, abt-627,xinlay",P25101
206,1973,Class A (Rhodopsin),small molecule,atropine,acm1_human,CHRM1,1973,-,977,nerve  antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P11229
207,1973,Class A (Rhodopsin),small molecule,atropine,acm2_human,CHRM2,1973,-,977,nerve  antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08172
208,1973,Class A (Rhodopsin),small molecule,atropine,acm3_human,CHRM3,1973,-,977,nerve  antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P20309
209,1973,Class A (Rhodopsin),small molecule,atropine,acm4_human,CHRM4,1973,-,977,nerve  antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08173
210,1973,Class A (Rhodopsin),small molecule,atropine,acm5_human,CHRM5,1973,-,977,nerve  antidote,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,inhaled atropine,P08912
211,0,Class A (Rhodopsin),small molecule,av608,nk1r_human,TACR1,-,-,278,Anti-depressant; irritable bowel syndrome; antispasmodic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,av608,P25103
212,0,Class A (Rhodopsin),small molecule,ave-1625,cnr1_human,CNR1,-,-,284,Anti-obesity ; for treatment for Alzheimer's disease,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,ave-1625,P21554
213,0,Class A (Rhodopsin),vaccine,avicine,lshr_human,LHCGR,-,-,563,Antineoplastic ; vaccine,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"ctp-37,avicine",P22888
214,0,Class A (Rhodopsin),small molecule,avn-101,5ht6r_human,HTR6,-,-,290,Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-101,P50406
215,0,Class A (Rhodopsin),small molecule,avn-211,5ht6r_human,HTR6,-,-,291,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-211,P50406
216,0,Class A (Rhodopsin),small molecule,avn-322,5ht6r_human,HTR6,-,-,292,Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-322,P50406
217,0,Class A (Rhodopsin),small molecule,avn-397,5ht6r_human,HTR6,-,-,2490,Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,avn-397,P50406
218,0,Class A (Rhodopsin),small molecule,avosentan,ednra_human,EDNRA,-,-,295,Antihypertensive,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"avosentan, spp 301",P25101
219,0,Class A (Rhodopsin),peptide nucleic acid,avr118,aa2ar_human,ADORA2A,-,-,2269,wound healing accelerant,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,avr123,P29274
220,0,Class A (Rhodopsin),peptide nucleic acid,avr118,aa2br_human,ADORA2B,-,-,2269,wound healing accelerant,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,avr123,P29275
221,0,Class A (Rhodopsin),peptide nucleic acid,avr118,aa3r_human,ADORA3,-,-,2269,wound healing accelerant,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,avr123,P0DMS8
222,1977,Class A (Rhodopsin),small molecule,azatadine,hrh1_human,HRH1,1977,1977,NRDD041,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
223,0,Class C (Glutamate) ,small molecule,azd2066,grm5_human,GRM5,-,-,308,Analgesics; gastroesophageal reflux disease,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,azd2066,P41594
224,0,Class A (Rhodopsin),small molecule,azd2423,ccr2_human,CCR2,-,-,2331,chronic obstructive pulmonary disorder;Analgesics; neuropathic pain,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,azd2423,P41597
225,0,Class A (Rhodopsin),small molecule,azd2820,mc4r_human,MC4R,-,-,MMAmay2016_0297,Anti-obesity,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,azd2820,P32245
226,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,,1996,313,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,azelastine,P35367
227,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,,1996,314,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"azelastine hydrochloride nasal spray,astepro",P35367
228,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,,1996,456,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"cdx-313, budesonide + azelastine nasal spray",P35367
229,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,,1996,MMAmay2016_0366,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"dymista, azelastine hydrochloride + fluticasone propionate",P35367
230,1996,Class A (Rhodopsin),small molecule,azelastine,hrh1_human,HRH1,,1996,679,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"dymista, azelastine hydrochloride + fluticasone propionate, mp29-02",P35367
231,0,Class A (Rhodopsin),small molecule,azilsartan,agtr1_human,AGTR1,-,-,315,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"azilsartan medoxomil, tak-491",P30556
232,0,Class A (Rhodopsin),small molecule,azilsartan,agtr1_human,AGTR1,-,-,MMAmay2016_0371,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"edarbyclor, azilsartan medoxomil + chlorthalidone",P30556
233,0,Class A (Rhodopsin),peptide,"azp-531, unacylated ghrelin",ghsr_human,GHSR,-,-,MMAapril2016_0315,Antidiabetic,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"azp-531, unacylated ghrelin",Q92847
234,2007,Class C (Glutamate) ,small molecule,baclofen,gabr1_human,GABBR1,2007,1977,115,alcohol dependance,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,alks 29,Q9UBS5
235,2007,Class C (Glutamate) ,small molecule,baclofen,gabr2_human,GABBR2,2007,1977,115,alcohol dependance,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,alks 29,O75899
236,2007,Class C (Glutamate) ,small molecule,baclofen,gabr2_human,GABBR2,2007,1977,MMAmay2016_0071,for type 1A Charcot-Marie-Tooth disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,"pxt3003, baclofen + naltrexone + sorbitol",O75899
237,2007,Class C (Glutamate) ,small molecule,baclofen,gabr1_human,GABBR1,2007,1977,MMAmay2016_0072,for type 1A Charcot-Marie-Tooth disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,"pxt3003, baclofen + naltrexone + sorbitol",Q9UBS5
238,0,Class C (Glutamate) ,small molecule,bci-838,grm2_human,GRM2,-,-,MMAmay2016_0306,Anti-depressant,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,bci-838,Q14416
239,0,Class C (Glutamate) ,small molecule,bci-838,grm3_human,GRM3,-,-,MMAmay2016_0307,Anti-depressant,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,bci-838,Q14832
240,1960,Class A (Rhodopsin),small molecule,benzphetamine,ada1a_human,ADRA1A,-,1960,NRDD046,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
241,1960,Class A (Rhodopsin),small molecule,benzphetamine,ada2a_human,ADRA2A,-,1960,NRDD046,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
242,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm1_human,CHRM1,,1974,NRDD047,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
243,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm2_human,CHRM2,,1974,NRDD047,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
244,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm3_human,CHRM3,,1974,NRDD047,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
245,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm4_human,CHRM4,,1974,NRDD047,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
246,1974,Class A (Rhodopsin),small molecule,benzquinamide,acm5_human,CHRM5,,1974,NRDD047,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
247,1974,Class A (Rhodopsin),small molecule,benzquinamide,hrh1_human,HRH1,,1974,NRDD047,Antiemetics; Antipsychotic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
248,1954,Class A (Rhodopsin),small molecule,benztropine,acm1_human,CHRM1,-,1954,NRDD049,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
249,2009,Class A (Rhodopsin),small molecule,bepotastine,hrh1_human,HRH1,2009,2009,336,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"bepotastine besilate,bepreve, talion",P35367
250,0,Class A (Rhodopsin),small molecule,beraprost,pi2r_human,PTGIR,-,-,337,Antihypertensive,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,beraprost,P43119
251,0,Class A (Rhodopsin),small molecule,betahistine,hrh1_human,HRH1,-,-,MMAmay2016_0919,vertigo,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,betahistine,P35367
252,0,Class A (Rhodopsin),small molecule,betahistine,hrh3_human,HRH3,-,-,MMAmay2016_0920,vertigo,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,betahistine,Q9Y5N1
253,0,Class A (Rhodopsin),small molecule,betahistine,hrh1_human,HRH1,-,-,1464,Anti-obesity,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"obe101,histalean,anti-obesity ",P35367
254,0,Class A (Rhodopsin),small molecule,betahistine,hrh3_human,HRH3,-,-,1464,Anti-obesity,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"obe101,histalean,anti-obesity ",Q9Y5N1
255,0,Class A (Rhodopsin),small molecule,betanechol,acm2_human,CHRM2,-,-,648,Antidiabetic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dm-71,P08172
256,1985,Class A (Rhodopsin),small molecule,betaxolol,adrb1_human,ADRB1,1985,1985,NRDD052,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
257,0,Class A (Rhodopsin),small molecule,betazole,hrh2_human,HRH2,,-,NRDD053,Diagnostic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021
258,1948,Class A (Rhodopsin),small molecule,bethanechol,acm1_human,CHRM1,1948,-,NRDD054,Parasympathomimetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
259,0,Class A (Rhodopsin),small molecule,bethanidine,ada1a_human,ADRA1A,-,-,NRDD055,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
260,0,Class A (Rhodopsin),small molecule,bethanidine,ada1b_human,ADRA1B,-,-,NRDD055,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
261,0,Class A (Rhodopsin),small molecule,bethanidine,ada1d_human,ADRA1D,-,-,NRDD055,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
262,0,Class A (Rhodopsin),small molecule,bethanidine,ada2a_human,ADRA2A,-,-,NRDD055,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
263,0,Class A (Rhodopsin),small molecule,bethanidine,ada2b_human,ADRA2B,-,-,NRDD055,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089
264,0,Class A (Rhodopsin),small molecule,bethanidine,ada2c_human,ADRA2C,-,-,NRDD055,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825
265,0,Class A (Rhodopsin),small molecule,bevantolol,adrb1_human,ADRB1,-,-,NRDD056,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
266,0,Class A (Rhodopsin),small molecule,bf-1,5ht2b_human,HTR2B,-,-,343,Anti-migraine,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bf-1,P41595
267,0,Class A (Rhodopsin),small molecule,bg-9928,aa1r_human,ADORA1,-,-,345,congestive heart failure,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,bg-9928,P30542
268,0,Class A (Rhodopsin),small molecule,bgc20-1531 ,pe2r4_human,PTGER4,-,-,347,Anti-migraine,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,bgc20-1531,P35408
269,0,Class A (Rhodopsin),small molecule,bifeprunox,drd2_human,DRD2,-,-,356,Antipsychotic ; Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P14416
270,0,Class A (Rhodopsin),small molecule,bifeprunox,drd3_human,DRD3,-,-,356,Antipsychotic ; Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P35462
271,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht1a_human,HTR1A,-,-,356,Antipsychotic ; Antiparkinson,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P08908
272,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht2a_human,HTR2A,-,-,356,Antipsychotic ; Antiparkinson,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P28223
273,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht2c_human,HTR2C,-,-,356,Antipsychotic ; Antiparkinson,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P28335
274,0,Class A (Rhodopsin),small molecule,bifeprunox,5ht7r_human,HTR7,-,-,356,Antipsychotic ; Antiparkinson,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"bifeprunox, du127090",P34969
275,0,Class A (Rhodopsin),small molecule,biib014,aa2ar_human,ADORA2A,-,-,2164,Antiparkinson,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,vipadenantis,P29274
276,0,Class A (Rhodopsin),small molecule,bim23a760,drd2_human,DRD2,-,-,358,Antineoplastic ; treatment for acromegaly,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,bim23a760,P14416
277,0,Class A (Rhodopsin),small molecule,bim23a760,ssr2_human,SSTR2,-,-,358,Antineoplastic ; treatment for acromegaly,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P30874
278,0,Class A (Rhodopsin),small molecule,bim23a760,ssr5_human,SSTR5,-,-,358,Antineoplastic ; treatment for acromegaly,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P35346
279,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r1_human,PTGER1,2001,2001,359,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P34995
280,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r3_human,PTGER3,2001,2001,359,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P43115
281,2001,Class A (Rhodopsin),small molecule,bimatoprost,pf2r_human,PTGFR,2001,2001,359,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"bimatoprost,  agn 192024,lumigan",P43088
282,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r1_human,PTGER1,2001,2001,MMAmar2016_0296,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P34995
283,2001,Class A (Rhodopsin),small molecule,bimatoprost,pf2r_human,PTGFR,2001,2001,MMAmar2016_0297,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P43088
284,2001,Class A (Rhodopsin),small molecule,bimatoprost,pe2r3_human,PTGER3,2001,2001,MMAmar2016_0298,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"helios insert, bimatoprost ocular insert",P43115
285,0,Class A (Rhodopsin),small molecule,binodenoson,aa2ar_human,ADORA2A,-,-,363,Diagnostic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"binodenoson, mre 0470,corvue",P29274
286,1959,Class A (Rhodopsin),small molecule,biperiden,acm1_human,CHRM1,1959,1959,NRDD057,Antidyskinetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
287,1992,Class A (Rhodopsin),small molecule,bisoprolol,adrb1_human,ADRB1,1992,1992,NRDD058,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
288,0,Class A (Rhodopsin),small molecule,bl-1020,drd2_human,DRD2,-,-,2424,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,bl-1020,P14416
289,0,Class A (Rhodopsin),small molecule,bl-1020,hrh1_human,HRH1,-,-,2424,schizophrenia,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,bl-1020,P35367
290,0,Class A (Rhodopsin),small molecule,bl-1020,5ht2a_human,HTR2A,-,-,2424,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bl-1020,P28223
291,0,Class A (Rhodopsin),peptide,bl-8040,cxcr4_human,CXCR4,-,-,APR13_0001,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,bl-8040,P61073
292,0,Class A (Rhodopsin),antibody,bms 936564,cxcr4_human,CXCR4,-,-,369,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"bms 936564, mdx-1338",P61073
293,2001,Class A (Rhodopsin),small molecule,bosentan,ednra_human,EDNRA,2001,2001,2053,Antihypertensive,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,tracleer,P25101
294,2001,Class A (Rhodopsin),small molecule,bosentan,ednrb_human,EDNRB,2001,2001,2053,Antihypertensive,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,tracleer,P24530
295,0,Class A (Rhodopsin),small molecule,"boxaban, hepatoren, vasculan, ifetroban",ta2r_human,TBXA2R,-,-,MMAjun2016_0011,Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"boxaban, hepatoren, vasculan, ifetroban",P21731
296,0,Class A (Rhodopsin),peptide,bremelanotide,mshr_human,MC1R,-,-,383,sexual dysfunction,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,Q01726
297,0,Class A (Rhodopsin),peptide,bremelanotide,mc4r_human,MC4R,-,-,383,sexual dysfunction,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,P32245
298,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,1996,1996,385,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P08913
299,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,1996,1996,385,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P18089
300,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,1996,1996,385,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate,alphagan",P18825
301,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,1996,1996,386,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P08913
302,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,1996,1996,386,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P18089
303,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,1996,1996,386,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P18825
304,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2a_human,ADRA2A,1996,1996,2274,erythema,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P08913
305,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2b_human,ADRA2B,1996,1996,2274,erythema,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P18089
306,1996,Class A (Rhodopsin),small molecule,brimonidine,ada2c_human,ADRA2C,1996,1996,2274,erythema,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cd07805/47, sansrosa, col-118",P18825
307,1978,Class A (Rhodopsin),small molecule,bromocriptine,drd2_human,DRD2,1978,1978,389,Antidiabetic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"bromocriptine mesylate,cycloset, ergoset",P14416
308,1978,Class A (Rhodopsin),small molecule,bromocriptine,drd3_human,DRD3,1978,1978,389,Antidiabetic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"bromocriptine mesylate,cycloset, ergoset",P35462
309,0,Class A (Rhodopsin),small molecule,bromodiphenhydramine,hrh1_human,HRH1,,-,NRDD062,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
310,1957,Class A (Rhodopsin),small molecule,brompheniramine,hrh1_human,HRH1,1957,-,NRDD063,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
311,0,Class A (Rhodopsin),small molecule,bucindolol,adrb1_human,ADRB1,-,-,396,heart failure,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"bucindolol hydrochloride,gencaro",P08588
312,0,Class A (Rhodopsin),small molecule,bucindolol,adrb2_human,ADRB2,-,-,396,heart failure,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"bucindolol hydrochloride,gencaro",P07550
313,0,Class A (Rhodopsin),small molecule,buclizine,acm1_human,CHRM1,,-,NRDD064,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
314,0,Class A (Rhodopsin),small molecule,buclizine,hrh1_human,HRH1,,-,NRDD064,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
315,0,Class A (Rhodopsin),small molecule,budiodarone,adrb1_human,ADRB1,-,-,404,Anti-Arrhythmia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"budiodarone, ati-2042",P08588
316,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprd_human,OPRD1,1981,1981,118,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41143
317,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,118,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,alks 5461,P41145
318,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,333,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema buprenorphine, buccal mucosa adhesive",P41145
319,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,333,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema buprenorphine, buccal mucosa adhesive",P35372
320,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,405,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41145
321,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,405,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P35372
322,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,406,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41145
323,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,406,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P35372
324,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,407,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine subcutaneous implant,probuphine",P41145
325,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,407,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine subcutaneous implant,probuphine",P35372
326,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,408,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine sublingual tablet,subutex",P41145
327,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,408,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine sublingual tablet,subutex",P35372
328,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,MMAmar2016_0045,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butab, rel-1028, oral, enteric-coated buprenorphine",P35372
329,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,MMAmar2016_0047,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butab, rel-1028, oral, enteric-coated buprenorphine",P41145
330,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,409,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",P41145
331,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,409,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",P35372
332,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,422,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,cam2038,P41145
333,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,422,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,cam2038,P35372
334,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,MMAmay2016_0514,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P35372
335,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,MMAmay2016_0516,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41145
336,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprd_human,OPRD1,1981,1981,2109,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P41143
337,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprk_human,OPRK1,1981,1981,2109,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P41145
338,1981,Class A (Rhodopsin),small molecule,buprenorphine,oprm_human,OPRM1,1981,1981,2109,Anti-depressant; Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,v1003,P35372
339,1986,Class A (Rhodopsin),small molecule,buspirone,drd2_human,DRD2,1986,1986,NRDD066,Anti-anxiety,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
340,1986,Class A (Rhodopsin),small molecule,buspirone,5ht1a_human,HTR1A,1986,1986,NRDD066,Anti-anxiety,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908
341,1978,Class A (Rhodopsin),small molecule,butorphanol,oprd_human,OPRD1,1978,1978,NRDD070,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143
342,1978,Class A (Rhodopsin),small molecule,butorphanol,oprk_human,OPRK1,1978,1978,NRDD070,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145
343,1978,Class A (Rhodopsin),small molecule,butorphanol,oprm_human,OPRM1,1978,1978,NRDD070,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
344,0,Class A (Rhodopsin),small molecule,bvt.115959,aa2ar_human,ADORA2A,-,-,411,Analgesics,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,bvt.115959,P29274
345,0,Class A (Rhodopsin),small molecule,bvt.28949,5ht2a_human,HTR2A,-,-,412,Antiglaucomic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,bvt.28949,P28223
346,1996,Class A (Rhodopsin),small molecule,cabergoline,drd2_human,DRD2,1996,1996,NRDD071,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
347,1999,Class A (Rhodopsin),small molecule,caffeine,aa1r_human,ADORA1,1999,-,NRDD072,Central Nervous System Stimulants,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,-,P30542
348,1999,Class A (Rhodopsin),small molecule,caffeine,aa2ar_human,ADORA2A,1999,-,NRDD072,Central Nervous System Stimulants,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,-,P29274
349,0,Class A (Rhodopsin),cell therapy,"cal-1, autologous t cell and blood stem cell therapy",ccr5_human,CCR5,-,-,MMAapril2016_0320,antiviral ; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"cal-1, autologous t cell and blood stem cell therapy",P51681
350,1986,Class B1 (Secretin),small molecule,calcitonin,calcr_human,CALCR,1986,-,376,Anti-osteoporotic,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,"bn-002,capsitonin",P30988
351,1986,Class B1 (Secretin),small molecule,calcitonin,calcr_human,CALCR,1986,-,2154,Anti-osteoporotic,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,viaderm-calcitonin,P30988
352,1998,Class A (Rhodopsin),small molecule,candesartan,agtr1_human,AGTR1,1998,-,427,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"candesartan cilexetil,atacand",P30556
353,2015,Class A (Rhodopsin),small molecule,cangrelor,p2y12_human,P2RY12,2015,2015,428,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"cangrelor, ar69931",Q9H244
354,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,-,-,MMAmar2016_0268,epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabidiol,P21554
355,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,-,-,MMAmar2016_0269,epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabidiol,P34972
356,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,-,-,MMAmar2016_0270,epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol",P21554
357,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,-,-,MMAmar2016_0271,epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"epidiolex, oral liquid cannabidiol",P34972
358,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr1_human,CNR1,-,-,MMAapril2016_0328,schizophrenia,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42003,P21554
359,0,Class A (Rhodopsin),small molecule,cannabidiol,cnr2_human,CNR2,-,-,MMAapril2016_0328,schizophrenia,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42003,P34972
360,0,Class A (Rhodopsin),small molecule,cannabidivarin,cnr1_human,CNR1,-,-,MMAmay2016_0402,epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42006,P21554
361,0,Class A (Rhodopsin),small molecule,cannabidivarin,cnr2_human,CNR2,-,-,MMAmay2016_0403,epilepsy,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42006,P34972
362,0,Class A (Rhodopsin),small molecule,"cannabinoids,  thc + cbd",cnr1_human,CNR1,-,-,MMAmay2016_0720,Antineoplastic ; for glioma,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"cannabinoids,  thc + cbd",P21554
363,0,Class A (Rhodopsin),small molecule,"cannabinoids,  thc + cbd",cnr2_human,CNR2,-,-,MMAmay2016_0721,Antineoplastic ; for glioma,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"cannabinoids,  thc + cbd",P34972
364,1972,Class A (Rhodopsin),small molecule,carbachol,acm1_human,CHRM1,1972,1972,NRDD077,Antiglaucomic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
365,1972,Class A (Rhodopsin),small molecule,carbachol,acm2_human,CHRM2,1972,1972,NRDD077,Antiglaucomic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
366,0,Class A (Rhodopsin),small molecule,carbetocin,oxyr_human,OXTR,-,-,NRDD078,Labor Inducing,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P30559
367,2003,Class A (Rhodopsin),small molecule,carbinoxamine,acm1_human,CHRM1,2003,-,NRDD080,Anti-Allergic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
368,2003,Class A (Rhodopsin),small molecule,carbinoxamine,hrh1_human,HRH1,2003,-,NRDD080,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
369,1965,Class A (Rhodopsin),small molecule,carboprost tromethamine,pe2r1_human,PTGER1,1965,1979,NRDD081,Abortifacient,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P34995
370,2015,Class A (Rhodopsin),small molecule,cariprazine,drd2_human,DRD2,2015,2015,433,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cariprazine, rgh-188",P14416
371,2015,Class A (Rhodopsin),small molecule,cariprazine,drd3_human,DRD3,2015,2015,433,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cariprazine, rgh-188",P35462
372,0,Class A (Rhodopsin),small molecule,carphenazine,drd1_human,DRD1,,-,NRDD082,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
373,0,Class A (Rhodopsin),small molecule,carphenazine,drd2_human,DRD2,,-,NRDD082,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
374,0,Class A (Rhodopsin),small molecule,carphenazine,drd5_human,DRD5,,-,NRDD082,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21918
375,1988,Class A (Rhodopsin),small molecule,carteolol,adrb1_human,ADRB1,1988,1988,NRDD084,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
376,1995,Class A (Rhodopsin),small molecule,carvedilol,ada1a_human,ADRA1A,1995,1995,434,congestive heart failure,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol, coreg",P35348
377,1995,Class A (Rhodopsin),small molecule,carvedilol,adrb1_human,ADRB1,1995,1995,435,cardiovascular disease,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol,coreg",P08588
378,1995,Class A (Rhodopsin),small molecule,carvedilol,adrb2_human,ADRB2,1995,1995,435,cardiovascular disease,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"carvedilol,coreg",P07550
379,0,Class A (Rhodopsin),small molecule,casopitant,nk1r_human,TACR1,-,-,436,Antiemetics,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"casopitant mesilate, 679769,rezonic, zunrisa",P25103
380,0,Class A (Rhodopsin),protein,ccl2-lpm,ccr2_human,CCR2,-,-,445,Anti-inflammatory,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccl2-lpm,P41597
381,0,Class A (Rhodopsin),small molecule,ccx025,ccr9_human,CCR9,-,-,446,Anti-inflammatory,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx025,P51686
382,0,Class A (Rhodopsin),small molecule,ccx140,ccr2_human,CCR2,-,-,447,Anti-inflammatory ; Antidiabetic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx140,P41597
383,0,Class A (Rhodopsin),small molecule,ccx168,c5ar1_human,C5AR1,-,-,448,Anti-inflammatory ; for treatment for autoimmune disease,Peptide ,,in trial,Complement peptide receptors,GPCR;Rhodopsin,not established,ccx168,P21730
384,0,Class A (Rhodopsin),small molecule,ccx282,ccr9_human,CCR9,-,-,449,Anti-inflammatory ; Crohn's disease; ulceraite colitis,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"ccx282, traficet-en",P51686
385,0,Class A (Rhodopsin),small molecule,ccx354,ccr1_human,CCR1,-,-,450,Anti-inflammatory ; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx354,P32246
386,0,Class A (Rhodopsin),small molecule,ccx507,ccr9_human,CCR9,-,-,MMAmay2016_0216,ulcerative colitis; inflammatory bowel disease,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx507,P51686
387,0,Class A (Rhodopsin),small molecule,ccx832,cml1_human,CMKLR1,-,-,451,Anti-inflammatory ; for treatment for autoimmune disease,Protein ,,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,ccx832,Q99788
388,0,Class A (Rhodopsin),small molecule,ccx872,ccr2_human,CCR2,-,-,MMAapril2016_0147,Antineoplastic ; pancreatic cancer,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx872,P41597
389,0,Class A (Rhodopsin),small molecule: combination,cer627,hcar3_human,HCAR3,-,-,MMA2015_0071,Dyslipidemia with low HDL,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019
390,0,Class A (Rhodopsin),small molecule: combination,cer627,hcar2_human,HCAR2,-,-,MMA2015_0072,Dyslipidemia with low HDL,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4
391,0,Class A (Rhodopsin),small molecule,"cerc-501, ly2456302",oprk_human,OPRK1,-,-,MMAfeb2016_0074,Substance use disorders,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,"cerc-501, ly2456302",P41145
392,0,Class A (Rhodopsin),small molecule,ceruletide,cckar_human,CCKAR,,-,NRDD085,Diagnostic,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32238
393,2007,Class A (Rhodopsin),small molecule,cetirizine,hrh1_human,HRH1,2007,1995,471,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"cetirizine hcl,zyrtec",P35367
394,2000,Class A (Rhodopsin),peptide,cetrorelix,gnrhr_human,GNRHR,2000,2000,472,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"cetrorelix,cetrotide",P30968
395,2000,Class A (Rhodopsin),small molecule,cevimeline,acm1_human,CHRM1,-,2000,NRDD086,Parasympathomimetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
396,2000,Class A (Rhodopsin),small molecule,cevimeline,acm3_human,CHRM3,-,2000,NRDD086,Parasympathomimetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
397,0,Class A (Rhodopsin),small molecule,cf-101,aa3r_human,ADORA3,-,-,473,Anti-inflammatory ; DMARD,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf-101,P0DMS8
398,0,Class A (Rhodopsin),small molecule,cf-102,aa3r_human,ADORA3,-,-,474,Antineoplastic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf-102,P0DMS8
399,0,Class A (Rhodopsin),small molecule,cf602,aa3r_human,ADORA3,-,-,MMAapril2016_0230,sexual dysfunction,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cf602,P0DMS8
400,0,Class B1 (Secretin),peptide,cgrp,calrl_human,CALCRL,-,-,477,Anti-Asthmatic,Peptide ,,in trial,Calcitonin receptors,GPCR;Secretin,not established,cgrp,Q16602
401,0,Class A (Rhodopsin),small molecule,chlophedianol,hrh1_human,HRH1,,-,NRDD087,Antitussive,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
402,1950,Class A (Rhodopsin),small molecule,chlorpheniramine,hrh1_human,HRH1,1950,-,NRDD094,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
403,0,Class A (Rhodopsin),small molecule,chlorprothixene,drd1_human,DRD1,-,-,NRDD096,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
404,0,Class A (Rhodopsin),small molecule,chlorprothixene,drd2_human,DRD2,-,-,NRDD096,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
405,0,Class A (Rhodopsin),small molecule,chlorprothixene,drd3_human,DRD3,-,-,NRDD096,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462
406,0,Class A (Rhodopsin),small molecule,chlorprothixene,hrh1_human,HRH1,-,-,NRDD096,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
407,0,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2a_human,HTR2A,-,-,NRDD096,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
408,0,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2b_human,HTR2B,-,-,NRDD096,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595
409,0,Class A (Rhodopsin),small molecule,chlorprothixene,5ht2c_human,HTR2C,-,-,NRDD096,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
410,2000,Class A (Rhodopsin),protein,choriogonadotropin alfa,fshr_human,FSHR,-,-,NRDD099,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945
411,2000,Class A (Rhodopsin),protein,choriogonadotropin alfa,lshr_human,LHCGR,-,-,NRDD099,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888
412,0,Class A (Rhodopsin),protein,chorionic gonadotropin (hcg),lshr_human,LHCGR,-,-,2529,Antineoplastic,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,ml-04,P22888
413,0,Class A (Rhodopsin),small molecule,cicletanine ,ada1a_human,ADRA1A,-,-,2271,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P35348
414,0,Class A (Rhodopsin),small molecule,cicletanine ,ada1d_human,ADRA1D,-,-,2271,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P25100
415,0,Class A (Rhodopsin),small molecule,cicletanine ,ada2a_human,ADRA2A,-,-,2271,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P08913
416,0,Class A (Rhodopsin),small molecule,cicletanine ,ada2b_human,ADRA2B,-,-,2271,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P18089
417,0,Class A (Rhodopsin),small molecule,cicletanine ,ada2c_human,ADRA2C,-,-,2271,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P18825
418,0,Class A (Rhodopsin),small molecule,cicletanine ,adrb2_human,ADRB2,-,-,2271,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,cicletanine hydrochloride,P07550
419,1977,Class A (Rhodopsin),small molecule,cimetidine,hrh2_human,HRH2,1977,1977,NRDD104,GI Anti-Ulcer ; antihistamines,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021
420,1977,Class A (Rhodopsin),small molecule,cimetidine,hrh2_human,HRH2,1977,1977,MMAmay2016_0601,Antihistamines,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"tl-118, hamsa-1, cyclophosphamide + diclofenac + sulfasalazine + cimetidine",P25021
421,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,2004,2004,NRDD105,Calcimimetics,Ion ,,approved,Calcium-sensing receptors,GPCR;Glutamate,established,-,P41180
422,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,2004,2004,2327,hyperparathyroidism,Ion ,,approved,Calcium-sensing receptors,GPCR;Glutamate,established,"cinacalcet hcl, amg 073,sensipar",P41180
423,0,Class A (Rhodopsin),small molecule,cinalukast,cltr1_human,CYSLTR1,-,-,NRDD106,Anti-Asthmatic,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271
424,1989,Class A (Rhodopsin),small molecule,cinnarizine,hrh1_human,HRH1,1989,-,NRDD107,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
425,1993,Class A (Rhodopsin),small molecule,cisapride,5ht4r_human,HTR4,1993,1993,NRDD109,Parasympathomimetics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,Q13639
426,0,Class A (Rhodopsin),small molecule,cis-uca eye drops,5ht2a_human,HTR2A,-,-,MMAmay2016_0333,for ocular surface inflammation,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cis-uca eye drops,P28223
427,0,Class A (Rhodopsin),small molecule,cis-urocanic acid,5ht2a_human,HTR2A,-,-,2488,dry eye,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,biocis,P28223
428,0,Class A (Rhodopsin),small molecule,clazosentan,ednra_human,EDNRA,-,-,495,for treatment and prevention of vasospasm,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"clazosentan, axv-343434,pivlaz",P25101
429,1977,Class A (Rhodopsin),small molecule,clemastine,hrh1_human,HRH1,1977,1977,NRDD112,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
430,0,Class A (Rhodopsin),small molecule,clenbuterol,adrb2_human,ADRB2,-,-,NRDD113,Bronchodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
431,0,Class A (Rhodopsin),small molecule,clidinium,acm1_human,CHRM1,,-,NRDD114,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
432,1974,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,1974,-,220,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P08913
433,1974,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,1974,-,220,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P18089
434,1974,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,1974,-,220,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"arc-4558, 0.1% clonidine hycrochloride gel",P18825
435,1974,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,1974,-,501,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P08913
436,1974,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,1974,-,501,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P18089
437,1974,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,1974,-,501,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",P18825
438,1974,Class A (Rhodopsin),small molecule,clonidine,ada2a_human,ADRA2A,1974,-,502,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P08913
439,1974,Class A (Rhodopsin),small molecule,clonidine,ada2b_human,ADRA2B,1974,-,502,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P18089
440,1974,Class A (Rhodopsin),small molecule,clonidine,ada2c_human,ADRA2C,1974,-,502,diabetic neuropathy; ADHD; antimucositic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"clonidine lauriad, ba-028",P18825
441,1997,Class A (Rhodopsin),small molecule,clopidogrel,p2y12_human,P2RY12,1997,1997,478,antiplatelet,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,cgt-2168,Q9H244
442,1997,Class A (Rhodopsin),small molecule,clopidogrel,p2y12_human,P2RY12,1997,1997,1619,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,plavix,Q9H244
443,1989,Class A (Rhodopsin),small molecule,clozapine,drd1_human,DRD1,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
444,1989,Class A (Rhodopsin),small molecule,clozapine,drd2_human,DRD2,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
445,1989,Class A (Rhodopsin),small molecule,clozapine,drd4_human,DRD4,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917
446,1989,Class A (Rhodopsin),small molecule,clozapine,hrh1_human,HRH1,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
447,1989,Class A (Rhodopsin),small molecule,clozapine,hrh4_human,HRH4,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,Q9H3N8
448,1989,Class A (Rhodopsin),small molecule,clozapine,5ht1a_human,HTR1A,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908
449,1989,Class A (Rhodopsin),small molecule,clozapine,5ht2a_human,HTR2A,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
450,1989,Class A (Rhodopsin),small molecule,clozapine,5ht2c_human,HTR2C,1989,1989,NRDD120,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
451,0,Class A (Rhodopsin),small molecule,cocaine,drd3_human,DRD3,,-,NRDD123,local anesthetic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462
452,0,Class A (Rhodopsin),small molecule,cocaine,oprk_human,OPRK1,,-,NRDD123,local anesthetic,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145
453,2009,Class A (Rhodopsin),small molecule,codeine,oprd_human,OPRD1,2009,-,NRDD124,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143
454,2009,Class A (Rhodopsin),small molecule,codeine,oprk_human,OPRK1,2009,-,NRDD124,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145
455,2009,Class A (Rhodopsin),small molecule,codeine,oprm_human,OPRM1,2009,-,NRDD124,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
456,2005,Class A (Rhodopsin),small molecule,conivaptan,v1ar_human,AVPR1A,2005,2005,519,hyponatremia,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P37288
457,2005,Class A (Rhodopsin),small molecule,conivaptan,v2r_human,AVPR2,2005,2005,519,hyponatremia,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P30518
458,0,Class A (Rhodopsin),protein,corifollitropin alfa,fshr_human,FSHR,-,-,526,Fertility,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"corifollitropin alfa,elonva",P23945
459,1955,Class A (Rhodopsin),protein,corticotropin,acthr_human,MC2R,1955,1950,NRDD127,Diagnostic,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718
460,0,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr1_human,CRHR1,-,-,528,peritumoral brain edema,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",P34998
461,0,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr2_human,CRHR2,-,-,528,peritumoral brain edema,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",Q13324
462,1970,Class A (Rhodopsin),peptide,cosyntropin,acthr_human,MC2R,1970,1970,NRDD128,Diagnostic,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718
463,0,Class A (Rhodopsin),small molecule,cpb-307,s1pr1_human,S1PR1,-,-,MMAmar2016_0127,autoimmune diseases,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,cpb-307,P21453
464,0,Class A (Rhodopsin),small molecule,cr665,oprk_human,OPRK1,-,-,539,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,cr665,P41145
465,0,Class A (Rhodopsin),small molecule,cr845,oprk_human,OPRK1,-,-,540,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,cr845,P41145
466,0,Class A (Rhodopsin),small molecule,crth2 receptor antagonist,pd2r2_human,GPR44,-,-,546,Anti-Allergic,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,crth2 receptor antagonist,Q9Y5Y4
467,0,Class A (Rhodopsin),protein,ctce-9908,cxcr4_human,CXCR4,-,-,2376,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,ctce-9908,P61073
468,0,Class A (Rhodopsin),small molecule,ctp-499,aa1r_human,ADORA1,-,-,2268,diabetic nephropathy,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ctp-499,P30542
469,0,Class A (Rhodopsin),small molecule,ctp-499,aa2ar_human,ADORA2A,-,-,2268,diabetic nephropathy,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ctp-499,P29274
470,0,Class F (Frizzled),small molecule,cur-61414,smo_human,SMO,-,-,2823,Antineoplastic,Protein ,,in trial,Frizzled,GPCR;Frizzled,established,cur-61414,Q99835
471,0,Class A (Rhodopsin),small molecule,cvt-3619,aa1r_human,ADORA1,-,-,568,Antihyperlipidemic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cvt-3619,P30542
472,0,Class A (Rhodopsin),small molecule,cvt-6883,aa2br_human,ADORA2B,-,-,569,Anti-Asthmatic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,cvt-6883,P29275
473,0,Class A (Rhodopsin),small molecule,cyclizine,hrh1_human,HRH1,,-,NRDD130,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
474,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,1977,1977,NRDD131,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
475,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,1977,1977,2489,Muscle Relaxants,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclobenzaprine hydrochloride extended-release capsules,amrix",P28223
476,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2a_human,HTR2A,1977,1977,MMAmay2016_0082,fibromyalgia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tnx-102,P28223
477,1974,Class A (Rhodopsin),small molecule,cyclopentolate,acm1_human,CHRM1,1974,-,NRDD132,Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
478,0,Class A (Rhodopsin),small molecule,cycrimine,acm1_human,CHRM1,-,-,NRDD134,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
479,1961,Class A (Rhodopsin),small molecule,cyproheptadine,hrh1_human,HRH1,1961,1961,NRDD135,Anti-Allergic ; Appetite Stimulant,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
480,1961,Class A (Rhodopsin),small molecule,cyproheptadine,5ht2a_human,HTR2A,1961,1961,NRDD135,Anti-Allergic ; Appetite Stimulant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
481,0,Class B1 (Secretin),peptide,dac:glp-1,glp1r_human,GLP1R,-,-,590,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"dac:glp-1, cjc-1131",P43220
482,0,Class B1 (Secretin),peptide,dac:grf,ghrhr_human,GHRHR,-,-,591,hormone replacement,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,dac:grf,Q02643
483,1976,Class A (Rhodopsin),small molecule,danazol,gnrhr_human,GNRHR,-,1976,NRDD139,Antiendometriosis ; Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968
484,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,-,1976,NRDD139,Antiendometriosis ; Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88
485,1976,Class A (Rhodopsin),small molecule,danazol,gnrhr_human,GNRHR,-,1976,2297,diabetic macular edema,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,optina,P30968
486,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,-,1976,2297,diabetic macular edema,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,optina,Q96P88
487,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1a_human,ADRA1A,1990,1990,NRDD141,opthalmological,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
488,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1b_human,ADRA1B,1990,1990,NRDD141,opthalmological,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
489,1990,Class A (Rhodopsin),small molecule,dapiprazole,ada1d_human,ADRA1D,1990,1990,NRDD141,opthalmological,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
490,2004,Class A (Rhodopsin),small molecule,darifenacin,acm3_human,CHRM3,2004,2004,598,overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"darifenacin,enablex, emselex",P20309
491,0,Class A (Rhodopsin),small molecule,darusentan,ednra_human,EDNRA,-,-,599,Antihypertensive,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,darusentan,P25101
492,0,Class A (Rhodopsin),small molecule,debrisoquin,ada1a_human,ADRA1A,-,-,NRDD143,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
493,0,Class A (Rhodopsin),small molecule,debrisoquin,ada1b_human,ADRA1B,-,-,NRDD143,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
494,0,Class A (Rhodopsin),small molecule,debrisoquin,ada1d_human,ADRA1D,-,-,NRDD143,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
495,0,Class A (Rhodopsin),small molecule,debrisoquin,ada2a_human,ADRA2A,-,-,NRDD143,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
496,0,Class A (Rhodopsin),small molecule,debrisoquin,ada2b_human,ADRA2B,-,-,NRDD143,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089
497,0,Class A (Rhodopsin),small molecule,debrisoquin,ada2c_human,ADRA2C,-,-,NRDD143,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825
498,2008,Class A (Rhodopsin),small molecule,degarelix,gnrhr_human,GNRHR,20082009,2008,610,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,degarelix,P30968
499,2008,Class A (Rhodopsin),small molecule,degarelix,gnrr2_human,GNRHR2,20082009,2008,610,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,degarelix,Q96P88
500,0,Class A (Rhodopsin),small molecule,denufosol,p2ry2_human,P2RY2,-,-,614,cystic fibrosis,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"denufosol tetrasodium, ins37217 respiratory",P41231
501,1964,Class A (Rhodopsin),small molecule,desipramine,adrb1_human,ADRB1,1964,-,NRDD148,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
502,1964,Class A (Rhodopsin),small molecule,desipramine,adrb2_human,ADRB2,1964,-,NRDD148,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
503,1964,Class A (Rhodopsin),small molecule,desipramine,acm1_human,CHRM1,1964,-,NRDD148,Anti-depressant,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
504,1964,Class A (Rhodopsin),small molecule,desipramine,acm2_human,CHRM2,1964,-,NRDD148,Anti-depressant,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
505,1964,Class A (Rhodopsin),small molecule,desipramine,hrh1_human,HRH1,1964,-,NRDD148,Anti-depressant,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
506,2001,Class A (Rhodopsin),small molecule,desloratadine,hrh1_human,HRH1,2001,2001,620,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"desloratadine , clarinex",P35367
507,1978,Class A (Rhodopsin),peptide,desmopressin,v1ar_human,AVPR1A,-,1978,1537,incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P37288
508,1978,Class A (Rhodopsin),peptide,desmopressin,v1br_human,AVPR1B,-,1978,1537,incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P47901
509,1978,Class A (Rhodopsin),peptide,desmopressin,v2r_human,AVPR2,-,1978,1537,incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P30518
510,0,Class A (Rhodopsin),peptide,desmopressin (vasopressin),v1ar_human,AVPR1A,-,-,MMAjun2016_0039,Antidiuretic,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P37288
511,0,Class A (Rhodopsin),peptide,desmopressin (vasopressin),v1br_human,AVPR1B,-,-,MMAjun2016_0040,Antidiuretic,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P47901
512,0,Class A (Rhodopsin),peptide,desmopressin (vasopressin),v2r_human,AVPR2,-,-,MMAjun2016_0041,Antidiuretic,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"nocdurna,  desmopressin",P30518
513,2002,Class C (Glutamate) ,small molecule,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",gabr2_human,GABBR2,-,2002,MMAmay2016_0771,sleep disorders; narcolepsy,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,jzp-386,O75899
514,2002,Class C (Glutamate) ,small molecule,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",gabr1_human,GABBR1,-,2002,MMAmay2016_0773,sleep disorders; narcolepsy,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,jzp-386,Q9UBS5
515,0,Class A (Rhodopsin),small molecule,dexbrompheniramine,hrh1_human,HRH1,,-,NRDD153,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
516,0,Class A (Rhodopsin),small molecule,dexloxiglumide,cckar_human,CCKAR,-,-,626,motilitant,Peptide ,,in trial,Cholecystokinin receptors,GPCR;Rhodopsin,established,"dexloxiglumide, cr 2017",P32238
517,0,Class A (Rhodopsin),small molecule,dexmedetomidin,ada2a_human,ADRA2A,-,-,MMAapril2016_0144,Analgesics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"dex-in, intranasal dexmedetomidin",P08913
518,1999,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2a_human,ADRA2A,1999,-,NRDD155,Analgesics; Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
519,0,Class A (Rhodopsin),small molecule,dexpramipexole,drd2_human,DRD2,-,-,627,amyotrophic lateral sclerosis (ALS),Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P14416
520,0,Class A (Rhodopsin),small molecule,dexpramipexole,drd3_human,DRD3,-,-,627,amyotrophic lateral sclerosis (ALS),Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P35462
521,0,Class A (Rhodopsin),small molecule,dexpramipexole,drd4_human,DRD4,-,-,627,amyotrophic lateral sclerosis (ALS),Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"dexpramipexole, kns-760704",P21917
522,1989,Class A (Rhodopsin),small molecule,dezocine,oprk_human,OPRK1,-,-,NRDD157,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145
523,1989,Class A (Rhodopsin),small molecule,dezocine,oprm_human,OPRM1,-,-,NRDD157,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
524,0,Class A (Rhodopsin),small molecule,dg041,pe2r3_human,PTGER3,-,-,629,Platelet Aggregation Inhibitor,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,dg041,P43115
525,0,Class A (Rhodopsin),small molecule,dg3173,ssr1_human,SSTR1,-,-,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30872
526,0,Class A (Rhodopsin),small molecule,dg3173,ssr2_human,SSTR2,-,-,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30874
527,0,Class A (Rhodopsin),small molecule,dg3173,ssr4_human,SSTR4,-,-,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P31391
528,0,Class A (Rhodopsin),small molecule,dg3173,ssr5_human,SSTR5,-,-,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P35346
529,1950,Class A (Rhodopsin),small molecule,dicyclomine,acm1_human,CHRM1,1950,1950,NRDD162,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
530,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1b_human,HTR1B,1997,-,1214,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"map-0004, tempo migraine,levadex",P28222
531,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1d_human,HTR1D,1997,-,1214,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"map-0004, tempo migraine,levadex",P28221
532,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1b_human,HTR1B,1997,-,1356,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mt 300,P28222
533,1997,Class A (Rhodopsin),small molecule,dihydroergotamine,5ht1d_human,HTR1D,1997,-,1356,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mt 300,P28221
534,0,Class A (Rhodopsin),small molecule,dimenhydrinate,hrh1_human,HRH1,-,-,NRDD170,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
535,1981,Class A (Rhodopsin),small molecule,dinoprost tromethamine,pi2r_human,PTGIR,-,1981,NRDD171,Abortifacient,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43119
536,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r1_human,PTGER1,-,1977,NRDD172,Abortifacient,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P34995
537,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r2_human,PTGER2,-,1977,NRDD172,Abortifacient,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43116
538,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r3_human,PTGER3,-,1977,NRDD172,Abortifacient,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43115
539,1977,Class A (Rhodopsin),small molecule,dinoprostone,pe2r4_human,PTGER4,-,1977,NRDD172,Abortifacient,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P35408
540,1976,Class A (Rhodopsin),small molecule,diphemanil methylsulfate,acm3_human,CHRM3,-,1976,NRDD173,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
541,1946,Class A (Rhodopsin),small molecule,diphenhydramine,hrh1_human,HRH1,1946,1946,NRDD174,Anti-Allergic ; Hypnotics and sedatives; Antiemetics; Antipruritics; Antitussives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
542,1967,Class A (Rhodopsin),small molecule,diphenidol,acm1_human,CHRM1,,1967,NRDD175,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
543,1967,Class A (Rhodopsin),small molecule,diphenidol,acm2_human,CHRM2,,1967,NRDD175,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
544,1967,Class A (Rhodopsin),small molecule,diphenidol,acm3_human,CHRM3,,1967,NRDD175,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
545,0,Class A (Rhodopsin),small molecule,diphenoxylate,oprm_human,OPRM1,,-,NRDD176,Antidiuretic,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
546,0,Class A (Rhodopsin),small molecule,diphenylpyraline,hrh1_human,HRH1,,-,NRDD177,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
547,0,Class A (Rhodopsin),small molecule,dipivefrin,ada2a_human,ADRA2A,-,-,NRDD178,opthalmological,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
548,0,Class A (Rhodopsin),small molecule,diquafosol,p2ry2_human,P2RY2,-,-,644,opthalmological,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"diquafosol tetrasodium, ins365 ophthalmic,prolacria",P41231
549,1978,Class A (Rhodopsin),small molecule,dobutamine,adrb1_human,ADRB1,1978,1978,NRDD182,Cardiotonic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
550,0,Class A (Rhodopsin),small molecule,domperidone,drd2_human,DRD2,,-,NRDD184,Antiemetics,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
551,1991,Class A (Rhodopsin),small molecule,doxacurium,acm2_human,CHRM2,-,-,NRDD185,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
552,1991,Class A (Rhodopsin),small molecule,doxacurium chloride,acm2_human,CHRM2,-,1991,NRDD186,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
553,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1a_human,ADRA1A,1990,1990,NRDD187,Anticholesteremic ; Antihypertensive ; Vasodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
554,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1b_human,ADRA1B,1990,1990,NRDD187,Anticholesteremic ; Antihypertensive ; Vasodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
555,1990,Class A (Rhodopsin),small molecule,doxazosin,ada1d_human,ADRA1D,1990,1990,NRDD187,Anticholesteremic ; Antihypertensive ; Vasodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
556,1969,Class A (Rhodopsin),small molecule,doxepin,acm1_human,CHRM1,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P11229
557,1969,Class A (Rhodopsin),small molecule,doxepin,acm2_human,CHRM2,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08172
558,1969,Class A (Rhodopsin),small molecule,doxepin,acm3_human,CHRM3,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P20309
559,1969,Class A (Rhodopsin),small molecule,doxepin,acm4_human,CHRM4,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08173
560,1969,Class A (Rhodopsin),small molecule,doxepin,acm5_human,CHRM5,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,silenor (so-101),P08912
561,1969,Class A (Rhodopsin),small molecule,doxepin,hrh1_human,HRH1,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P35367
562,1969,Class A (Rhodopsin),small molecule,doxepin,hrh2_human,HRH2,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P25021
563,1969,Class A (Rhodopsin),small molecule,doxepin,5ht2a_human,HTR2A,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P28223
564,1969,Class A (Rhodopsin),small molecule,doxepin,5ht2b_human,HTR2B,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P41595
565,1969,Class A (Rhodopsin),small molecule,doxepin,5ht2c_human,HTR2C,1969,1969,1851,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,silenor (so-101),P28335
566,1948,Class A (Rhodopsin),small molecule,doxylamine,hrh1_human,HRH1,1948,1948,NRDD188,Anti-Allergic ; Antiemetics; Antitussive ; Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
567,1948,Class A (Rhodopsin),small molecule,doxylamine,hrh1_human,HRH1,1948,1948,MMAmay2016_0669,Antihistamine; for nausea and vomiting of pregnancy,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,diclectin + diclegis; doxylamine succinate + pyridoxine hydrochloride dr tablets,P35367
568,0,Class A (Rhodopsin),small molecule,"drm04, anticholinergic",acm3_human,CHRM3,-,-,MMAfeb2016_0095,hyperhidrosis,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"drm04, anticholinergic",P20309
569,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr1_human,CNR1,-,1985,437,Analgesics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"cat-310 , relivar",P21554
570,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr2_human,CNR2,-,1985,438,Analgesics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"cat-310,relivar",P34972
571,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr1_human,CNR1,-,1985,667,Appetite stimulant,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"dronabinol ,marinol",P21554
572,1985,Class A (Rhodopsin),small molecule,dronabinol,cnr2_human,CNR2,-,1985,667,Appetite stimulant,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"dronabinol ,marinol",P34972
573,2009,Class A (Rhodopsin),small molecule,dronedarone,ada1a_human,ADRA1A,2009,2009,NRDD190,Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
574,2009,Class A (Rhodopsin),small molecule,dronedarone,adrb1_human,ADRB1,2009,2009,NRDD190,Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
575,2009,Class A (Rhodopsin),small molecule,dronedarone,ada1a_human,ADRA1A,2009,2009,2270,Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dronedarone,P35348
576,2009,Class A (Rhodopsin),small molecule,dronedarone,adrb1_human,ADRB1,2009,2009,2270,Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dronedarone,P08588
577,1970,Class A (Rhodopsin),small molecule,droperidol,drd2_human,DRD2,1970,-,NRDD191,Adjuvants; Anesthesia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
578,2014,Class A (Rhodopsin),small molecule,droxidopa,ada1a_human,ADRA1A,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P35348
579,2014,Class A (Rhodopsin),small molecule,droxidopa,ada1b_human,ADRA1B,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P35368
580,2014,Class A (Rhodopsin),small molecule,droxidopa,ada1d_human,ADRA1D,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P25100
581,2014,Class A (Rhodopsin),small molecule,droxidopa,ada2a_human,ADRA2A,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P08913
582,2014,Class A (Rhodopsin),small molecule,droxidopa,ada2b_human,ADRA2B,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P18089
583,2014,Class A (Rhodopsin),small molecule,droxidopa,ada2c_human,ADRA2C,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P18825
584,2014,Class A (Rhodopsin),small molecule,droxidopa,adrb1_human,ADRB1,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P08588
585,2014,Class A (Rhodopsin),small molecule,droxidopa,adrb2_human,ADRB2,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P07550
586,2014,Class A (Rhodopsin),small molecule,droxidopa,adrb3_human,ADRB3,2014,2014,2272,orthostatic hypotension,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,droxidopa,P13945
587,0,Class A (Rhodopsin),peptide,dsc127,agtr1_human,AGTR1,-,-,2280,diabetic foot ulcers,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,dsc127,P30556
588,0,Class A (Rhodopsin),small molecule,ecopipam,drd1_human,DRD1,-,-,686,tourettes syndrome; pathological gambling,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ecopipam,P21728
589,0,Class B1 (Secretin),peptide,"efpeglenatide, hm11260c",glp1r_human,GLP1R,-,-,MMAmar2016_0245,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"efpeglenatide, hm11260c",P43220
590,2002,Class A (Rhodopsin),small molecule,eletriptan,5ht1d_human,HTR1D,2002,2002,1731,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,relpax,P28221
591,0,Class A (Rhodopsin),small molecule,elinogrel,p2y12_human,P2RY12,-,-,701,antiplatelet,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,established,"elinogrel, prt060128, adp receptor antagonist",Q9H244
592,0,Class B1 (Secretin),peptide,elsiglutide,glp2r_human,GLP2R,-,-,2464,Antidiuretic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1846,O95838
593,0,Class A (Rhodopsin),small molecule,eltoprazine,5ht1a_human,HTR1A,-,-,MMAmar2016_0086,adverse effects; dyskinesias,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eltoprazine,P08908
594,0,Class A (Rhodopsin),small molecule,eltoprazine,5ht1b_human,HTR1B,-,-,MMAmar2016_0087,adverse effects; dyskinesias,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eltoprazine,P28222
595,0,Class A (Rhodopsin),small molecule,ema401,agtr2_human,AGTR2,-,-,MMAmay2016_0377,peripheral neuropathic pain; post herpetic neuralgia,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ema401,P50052
596,1997,Class A (Rhodopsin),small molecule,emedastine,hrh1_human,HRH1,19971999,1997,NRDD199,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
597,0,Class A (Rhodopsin),peptide,ep-100,gnrhr_human,GNRHR,-,-,715,Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ep-100,P30968
598,0,Class A (Rhodopsin),peptide,ep-100,gnrr2_human,GNRHR2,-,-,715,Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ep-100,Q96P88
599,0,Class A (Rhodopsin),small molecule,ephedrine,ada1a_human,ADRA1A,,-,NRDD204,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
600,2003,Class A (Rhodopsin),small molecule,epinastine,hrh1_human,HRH1,2003,2003,719,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,epinastine,P35367
601,2003,Class A (Rhodopsin),small molecule,epinastine,hrh2_human,HRH2,2003,2003,719,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,epinastine,P25021
602,1976,Class A (Rhodopsin),small molecule,epinephrine,ada1a_human,ADRA1A,-,1976,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P35348
603,1976,Class A (Rhodopsin),small molecule,epinephrine,ada1b_human,ADRA1B,-,1976,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P35368
604,1976,Class A (Rhodopsin),small molecule,epinephrine,ada1d_human,ADRA1D,-,1976,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P25100
605,1976,Class A (Rhodopsin),small molecule,epinephrine,ada2a_human,ADRA2A,-,1976,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P08913
606,1976,Class A (Rhodopsin),small molecule,epinephrine,ada2b_human,ADRA2B,-,1976,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P18089
607,1976,Class A (Rhodopsin),small molecule,epinephrine,adrb1_human,ADRB1,-,1976,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P08588
608,1976,Class A (Rhodopsin),small molecule,epinephrine,adrb2_human,ADRB2,-,1976,2066,Anesthetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"transdermal lidocaine/epinephrine patch,lidosite",P07550
609,0,Class A (Rhodopsin),small molecule,eplivanserine,5ht2a_human,HTR2A,-,-,721,insomnia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"eplivanserine, sr 46349,ciltyri",P28223
610,0,Class A (Rhodopsin),small molecule,eplivanserine,5ht2c_human,HTR2C,-,-,721,insomnia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"eplivanserine, sr 46349,ciltyri",P28335
611,1995,Class A (Rhodopsin),small molecule,epoprostenol,pi2r_human,PTGIR,-,1995,NRDD206,Antihypertensive ; Platelet Aggregation Inhibitors,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,-,P43119
612,1997,Class A (Rhodopsin),small molecule,eprosartan,agtr1_human,AGTR1,1997,1997,NRDD207,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556
613,0,Class A (Rhodopsin),small molecule,ergoloid mesylate,ada1a_human,ADRA1A,-,-,NRDD209,Nootropic ; Vasodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
614,0,Class A (Rhodopsin),small molecule,ergoloid mesylate,ada2a_human,ADRA2A,-,-,NRDD209,Nootropic ; Vasodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
615,1960,Class A (Rhodopsin),small molecule,ergotamine,5ht1b_human,HTR1B,1960,-,NRDD210,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28222
616,1960,Class A (Rhodopsin),small molecule,ergotamine,5ht1d_human,HTR1D,1960,-,NRDD210,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28221
617,0,Class A (Rhodopsin),small molecule,esmirtazapine,ada2a_human,ADRA2A,-,-,732,insomnia; menopausal symptoms,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"esmirtazapine, org-4420",P08913
618,0,Class A (Rhodopsin),small molecule,esmirtazapine,5ht2a_human,HTR2A,-,-,732,insomnia; menopausal symptoms,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"esmirtazapine, org-4420",P28223
619,1986,Class A (Rhodopsin),small molecule,esmolol,adrb1_human,ADRB1,1986,1986,NRDD212,Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
620,0,Class C (Glutamate) ,peptide,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",casr_human,CASR,-,-,MMAapril2016_0047,parathyroid disorders,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",P41180
621,0,Class A (Rhodopsin),small molecule,ethopropazine,acm1_human,CHRM1,-,-,NRDD217,Antidyskinetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
622,0,Class A (Rhodopsin),small molecule,etilevodopa,drd1_human,DRD1,-,-,749,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21728
623,0,Class A (Rhodopsin),small molecule,etilevodopa,drd2_human,DRD2,-,-,749,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P14416
624,0,Class A (Rhodopsin),small molecule,etilevodopa,drd3_human,DRD3,-,-,749,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P35462
625,0,Class A (Rhodopsin),small molecule,etilevodopa,drd4_human,DRD4,-,-,749,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21917
626,0,Class A (Rhodopsin),small molecule,etilevodopa,drd5_human,DRD5,-,-,749,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"etilevodopa, tv-1203",P21918
627,1982,Class A (Rhodopsin),small molecule,etomidate,ada2b_human,ADRA2B,1982,1982,NRDD222,Anesthetics; Intravenous,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089
628,2005,Class B1 (Secretin),peptide,exenatide,glp1r_human,GLP1R,-,2005,769,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,exenatide,P43220
629,2005,Class B1 (Secretin),peptide,exenatide,glp1r_human,GLP1R,-,2005,1046,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,itca 650,P43220
630,0,Class B1 (Secretin),peptide,exendin (9-39) ,glp1r_human,GLP1R,-,-,MMAjun2016_0019,hypoglycemia,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,exendin (9-39) ,P43220
631,2005,Class B1 (Secretin),peptide,exendin-4,glp1r_human,GLP1R,20052006,-,1572,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,pc-dac:exendin-4,P43220
632,1986,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,1986,1986,929,acid reducer,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"hzt-501,  ibuprofen + famotidine,duexa",P25021
633,1986,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,1986,1986,929,gastric ulcer and gastroesophageal reflux,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"hzt-501,  ibuprofen + famotidine,duexa",P25021
634,1986,Class A (Rhodopsin),small molecule,famotidine,hrh2_human,HRH2,1986,1986,1539,acid reducer,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,ox17,P25021
635,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm1_human,GRM1,-,-,MMAmar2016_0121,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q13255
636,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm5_human,GRM5,-,-,MMAmar2016_0122,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,nfc-1,P41594
637,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm3_human,GRM3,-,-,MMAmar2016_0123,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14832
638,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm7_human,GRM7,-,-,MMAmar2016_0124,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14831
639,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm2_human,GRM2,-,-,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14416
640,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm4_human,GRM4,-,-,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14833
641,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm6_human,GRM6,-,-,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O15303
642,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm8_human,GRM8,-,-,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O00222
643,0,Class A (Rhodopsin),peptide,felypressin,v1ar_human,AVPR1A,-,-,NRDD226,Hemostatic s; Vasoconstricting,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P37288
644,0,Class A (Rhodopsin),small molecule,fenfluramine,5ht2b_human,HTR2B,,-,MMAmar2016_0273,epilepsy; Dravet's syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zx008, brabafen, low-dose fenfluramine",P41595
645,0,Class A (Rhodopsin),small molecule,fenfluramine,5ht2c_human,HTR2C,,-,MMAmar2016_0274,epilepsy; Dravet's syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zx008, brabafen, low-dose fenfluramine",P28335
646,1997,Class A (Rhodopsin),small molecule,fenoldopam,drd1_human,DRD1,1997,1997,778,Antihypertensive,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"fenoldopam mesylate, skf-82526,corlopam",P21728
647,1997,Class A (Rhodopsin),small molecule,fenoldopam,drd5_human,DRD5,1997,1997,778,Antihypertensive,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"fenoldopam mesylate, skf-82526,corlopam",P21918
648,0,Class A (Rhodopsin),small molecule,fenoterol,adrb2_human,ADRB2,,-,NRDD229,Bronchodilator ; Tocolytic,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
649,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,51,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ad 923,P41143
650,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,51,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ad 923,P35372
651,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,69,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,aerolef,P41143
652,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,69,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,aerolef,P35372
653,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,259,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,at3022,P41143
654,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,259,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,at3022,P35372
655,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,303,adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"az-003, staccato fentanyl",P41143
656,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,303,adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"az-003, staccato fentanyl",P35372
657,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema fentanyl,onsolis, breakyl",P41143
658,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"bema fentanyl,onsolis, breakyl",P35372
659,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,394,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,buccal fentanyl,P41143
660,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,394,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,buccal fentanyl,P35372
661,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,775,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"febt,fentora, effentora",P41143
662,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,775,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"febt,fentora, effentora",P35372
663,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,780,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl (sublingual), kw-2246,abstral, rapinyl",P41143
664,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,780,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl (sublingual), kw-2246,abstral, rapinyl",P35372
665,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,781,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl citrate,pecfent, nasalfent",P41143
666,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,781,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl citrate,pecfent, nasalfent",P35372
667,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,782,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl lauriad, ba-041",P41143
668,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,782,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl lauriad, ba-041",P35372
669,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,783,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl mdts,P41143
670,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,783,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl mdts,P35372
671,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,784,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl spray, intranasal,instanyl",P41143
672,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,784,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl spray, intranasal,instanyl",P35372
673,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,785,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl sublingual spray,P41143
674,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,785,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl sublingual spray,P35372
675,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,786,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl taifun,P41143
676,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,786,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,fentanyl taifun,P35372
677,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,787,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl transdermal system,duragesic, ionsys",P41143
678,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,787,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"fentanyl transdermal system,duragesic, ionsys",P35372
679,1968,Class A (Rhodopsin),small molecule,fentanyl,oprd_human,OPRD1,1968,-,2069,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"transmucosal fentanyl,actiq",P41143
680,1968,Class A (Rhodopsin),small molecule,fentanyl,oprm_human,OPRM1,1968,-,2069,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"transmucosal fentanyl,actiq",P35372
681,2007,Class A (Rhodopsin),small molecule,fesoterodine,acm3_human,CHRM3,20072008,2008,788,overactive bladder syndrome,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"fesoterodine fumarate, spm 907,toviaz",P20309
682,1996,Class A (Rhodopsin),small molecule,fexofenadine,hrh1_human,HRH1,1996,1996,789,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P35367
683,2010,Class A (Rhodopsin),small molecule,fingolimod,s1pr1_human,S1PR1,2010,2010,794,Multiple Sclerosis,Lipid ,,approved,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,"fingolimod, fty 720,gilenia, gilenya",P21453
684,0,Class A (Rhodopsin),small molecule,fipamezole,ada2a_human,ADRA2A,-,-,795,Antiparkinson,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole , jp-1730",P08913
685,0,Class A (Rhodopsin),small molecule,fipamezole,ada2b_human,ADRA2B,-,-,796,Antiparkinson,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole, jp-1730",P18089
686,0,Class A (Rhodopsin),small molecule,fipamezole,ada2c_human,ADRA2C,-,-,796,Antiparkinson,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"fipamezole, jp-1730",P18825
687,0,Class A (Rhodopsin),small molecule,fk352b,aa1r_human,ADORA1,-,-,799,Antihypertensive,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,fk352b,P30542
688,1970,Class A (Rhodopsin),small molecule,flavoxate,acm1_human,CHRM1,1970,1970,NRDD230,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
689,1970,Class A (Rhodopsin),small molecule,flavoxate,acm2_human,CHRM2,1970,1970,NRDD230,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
690,2015,Class A (Rhodopsin),small molecule,flibanserin,5ht1a_human,HTR1A,2015,2015,801,sexual dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flibanserin,P08908
691,2015,Class A (Rhodopsin),small molecule,flibanserin,5ht2a_human,HTR2A,2015,2015,801,sexual dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flibanserin,P28223
692,0,Class A (Rhodopsin),small molecule,flunarizine,hrh1_human,HRH1,-,-,NRDD236,Anticonvulsants; Vasodilator,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
693,1987,Class A (Rhodopsin),small molecule,fluoxetine,5ht2a_human,HTR2A,1987,1987,1440,autism,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"npl-2008, fluoxetine",P28223
694,0,Class A (Rhodopsin),small molecule,flupenthixol,drd1_human,DRD1,-,-,NRDD240,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
695,0,Class A (Rhodopsin),small molecule,flupenthixol,drd2_human,DRD2,-,-,NRDD240,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
696,1959,Class A (Rhodopsin),small molecule,fluphenazine,drd1_human,DRD1,1959,1959,NRDD241,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
697,1959,Class A (Rhodopsin),small molecule,fluphenazine,drd2_human,DRD2,1959,1959,NRDD241,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
698,0,Class A (Rhodopsin),small molecule,fluspirilene,drd2_human,DRD2,,-,NRDD244,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
699,0,Class A (Rhodopsin),protein,follitropin alfa,fshr_human,FSHR,-,-,MMAmay2016_0738,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"bemfola, afolia recombinant follicle stimulating hormone",P23945
700,0,Class A (Rhodopsin),protein,follitropin alpha,fshr_human,FSHR,-,-,814,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"follitropin alpha ,gonal-f",P23945
701,1997,Class A (Rhodopsin),protein,follitropin beta,fshr_human,FSHR,-,-,NRDD246,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945
702,0,Class A (Rhodopsin),small molecule,forasartan,agtr1_human,AGTR1,-,-,NRDD248,Antihypertensive,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556
703,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,MMAmay2016_0044,Anti-Asthmatic ; COPD,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,aclidinium,P07550
704,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,2275,Appetite stimulant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,apd209,P07550
705,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,397,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"budesonide + formoterol,symbicort",P07550
706,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,481,Anti-Asthmatic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"chf-1535, beclomethasone dipropionate + formoterol fumarate",P07550
707,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,815,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"formoterol ,foradil",P07550
708,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,816,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"formoterol fumarate,perforomist",P07550
709,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,1215,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,map-0005,P07550
710,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,1325,Anti-Asthmatic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"mometasone furoate + formoterol fumarate dihydrate,dulera",P07550
711,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,1681,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"pt003, glycopyrrolate + formoterol inhalation aerosol",P07550
712,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,1682,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"pt005, formoterol fumarate hydrofluoroalkane metered dose inhaler",P07550
713,2001,Class A (Rhodopsin),small molecule,formoterol,adrb2_human,ADRB2,2001,2001,1861,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"skyepharma,flutiform",P07550
714,2001,Class A (Rhodopsin),small molecule,frovatriptan,5ht1b_human,HTR1B,2001,2001,823,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"frovatriptan,frovelan, frova",P28222
715,2001,Class A (Rhodopsin),small molecule,frovatriptan,5ht1d_human,HTR1D,2001,2001,823,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"frovatriptan,frovelan, frova",P28221
716,1997,Class A (Rhodopsin),protein,fsh-gex,fshr_human,FSHR,1997,-,825,Fertility,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,fsh-gex,P23945
717,0,Class A (Rhodopsin),small molecule,fx125l,ccr1_human,CCR1,-,-,831,Anti-Asthmatic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P32246
718,0,Class A (Rhodopsin),small molecule,fx125l,cxcr1_human,CXCR1,-,-,831,Anti-Asthmatic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P25024
719,0,Class A (Rhodopsin),small molecule,fx125l,cxcr2_human,CXCR2,-,-,831,Anti-Asthmatic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,fx125l,P25025
720,0,Class A (Rhodopsin),small molecule,fx125l,cxcr4_human,CXCR4,-,-,831,Anti-Asthmatic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,fx125l,P61073
721,2002,Class C (Glutamate) ,small molecule,gamma hydroxybutyric acid,gabr1_human,GABBR1,2002,-,1871,Hypnotics and Sedatives,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,sodium oxybate,Q9UBS5
722,2002,Class C (Glutamate) ,small molecule,gamma hydroxybutyric acid,gabr2_human,GABBR2,2002,-,1871,Hypnotics and Sedatives,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,sodium oxybate,O75899
723,0,Class A (Rhodopsin),small molecule,gc021109,p2ry6_human,P2RY6,-,-,MMAfeb2016_0055,Alzheimer's disease,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,gc021109,Q15077
724,0,Class A (Rhodopsin),small molecule,gepirone,5ht1a_human,HTR1A,-,-,848,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gepirone,P08908
725,0,Class B1 (Secretin),peptide,glp,glp1r_human,GLP1R,-,-,699,Appetite suppressant,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,eligen pyy-3-36 + glp-1,P43220
726,0,Class B1 (Secretin),unknown,glp1 agonist ,glp1r_human,GLP1R,-,-,2155,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,viaderm-glp1 agonist,P43220
727,0,Class A (Rhodopsin),small molecule,glpg0974,ffar2_human,FFAR2,-,-,MMAmay2016_0156,Anti-inflammatory ; neutrophil driven inflammation; ulcerative colitis,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,glpg0974,O15552
728,0,Class A (Rhodopsin),small molecule,glpg1205,gpr84_human,GPR84,-,-,MMAapril2016_0323,for ulcerative colitis; IBS,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,glpg1205,Q9NQS5
729,1960,Class B1 (Secretin),peptide,glucagon,glr_human,GCGR,1960,1960,2458,for prevention of hypoglycemia,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,dio-901,P47871
730,1960,Class B1 (Secretin),peptide,glucagon,glr_human,GCGR,1960,1960,MMAmar2016_0239,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,zp-glucagon,P47871
731,1960,Class B1 (Secretin),peptide,glucagon recombinant,glr_human,GCGR,-,-,NRDD256,Antihypoglycemic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,P47871
732,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,19612012,1961,MMAmay2016_0378,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ep-101,P11229
733,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,19612012,1961,864,Antineoplastic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"glycopyrrolate, fhpc-02,cuvposa",P11229
734,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,19612012,1961,1680,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,pt001,P11229
735,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm1_human,CHRM1,19612012,1961,1681,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"pt003, glycopyrrolate + formoterol inhalation aerosol",P11229
736,0,Class A (Rhodopsin),small molecule,glycopyrronium,acm1_human,CHRM1,-,-,1457,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"nva237, inhaled glycopyrronium bromide",P11229
737,0,Class A (Rhodopsin),small molecule,glycopyrronium bromide,adrb2_human,ADRB2,-,-,1702,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"qva149, glycopyrronium bromide + i/",P07550
738,1982,Class A (Rhodopsin),small molecule,gonadorelin,gnrhr_human,GNRHR,-,1982,NRDD259,Fertility,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968
739,1982,Class A (Rhodopsin),small molecule,gonadorelin,gnrr2_human,GNRHR2,-,1982,NRDD259,Fertility,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88
740,0,Class A (Rhodopsin),protein,gonadotropin,lshr_human,LHCGR,-,-,1904,stroke,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"stem,ntx-265",P22888
741,1989,Class A (Rhodopsin),peptide,goserelin,lshr_human,LHCGR,1989,1989,NRDD260,Antineoplastic s; Hormonal,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888
742,0,Class A (Rhodopsin),small molecule,gsk-1004723,hrh1_human,HRH1,-,-,878,Anti-Allergic,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,gsk-1004723,P35367
743,0,Class A (Rhodopsin),small molecule,gsk-1004723,hrh3_human,HRH3,-,-,878,Anti-Allergic,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,gsk-1004723,Q9Y5N1
744,0,Class A (Rhodopsin),small molecule,gsk-961081,adrb2_human,ADRB2,-,-,881,Bronchodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,gsk-961081,P07550
745,0,Class A (Rhodopsin),small molecule,gsk-961081,acm3_human,CHRM3,-,-,881,Bronchodilator,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,gsk-961081,P20309
746,0,Class B1 (Secretin),protein,gtp-010,glp1r_human,GLP1R,-,-,885,irritable bowel syndrome,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,gtp-010,P43220
747,0,Class A (Rhodopsin),peptide,gtp-200,ghsr_human,GHSR,-,-,886,Appetite stimulant,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,gtp-200,Q92847
748,0,Class A (Rhodopsin),small molecule,gtx-758,lshr_human,LHCGR,-,-,888,Antineoplastic,Protein ,,in trial,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,gtx-758,P22888
749,1982,Class A (Rhodopsin),small molecule,guanabenz,ada2a_human,ADRA2A,1982,1982,NRDD261,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
750,1986,Class A (Rhodopsin),small molecule,guanfacine,ada2a_human,ADRA2A,1986,1986,889,ADHD,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"guanfacine, spd 503,intuniv",P08913
751,0,Class A (Rhodopsin),small molecule,gw642444,adrb2_human,ADRB2,-,-,892,Bronchodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,gw642444,P07550
752,1967,Class A (Rhodopsin),small molecule,haloperidol,drd2_human,DRD2,1967,1967,NRDD266,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
753,0,Class A (Rhodopsin),small molecule,histamine,hrh2_human,HRH2,-,-,463,cytorprotective  during cancer treatment,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,ceplene,P25021
754,1991,Class A (Rhodopsin),small molecule,histrelin,gnrhr_human,GNRHR,1991,1991,2177,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"vp 002, histrelin implant,vantas, supprelin",P30968
755,1991,Class A (Rhodopsin),small molecule,histrelin,gnrr2_human,GNRHR2,1991,1991,2177,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"vp 002, histrelin implant,vantas, supprelin",Q96P88
756,0,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm1_human,CHRM1,-,-,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
757,0,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm2_human,CHRM2,-,-,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
758,0,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm3_human,CHRM3,-,-,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
759,0,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm4_human,CHRM4,-,-,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
760,0,Class A (Rhodopsin),small molecule,homatropine methylbromide,acm5_human,CHRM5,-,-,NRDD271,GI Anti-Ulcer ; Antimuscarinics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
761,0,Class A (Rhodopsin),protein,homspera,nk1r_human,TACR1,-,-,1907,idiopathic pulmonary fibrosis,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"substance p,homspera, radilex, viprovex",P25103
762,0,Class B1 (Secretin),peptide,h-pth 1-34,pth1r_human,PTH1R,2015,-,2153,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,viaderm hpth 1-34,Q03431
763,0,Class B1 (Secretin),peptide,h-pth 1-34,pth2r_human,PTH2R,2015,-,2153,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,viaderm hpth 1-34,P49190
764,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,2013,-,MMAmay2016_0753,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone bitartrate with acetaminophen,P35372
765,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,2013,-,MMAmay2016_0754,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone bitartrate with acetaminophen,P41143
766,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,2013,-,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41143
767,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,2013,-,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P35372
768,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,2013,-,MMAmar2016_0081,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"s-718632, extended release hydrocodone",P35372
769,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,2013,-,MMAmar2016_0082,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"s-718632, extended release hydrocodone",P41143
770,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprd_human,OPRD1,2013,-,2254,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"zx002, hydrocodone bitartrate",P41143
771,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprm_human,OPRM1,2013,-,2254,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"zx002, hydrocodone bitartrate",P35372
772,2014,Class A (Rhodopsin),small molecule,hydrocodone bitartrate,oprm_human,OPRM1,-,-,MMAmar2016_0009,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"hysingla er, hydrocodone bitartrate extended release",P35372
773,2014,Class A (Rhodopsin),small molecule,hydrocodone bitartrate,oprd_human,OPRD1,-,-,MMAmar2016_0010,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"hysingla er, hydrocodone bitartrate extended release",P41143
774,0,Class A (Rhodopsin),small molecule,hydrocodone deterx,oprm_human,OPRM1,-,-,MMAapril2016_0192,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone deterx,P35372
775,0,Class A (Rhodopsin),small molecule,hydrocodone deterx,oprd_human,OPRD1,-,-,MMAapril2016_0193,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone deterx,P41143
776,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprm_human,OPRM1,1984,-,MMAapril2016_0260,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P35372
777,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprd_human,OPRD1,1984,-,MMAapril2016_0261,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P41143
778,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprk_human,OPRK1,1984,-,MMAapril2016_0262,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ltx-04,  hydromorphone hcl",P41145
779,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprd_human,OPRD1,1984,-,1422,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P41143
780,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprk_human,OPRK1,1984,-,1422,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P41145
781,1984,Class A (Rhodopsin),small molecule,hydromorphone,oprm_human,OPRM1,1984,-,1422,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nmed-1077,exalgo, jurnista, dilaudid",P35372
782,1956,Class A (Rhodopsin),small molecule,hydroxyzine,hrh1_human,HRH1,1956,1956,NRDD275,Antipruritics; Anxiolytics sedatives and hypnotics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
783,2008,Class A (Rhodopsin),small molecule,icatibant,bkrb2_human,BDKRB2,20082011,2011,797,hereditary angioedema,Peptide ,,approved,Bradykinin receptors,GPCR;Rhodopsin,established,"firazyr, icatibant, je049",P30411
784,0,Class A (Rhodopsin),small molecule,iferanserin,5ht2a_human,HTR2A,-,-,942,Antihemorrhoidal,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,iferanserin ointment,P28223
785,0,Class A (Rhodopsin),small molecule,iferanserin,5ht2a_human,HTR2A,-,-,MMAmay2016_0414,Antihemorrhoidal,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iferanserin ointment, ven 309",P28223
786,2009,Class A (Rhodopsin),small molecule,iloperidone,ada1a_human,ADRA1A,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35348
787,2009,Class A (Rhodopsin),small molecule,iloperidone,ada2c_human,ADRA2C,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P18825
788,2009,Class A (Rhodopsin),small molecule,iloperidone,drd1_human,DRD1,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P21728
789,2009,Class A (Rhodopsin),small molecule,iloperidone,drd2_human,DRD2,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P14416
790,2009,Class A (Rhodopsin),small molecule,iloperidone,drd3_human,DRD3,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35462
791,2009,Class A (Rhodopsin),small molecule,iloperidone,hrh1_human,HRH1,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P35367
792,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht1a_human,HTR1A,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P08908
793,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht2a_human,HTR2A,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P28223
794,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht6r_human,HTR6,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P50406
795,2009,Class A (Rhodopsin),small molecule,iloperidone,5ht7r_human,HTR7,2009,2009,951,Antipsychotic ; atypical,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iloperidone,fanapt, fiapta, zomaril",P34969
796,2004,Class A (Rhodopsin),small molecule,iloprost,pe2r1_human,PTGER1,2004,2004,952,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",P34995
797,2004,Class A (Rhodopsin),small molecule,iloprost,pi2r_human,PTGIR,2004,2004,952,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",P43119
798,0,Class A (Rhodopsin),small molecule,incb3284,ccr2_human,CCR2,-,-,966,Anti-inflammatory ; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,incb3284,P41597
799,2009,Class A (Rhodopsin),small molecule,indacaterol,adrb2_human,ADRB2,20092011,2011,969,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,indacaterol,P07550
800,2009,Class A (Rhodopsin),small molecule,indacaterol,acm1_human,CHRM1,20092011,2011,1702,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"qva149, glycopyrronium bromide + indacaterol",P11229
801,0,Class A (Rhodopsin),small molecule,ino-8875,aa1r_human,ADORA1,-,-,985,Antiglaucomic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,ino-8875,P30542
802,0,Class A (Rhodopsin),small molecule,ins37217,p2ry2_human,P2RY2,-,-,990,rhegmatogenous retinal detachment,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,ins37217,P41231
803,0,Class A (Rhodopsin),small molecule,ins37217,p2ry2_human,P2RY2,-,-,991,cystic fibrosis; perennial allergic rhinitis,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,ins37217 intranasal,P41231
804,0,Class A (Rhodopsin),unknown,ins-50589,p2y12_human,P2RY12,-,-,992,antithrombotic,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,established,ins-50589,Q9H244
805,0,Class A (Rhodopsin),small molecule,int-767,gpbar_human,GPBAR1,-,-,MMAapril2016_0196,Treatment of liver fibrosis,Steroid ,,in trial,Bile acid receptors,GPCR;Rhodopsin,not established,int-767,Q8TDU6
806,0,Class A (Rhodopsin),small molecule,"inv102, nadolol",adrb2_human,ADRB2,-,-,MMAmay2016_0225,for inflammatory lung disease,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"inv102, nadolol",P07550
807,0,Class F (Frizzled),small molecule,ipi-926,smo_human,SMO,-,-,2824,Antineoplastic,Protein ,,in trial,Frizzled,GPCR;Frizzled,established,ipi-926,Q99835
808,1986,Class A (Rhodopsin),small molecule,ipratropium,acm1_human,CHRM1,1986,1986,1021,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P11229
809,1986,Class A (Rhodopsin),small molecule,ipratropium,acm2_human,CHRM2,1986,1986,1021,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P08172
810,1997,Class A (Rhodopsin),small molecule,irbesartan,agtr1_human,AGTR1,1997,1997,1023,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"irbesartan,avapro, irbetan",P30556
811,0,Class B1 (Secretin),antisense oligo,isis 325568,glr_human,GCGR,-,-,1030,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,isis 325568,P47871
812,0,Class A (Rhodopsin),small molecule,isoetharine,adrb1_human,ADRB1,-,-,NRDD290,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
813,0,Class A (Rhodopsin),small molecule,isometheptene mucate,ada1a_human,ADRA1A,-,-,MMAmar2016_0022,Anti-migraine,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tnx-201, single isomer isometheptene, imh",P35348
814,0,Class A (Rhodopsin),small molecule,isoproterenol,adrb1_human,ADRB1,-,-,NRDD293,Bronchodilator ; Cardiotonic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
815,0,Class A (Rhodopsin),small molecule,isoproterenol,adrb2_human,ADRB2,-,-,NRDD293,Bronchodilator ; Cardiotonic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
816,0,Class A (Rhodopsin),small molecule,istradefylline,aa2ar_human,ADORA2A,,-,1043,Antiparkinson,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"istradefylline, kw-6002",P29274
817,0,Class A (Rhodopsin),small molecule,iti-007,drd2_human,DRD2,-,-,1048,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"iti-007, iti-722",P14416
818,0,Class A (Rhodopsin),small molecule,iti-007,5ht2a_human,HTR2A,-,-,1048,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"iti-007, iti-722",P28223
819,0,Class A (Rhodopsin),small molecule,itopride,drd2_human,DRD2,-,-,1049,motilitant,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"itopride,itax",P14416
820,1992,Class F (Frizzled),small molecule,itraconazole,smo_human,SMO,-,1992,MMAmar2016_0140,Antineoplastic,Protein ,,approved,Frizzled,GPCR;Frizzled,established,suba-itraconazole,Q99835
821,0,Class A (Rhodopsin),small molecule,jnj-37822681,drd2_human,DRD2,-,-,1054,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,jnj-37822681,P14416
822,0,Class A (Rhodopsin),dna plasmid,jvs-100,cxcr4_human,CXCR4,-,-,1056,cardioprotectant,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,jvs-100,P61073
823,0,Class C (Glutamate) ,peptide,kai-4169,casr_human,CASR,-,-,2328,hyperparathyroidism,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,kai-4169,P41180
824,1999,Class A (Rhodopsin),small molecule,ketotifen,hrh1_human,HRH1,1999,1999,1074,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"ketotifen fumarate,zaditen, zaditor",P35367
825,0,Class A (Rhodopsin),small molecule,kn38-7271,cnr1_human,CNR1,-,-,1076,neuroprotectant,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,kn38-7271,P21554
826,0,Class A (Rhodopsin),small molecule,kn38-7271,cnr2_human,CNR2,-,-,1076,neuroprotectant,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,kn38-7271,P34972
827,0,Class A (Rhodopsin),small molecule,kos-2187,mtlr_human,MLNR,-,-,1078,gastrointestinal motility disorders,Peptide ,,in trial,Motilin receptors,GPCR;Rhodopsin,not established,kos-2187,O43193
828,0,Class A (Rhodopsin),small molecule,kp201,oprd_human,OPRD1,-,-,1079,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P41143
829,0,Class A (Rhodopsin),small molecule,kp201,oprk_human,OPRK1,-,-,1079,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P41145
830,0,Class A (Rhodopsin),small molecule,kp201,oprm_human,OPRM1,-,-,1079,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,kp201 (prodrug of hydrocodone),P35372
831,0,Class A (Rhodopsin),small molecule,kuc-7483,adrb3_human,ADRB3,-,-,1082,overactive bladder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,kuc-7483,P13945
832,1984,Class A (Rhodopsin),small molecule,labetalol,ada1a_human,ADRA1A,1984,1984,NRDD296,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
833,1984,Class A (Rhodopsin),small molecule,labetalol,ada1b_human,ADRA1B,1984,1984,NRDD296,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
834,1984,Class A (Rhodopsin),small molecule,labetalol,adrb1_human,ADRB1,1984,1984,NRDD296,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
835,1984,Class A (Rhodopsin),small molecule,labetalol,adrb2_human,ADRB2,1984,1984,NRDD296,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
836,2001,Class A (Rhodopsin),small molecule,lanreotide,ssr1_human,SSTR1,20012007,2007,1088,acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"lanreotide ,somatuline autogel, somatuline depot",P30872
837,2001,Class A (Rhodopsin),small molecule,lanreotide,ssr5_human,SSTR5,20012007,2007,1089,acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"lanreotide,somatuline autogel, somatuline depot",P35346
838,0,Class A (Rhodopsin),small molecule,laropiprant,pd2r_human,PTGDR,-,-,1300,for counteracting niacin-induced flushing,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Q13258
839,0,Class A (Rhodopsin),small molecule,laropiprant,pd2r_human,PTGDR,-,-,1301,for counteracting niacin-induced flushing,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",Q13258
840,0,Class A (Rhodopsin),small molecule,las-100977,adrb2_human,ADRB2,-,-,1092,Bronchodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,las-100977,P07550
841,0,Class A (Rhodopsin),small molecule,lasmiditan,5ht1f_human,HTR1F,-,-,1093,Anti-migraine,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lasmiditan, col-144, ly-573144",P30939
842,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1996,1996,MMAmay2016_0719,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"eye-d, controlled-release latanoprost insert",P43088
843,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1996,1996,1095,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P43088
844,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1996,1996,1096,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost, (sustained release, punctal plug delivery system)",P43088
845,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1996,1996,1097,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"latanoprost,xalatan fixed flow device",P43088
846,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1996,1996,1436,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"nova21027,catioprost",P43088
847,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1996,1996,MMAfeb2016_0059,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"roclatan, rhopressa + latanoprost",P43088
848,1996,Class A (Rhodopsin),small molecule,latanoprost,pf2r_human,PTGFR,1996,1996,1918,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,sustained release latanoprost,P43088
849,0,Class C (Glutamate) ,small molecule,lesogaberan,gabr1_human,GABBR1,-,-,1108,gastrointestinal reflux disease,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,"lesogaberan, azd-3355",Q9UBS5
850,0,Class C (Glutamate) ,small molecule,lesogaberan,gabr2_human,GABBR2,-,-,1108,gastrointestinal reflux disease,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,"lesogaberan, azd-3355",O75899
851,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1985,1985,697,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,eligard,P30968
852,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1985,1985,1113,Antineoplastic ; endometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,leuprolide,P30968
853,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1985,1985,1114,Antineoplastic ; endometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"leuprolide acetate, tap-144 sr",P30968
854,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1985,1985,1115,Antineoplastic ; endometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,leupromaxx,P30968
855,1985,Class A (Rhodopsin),peptide,leuprolide,gnrhr_human,GNRHR,1985,1985,1250,Alzheimer's disease,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,memryte,P30968
856,0,Class A (Rhodopsin),small molecule,levallorphan,oprm_human,OPRM1,,-,NRDD298,Opiate Antagonists,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
857,1985,Class A (Rhodopsin),small molecule,levobunolol,adrb1_human,ADRB1,1985,1985,NRDD299,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
858,1985,Class A (Rhodopsin),small molecule,levobunolol,adrb2_human,ADRB2,1985,1985,NRDD299,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
859,1993,Class A (Rhodopsin),small molecule,levocabastine,hrh1_human,HRH1,1993,1993,NRDD301,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
860,0,Class A (Rhodopsin),small molecule,levocetirizine,hrh1_human,HRH1,-,-,1118,Anti-Allergic,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"levocetirizine dihydrochloride,xusal, xyzal",P35367
861,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,1993,1970,646,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21728
862,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,1993,1970,646,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P14416
863,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,1993,1970,646,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P35462
864,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,1993,1970,646,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21917
865,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,1993,1970,646,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,dm-1992,P21918
866,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,1993,1970,712,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21728
867,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,1993,1970,712,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P14416
868,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,1993,1970,712,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P35462
869,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,1993,1970,712,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21917
870,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,1993,1970,712,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"entacapone/levodopa/carbidopa,stalevo",P21918
871,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,1993,1970,1119,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21728
872,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,1993,1970,1119,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P14416
873,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,1993,1970,1119,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P35462
874,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,1993,1970,1119,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21917
875,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,1993,1970,1119,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"levodopa + carbidopa,duodopa",P21918
876,1993,Class A (Rhodopsin),small molecule,levodopa,drd2_human,DRD2,1993,1970,MMAmay2016_0101,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P14416
877,1993,Class A (Rhodopsin),small molecule,levodopa,drd1_human,DRD1,1993,1970,MMAmay2016_0102,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21728
878,1993,Class A (Rhodopsin),small molecule,levodopa,drd4_human,DRD4,1993,1970,MMAmay2016_0103,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21917
879,1993,Class A (Rhodopsin),small molecule,levodopa,drd5_human,DRD5,1993,1970,MMAmay2016_0104,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P21918
880,1993,Class A (Rhodopsin),small molecule,levodopa,drd3_human,DRD3,1993,1970,MMAmay2016_0105,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"nd0612,  levodopa/carbidopa subcutaneous patch",P35462
881,1993,Class A (Rhodopsin),small molecule,levomethadyl acetate,oprm_human,OPRM1,1993,1993,NRDD302,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
882,1953,Class A (Rhodopsin),small molecule,levorphanol,oprm_human,OPRM1,1953,-,NRDD303,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
883,0,Class B1 (Secretin),small molecule,lgd-6972,glr_human,GCGR,-,-,MMAmay2016_0453,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,lgd-6972,P47871
884,2009,Class B1 (Secretin),protein,liraglutide,glp1r_human,GLP1R,20092010,-,MMAmay2016_0808,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,"ideglira,  insulin degludec + liraglutide,  nn-9068",P43220
885,2009,Class B1 (Secretin),protein,liraglutide,glp1r_human,GLP1R,20092010,-,1154,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,liraglutide,P43220
886,2010,Class B1 (Secretin),peptide,liraglutide recombinant,glp1r_human,GLP1R,-,2010,NRDD305,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,P43220
887,2007,Class A (Rhodopsin),small molecule,lisdexamfetamine,ada1a_human,ADRA1A,2007,2007,NRDD306,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
888,2007,Class A (Rhodopsin),small molecule,lisdexamfetamine,ada1b_human,ADRA1B,2007,2007,NRDD306,Central Nervous System Stimulants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
889,2011,Class A (Rhodopsin),small molecule,lisuride,drd1_human,DRD1,2011,-,NRDD307,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
890,2011,Class A (Rhodopsin),small molecule,lisuride,drd2_human,DRD2,2011,-,NRDD307,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
891,2011,Class A (Rhodopsin),small molecule,lisuride,5ht1a_human,HTR1A,2011,-,NRDD307,Antiparkinson,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908
892,2013,Class B1 (Secretin),small molecule,lixisenatide,glp1r_human,GLP1R,20132016,2016,MMAmar2016_0257,Antidiabetic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,"lixilan, lantus (basal insulin) + lyxumia (lixisenatide)",P43220
893,0,Class A (Rhodopsin),small molecule,lixivaptan,v2r_human,AVPR2,-,-,1157,hyponatremia,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,lixivaptan,P30518
894,0,Class A (Rhodopsin),peptide,ljpc-501,agtr1_human,AGTR1,-,-,MMA2015_0090,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,athos-3,P30556
895,0,Class A (Rhodopsin),peptide,ljpc-501,agtr2_human,AGTR2,-,-,MMA2015_0091,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,athos-3,P50052
896,0,Class A (Rhodopsin),small molecule,lofexidine,ada2a_human,ADRA2A,-,-,1159,opiate withdrawal,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P08913
897,0,Class A (Rhodopsin),small molecule,lofexidine,ada2b_human,ADRA2B,-,-,1159,opiate withdrawal,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P18089
898,0,Class A (Rhodopsin),small molecule,lofexidine,ada2c_human,ADRA2C,-,-,1159,opiate withdrawal,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lofexidine,britlofex",P18825
899,1976,Class A (Rhodopsin),small molecule,loperamide,oprm_human,OPRM1,1976,1976,NRDD308,Antidiuretic,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
900,1993,Class A (Rhodopsin),small molecule,loratadine,hrh1_human,HRH1,1993,1993,1163,Anti-Asthmatic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"loratadine + montelukast sodium,claritin + singulair",P35367
901,2012,Class A (Rhodopsin),small molecule,lorcaserin,5ht2c_human,HTR2C,2012,2012,1164,Anti-obesity,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lorcaserin,P28335
902,1995,Class A (Rhodopsin),small molecule,losartan,agtr1_human,AGTR1,1995,1995,NRDD310,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556
903,1995,Class A (Rhodopsin),small molecule,losartan,agtr1_human,AGTR1,1995,1995,MMAmay2016_0431,Antihypertensive ; for Diabetic neuropathy,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,inv-144,P30556
904,1975,Class A (Rhodopsin),small molecule,loxapine,drd2_human,DRD2,1975,1975,304,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,az-004,P14416
905,1975,Class A (Rhodopsin),small molecule,loxapine,5ht2a_human,HTR2A,1975,1975,304,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,az-004,P28223
906,0,Class A (Rhodopsin),unknown,lu 02-750,drd1_human,DRD1,-,-,1170,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21728
907,0,Class A (Rhodopsin),unknown,lu 02-750,drd2_human,DRD2,-,-,1170,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P14416
908,0,Class A (Rhodopsin),unknown,lu 02-750,drd3_human,DRD3,-,-,1170,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P35462
909,0,Class A (Rhodopsin),unknown,lu 02-750,drd4_human,DRD4,-,-,1170,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21917
910,0,Class A (Rhodopsin),unknown,lu 02-750,drd5_human,DRD5,-,-,1170,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu 02-750,P21918
911,0,Class A (Rhodopsin),unknown,lu ae04621,drd1_human,DRD1,-,-,1175,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21728
912,0,Class A (Rhodopsin),unknown,lu ae04621,drd2_human,DRD2,-,-,1175,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P14416
913,0,Class A (Rhodopsin),unknown,lu ae04621,drd3_human,DRD3,-,-,1175,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P35462
914,0,Class A (Rhodopsin),unknown,lu ae04621,drd4_human,DRD4,-,-,1175,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21917
915,0,Class A (Rhodopsin),unknown,lu ae04621,drd5_human,DRD5,-,-,1175,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu ae04621,P21918
916,0,Class A (Rhodopsin),small molecule,lu-ae58054,5ht6r_human,HTR6,-,-,1177,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lu-ae58054 , ly-483518, sgs518",P50406
917,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht1a_human,HTR1A,20102014,2010,MMAapril2016_0233,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P08908
918,2010,Class A (Rhodopsin),small molecule,lurasidone,drd2_human,DRD2,20102014,2010,MMAapril2016_0234,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P14416
919,2010,Class A (Rhodopsin),small molecule,lurasidone,ada2c_human,ADRA2C,20102014,2010,MMAapril2016_0235,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P18825
920,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht2a_human,HTR2A,20102014,2010,MMAapril2016_0236,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P28223
921,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht7r_human,HTR7,20102014,2010,MMAapril2016_0237,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cyclurad, d-cycloserine + lurasidone",P34969
922,2010,Class A (Rhodopsin),small molecule,lurasidone,ada2c_human,ADRA2C,20102014,2010,1184,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P18825
923,2010,Class A (Rhodopsin),small molecule,lurasidone,drd2_human,DRD2,20102014,2010,1184,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P14416
924,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht1a_human,HTR1A,20102014,2010,1184,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P08908
925,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht2a_human,HTR2A,20102014,2010,1184,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P28223
926,2010,Class A (Rhodopsin),small molecule,lurasidone,5ht7r_human,HTR7,20102014,2010,1184,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lurasidone, sm-13496,latuda",P34969
927,0,Class A (Rhodopsin),peptide,luteinizing hormone-releasing hormone,gnrhr_human,GNRHR,-,-,2097,Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"tztx-001,teverelix la",P30968
928,0,Class A (Rhodopsin),peptide,luteinizing hormone-releasing hormone,gnrr2_human,GNRHR2,-,-,2097,Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"tztx-001,teverelix la",Q96P88
929,2004,Class A (Rhodopsin),peptide,lutropin alfa,lshr_human,LHCGR,-,-,NRDD311,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888
930,0,Class C (Glutamate) ,small molecule,ly2140023,grm2_human,GRM2,-,-,1190,schizophrenia,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,ly2140023,Q14416
931,0,Class C (Glutamate) ,small molecule,ly2140023,grm3_human,GRM3,-,-,1190,schizophrenia,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,ly2140023,Q14832
932,0,Class B1 (Secretin),peptide,ly-2189265,glp1r_human,GLP1R,-,-,1192,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,ly-2189265,P43220
933,0,Class A (Rhodopsin),small molecule,m0002,v2r_human,AVPR2,-,-,1204,for treatemnt of ascites,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,m0002,P30518
934,0,Class A (Rhodopsin),peptide,"macimorelin,  aezs-130",ghsr_human,GHSR,-,-,MMAmay2016_0080,cancer cachexia,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,"macimorelin,  aezs-130",Q92847
935,2013,Class A (Rhodopsin),small molecule,macitentan,ednra_human,EDNRA,2013,2013,1209,cardiovascular disease,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,"macitentan , act-064992",P25101
936,2013,Class A (Rhodopsin),small molecule,macitentan,ednrb_human,EDNRB,2013,2013,1210,cardiovascular disease,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,"macitentan, act-064992",P24530
937,0,Class B1 (Secretin),peptide,mar701,gipr_human,GIPR,-,-,1217,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,not established,mar701,P48546
938,0,Class B1 (Secretin),peptide,mar701,glp1r_human,GLP1R,-,-,1217,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,mar701,P43220
939,2007,Class A (Rhodopsin),small molecule,maraviroc,ccr5_human,CCR5,2007,2007,1834,antiviral ; HIV,Protein ,,approved,Chemokine receptors,GPCR;Rhodopsin,established,selzentry,P51681
940,1985,Class A (Rhodopsin),small molecule,marinol,cnr1_human,CNR1,-,-,NRDD314,Antiemetics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,-,P21554
941,0,Class A (Rhodopsin),small molecule,mbx-2982,gp119_human,GPR119,-,-,1225,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,mbx-2982,Q8TDV5
942,0,Class A (Rhodopsin),small molecule,mc-1,lpar4_human,LPAR4,-,-,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,Q99677
943,0,Class A (Rhodopsin),small molecule,mc-1,lpar6_human,LPAR6,-,-,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,P43657
944,0,Class A (Rhodopsin),small molecule,mc-1,p2ry1_human,P2RY1,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P47900
945,0,Class A (Rhodopsin),small molecule,mc-1,p2y10_human,P2RY10,-,-,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,O00398
946,0,Class A (Rhodopsin),small molecule,mc-1,p2y11_human,P2RY11,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q96G91
947,0,Class A (Rhodopsin),small molecule,mc-1,p2y12_human,P2RY12,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,established,mc-4232,Q9H244
948,0,Class A (Rhodopsin),small molecule,mc-1,p2y13_human,P2RY13,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q9BPV8
949,0,Class A (Rhodopsin),small molecule,mc-1,p2y14_human,P2RY14,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q15391
950,0,Class A (Rhodopsin),small molecule,mc-1,p2ry2_human,P2RY2,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P41231
951,0,Class A (Rhodopsin),small molecule,mc-1,p2ry4_human,P2RY4,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P51582
952,0,Class A (Rhodopsin),small molecule,mc-1,p2ry6_human,P2RY6,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q15077
953,0,Class A (Rhodopsin),small molecule,mc-1,p2ry8_human,P2RY8,-,-,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,Q86VZ1
954,0,Class A (Rhodopsin),small molecule,mcd-386,acm1_human,CHRM1,-,-,1228,Alzheimer's disease,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mcd-386,P11229
955,1957,Class A (Rhodopsin),small molecule,meclizine,hrh1_human,HRH1,1957,-,NRDD315,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
956,2005,Class A (Rhodopsin),small molecule,melatonin,mtr1a_human,MTNR1A,2005,-,NRDD320,Hypnotics and Sedatives,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,-,P48039
957,2005,Class A (Rhodopsin),small molecule,melatonin,mtr1b_human,MTNR1B,2005,-,NRDD320,Hypnotics and Sedatives,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,-,P49286
958,0,Class A (Rhodopsin),small molecule,melevodopa,drd1_human,DRD1,-,-,2110,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21728
959,0,Class A (Rhodopsin),small molecule,melevodopa,drd2_human,DRD2,-,-,2110,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P14416
960,0,Class A (Rhodopsin),small molecule,melevodopa,drd3_human,DRD3,-,-,2110,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P35462
961,0,Class A (Rhodopsin),small molecule,melevodopa,drd4_human,DRD4,-,-,2110,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21917
962,0,Class A (Rhodopsin),small molecule,melevodopa,drd5_human,DRD5,-,-,2110,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"v-1512, chf-1512,levomet complex, sirio",P21918
963,0,Class A (Rhodopsin),protein,menotropins,fshr_human,FSHR,-,-,NRDD322,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945
964,0,Class A (Rhodopsin),protein,menotropins,lshr_human,LHCGR,-,-,NRDD322,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P22888
965,1956,Class A (Rhodopsin),small molecule,mepenzolate,hcar2_human,HCAR2,-,1956,NRDD324,Antispasmodics,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,-,Q8TDS4
966,1956,Class A (Rhodopsin),small molecule,mepenzolate,hcar3_human,HCAR3,-,1956,NRDD324,Antispasmodics,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,-,P49019
967,1942,Class A (Rhodopsin),small molecule,meperidine,oprk_human,OPRK1,-,1942,NRDD325,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145
968,0,Class A (Rhodopsin),small molecule,mephentermine,ada1a_human,ADRA1A,,-,NRDD326,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
969,0,Class A (Rhodopsin),small molecule,mequitazine,hrh1_human,HRH1,-,-,NRDD329,Anti-Allergic,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
970,1970,Class A (Rhodopsin),small molecule,mesoridazine,drd2_human,DRD2,1970,1970,NRDD331,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
971,1970,Class A (Rhodopsin),small molecule,mesoridazine,5ht2a_human,HTR2A,1970,1970,NRDD331,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
972,1954,Class A (Rhodopsin),small molecule,metaraminol,ada1a_human,ADRA1A,1954,-,NRDD333,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
973,1947,Class A (Rhodopsin),small molecule,methadone,oprm_human,OPRM1,1947,-,NRDD334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
974,1993,Class A (Rhodopsin),small molecule,methadyl acetate,oprm_human,OPRM1,-,-,NRDD335,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
975,1943,Class A (Rhodopsin),small molecule,methamphetamine,ada2a_human,ADRA2A,1943,-,1167,neuroprotectant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P08913
976,1943,Class A (Rhodopsin),small molecule,methamphetamine,ada2b_human,ADRA2B,1943,-,1167,neuroprotectant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P18089
977,1943,Class A (Rhodopsin),small molecule,methamphetamine,ada2c_human,ADRA2C,1943,-,1167,neuroprotectant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,P18825
978,1943,Class A (Rhodopsin),small molecule,methamphetamine,taar1_human,TAAR1,1943,-,1167,neuroprotectant,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,low dose intravenous methamphetamine,Q96RJ0
979,1951,Class A (Rhodopsin),small molecule,methantheline,acm1_human,CHRM1,-,1951,NRDD336,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
980,0,Class A (Rhodopsin),small molecule,methdilazine,hrh1_human,HRH1,,-,NRDD339,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
981,0,Class A (Rhodopsin),small molecule,methotrimeprazine,ada1a_human,ADRA1A,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
982,0,Class A (Rhodopsin),small molecule,methotrimeprazine,ada1b_human,ADRA1B,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
983,0,Class A (Rhodopsin),small molecule,methotrimeprazine,ada1d_human,ADRA1D,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
984,0,Class A (Rhodopsin),small molecule,methotrimeprazine,acm1_human,CHRM1,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
985,0,Class A (Rhodopsin),small molecule,methotrimeprazine,acm2_human,CHRM2,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
986,0,Class A (Rhodopsin),small molecule,methotrimeprazine,acm3_human,CHRM3,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
987,0,Class A (Rhodopsin),small molecule,methotrimeprazine,acm4_human,CHRM4,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
988,0,Class A (Rhodopsin),small molecule,methotrimeprazine,acm5_human,CHRM5,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
989,0,Class A (Rhodopsin),small molecule,methotrimeprazine,drd3_human,DRD3,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P35462
990,0,Class A (Rhodopsin),small molecule,methotrimeprazine,hrh1_human,HRH1,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
991,0,Class A (Rhodopsin),small molecule,methotrimeprazine,5ht2b_human,HTR2B,-,-,NRDD342,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595
992,0,Class A (Rhodopsin),small molecule,methoxamine,ada1a_human,ADRA1A,,-,NRDD343,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
993,0,Class A (Rhodopsin),small molecule,methoxamine,ada1b_human,ADRA1B,,-,NRDD343,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
994,1962,Class A (Rhodopsin),small molecule,methyldopa,ada2a_human,ADRA2A,1962,1962,NRDD346,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
995,1946,Class A (Rhodopsin),small molecule,methylergonovine,drd1_human,DRD1,1946,-,NRDD347,Abortifacient,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
996,2008,Class A (Rhodopsin),small molecule,methylnaltrexone,oprm_human,OPRM1,2008,-,1262,opioid-induced constipation,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,methylnaltrexone,P35372
997,2008,Class A (Rhodopsin),small molecule,methylnaltrexone bromide,oprm_human,OPRM1,-,2008,NRDD348,OIC treatment,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
998,1953,Class A (Rhodopsin),small molecule,methylscopolamine,acm1_human,CHRM1,-,-,NRDD351,Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
999,1962,Class A (Rhodopsin),small molecule,methysergide,5ht1a_human,HTR1A,1962,1962,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P08908
1000,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2a_human,HTR2A,1962,1962,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1001,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2c_human,HTR2C,1962,1962,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
1002,1962,Class A (Rhodopsin),small molecule,methysergide,5ht7r_human,HTR7,1962,1962,NRDD353,Anti-migraine s; Vasoconstrictor,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P34969
1003,1989,Class A (Rhodopsin),small molecule,metipranolol,adrb1_human,ADRB1,1989,1989,NRDD354,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1004,1989,Class A (Rhodopsin),small molecule,metipranolol,adrb2_human,ADRB2,1989,1989,NRDD354,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1005,0,Class A (Rhodopsin),small molecule,metixene,acm1_human,CHRM1,-,-,NRDD355,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1006,0,Class A (Rhodopsin),small molecule,metixene,acm2_human,CHRM2,-,-,NRDD355,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1007,0,Class A (Rhodopsin),small molecule,metixene,acm3_human,CHRM3,-,-,NRDD355,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
1008,0,Class A (Rhodopsin),small molecule,metixene,acm4_human,CHRM4,-,-,NRDD355,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
1009,0,Class A (Rhodopsin),small molecule,metixene,acm5_human,CHRM5,-,-,NRDD355,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
1010,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1979,1979,758,diabetic gastroparesis,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,evk-001,P11229
1011,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1979,1979,758,diabetic gastroparesis,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,evk-001,P14416
1012,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1979,1979,MMAmay2016_0859,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"evk-001, metoclopramide nasal spray",P11229
1013,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1979,1979,MMAmay2016_0860,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"evk-001, metoclopramide nasal spray",P14416
1014,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1979,1979,1268,motilitant; gastroesophageal reflux disease,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"metoclopramide hcl,metzoliv odt",P11229
1015,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1979,1979,1268,motilitant; gastroesophageal reflux disease,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"metoclopramide hcl,metzoliv odt",P14416
1016,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1979,1979,1269,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"metoclopramide,emitasol, pramidin",P11229
1017,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1979,1979,1269,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"metoclopramide,emitasol, pramidin",P14416
1018,1979,Class A (Rhodopsin),small molecule,metoclopramide,acm1_human,CHRM1,1979,1979,1355,Anti-migraine,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mt 100,P11229
1019,1979,Class A (Rhodopsin),small molecule,metoclopramide,drd2_human,DRD2,1979,1979,1355,Anti-migraine,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mt 100,P14416
1020,1978,Class A (Rhodopsin),small molecule,metoprolol,adrb1_human,ADRB1,1978,1978,NRDD359,Anti-Arrhythmia ; Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1021,0,Class A (Rhodopsin),small molecule,metoprolol ,adrb1_human,ADRB1,-,-,1270,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"metoprolol succinate,toprol-xl",P08588
1022,0,Class A (Rhodopsin),small molecule,"mg01ci, extended-release metadoxine,",5ht2b_human,HTR2B,-,-,MMAmay2016_0480,neurologic disorders; ADHD,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mg01ci, extended-release metadoxine,",P41595
1023,0,Class A (Rhodopsin),small molecule,mianserin,ada2a_human,ADRA2A,,-,NRDD363,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
1024,0,Class A (Rhodopsin),small molecule,mianserin,hrh1_human,HRH1,,-,NRDD363,Anti-depressant,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1025,0,Class A (Rhodopsin),small molecule,mianserin,5ht2a_human,HTR2A,,-,NRDD363,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1026,0,Class A (Rhodopsin),small molecule,mianserin,5ht2c_human,HTR2C,,-,NRDD363,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
1027,1996,Class A (Rhodopsin),small molecule,midodrine,ada1a_human,ADRA1A,1996,1996,NRDD365,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1028,1996,Class A (Rhodopsin),small molecule,midodrine,ada1b_human,ADRA1B,1996,1996,NRDD365,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1029,0,Class A (Rhodopsin),small molecule,milveterol,adrb2_human,ADRB2,-,-,1290,Bronchodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"milveterol. td-3327, gsk-159797",P07550
1030,0,Class A (Rhodopsin),small molecule,"min-001,  cyr-101",5ht2a_human,HTR2A,-,-,MMAapril2016_0202,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"min-001,  cyr-101",P28223
1031,0,Class A (Rhodopsin),small molecule,min-117,5ht2a_human,HTR2A,-,-,MMAapril2016_0203,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,min-117,P28223
1032,0,Class A (Rhodopsin),small molecule,min-117,5ht1a_human,HTR1A,-,-,MMAapril2016_0204,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,min-117,P08908
1033,0,Class A (Rhodopsin),small molecule,min-117,ada1a_human,ADRA1A,-,-,MMAapril2016_0206,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,min-117,P35348
1034,0,Class A (Rhodopsin),small molecule,min-117,ada1b_human,ADRA1B,-,-,MMAapril2016_0207,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,min-117,P35368
1035,0,Class A (Rhodopsin),small molecule,"min-202, jnj-42847922",ox2r_human,HCRTR2,-,-,MMA2016_0029,Anti-depressant and sleep disorder therapy,Peptide ,,in trial,Orexin receptors,GPCR;Rhodopsin,established,"min-202, jnj-42847922",O43614
1036,0,Class A (Rhodopsin),small molecule,minaprine,drd1_human,DRD1,-,-,NRDD368,Anti-depressant,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1037,0,Class A (Rhodopsin),small molecule,minaprine,drd2_human,DRD2,-,-,NRDD368,Anti-depressant,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1038,0,Class A (Rhodopsin),small molecule,minaprine,5ht2a_human,HTR2A,-,-,NRDD368,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1039,0,Class A (Rhodopsin),small molecule,minaprine,5ht2b_human,HTR2B,-,-,NRDD368,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595
1040,0,Class A (Rhodopsin),small molecule,minaprine,5ht2c_human,HTR2C,-,-,NRDD368,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
1041,1996,Class A (Rhodopsin),small molecule,mirtazapine,ada2a_human,ADRA2A,1996,1996,1295,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"mirtazapine,remeron, remeron soltab, reflex",P08913
1042,1996,Class A (Rhodopsin),small molecule,mirtazapine,5ht2a_human,HTR2A,1996,1996,1295,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mirtazapine,remeron, remeron soltab, reflex",P28223
1043,1988,Class A (Rhodopsin),small molecule,misoprostol,pi2r_human,PTGIR,1988,1988,202,Labor Inducing,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"apl-202,isprelor",P43119
1044,0,Class A (Rhodopsin),small molecule,mitemcinal,mtlr_human,MLNR,-,-,1296,gastroparesis,Peptide ,,in trial,Motilin receptors,GPCR;Rhodopsin,not established,"mitemcinal, gm-611",O43193
1045,1992,Class A (Rhodopsin),small molecule,mivacurium,acm2_human,CHRM2,1992,1992,NRDD370,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1046,0,Class B1 (Secretin),protein,mkc-253,glp1r_human,GLP1R,-,-,1308,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,mkc-253,P43220
1047,0,Class A (Rhodopsin),small molecule,"mle4901,  azd4901",nk3r_human,TACR3,-,-,MMAapril2016_0263,for Polycystic Ovarian Syndrome,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"mle4901,  azd4901",P29371
1048,0,Class A (Rhodopsin),antibody,mln-1202,ccr2_human,CCR2,-,-,1310,Anti-inflammatory ; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mln-1202,P41597
1049,0,Class A (Rhodopsin),unknown,mn-221,adrb2_human,ADRB2,-,-,1317,Anti-Asthmatic,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,mn-221,P07550
1050,0,Class A (Rhodopsin),small molecule,mn-246,adrb3_human,ADRB3,-,-,1318,overactive bladder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,mn-246,P13945
1051,0,Class A (Rhodopsin),small molecule,mn-305,5ht1a_human,HTR1A,-,-,1319,Anti-depressant; hypnotic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mn-305,P08908
1052,0,Class B1 (Secretin),peptide,"mod-6031, long-acting oxyntomodulin",glp1r_human,GLP1R,-,-,MMAmay2016_0898,metabolic disorders; type II diabetes; obesity,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"mod-6031, long-acting oxyntomodulin",P43220
1053,0,Class B1 (Secretin),peptide,"mod-6031, long-acting oxyntomodulin",glr_human,GCGR,-,-,MMAmay2016_0899,metabolic disorders; type II diabetes; obesity,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"mod-6031, long-acting oxyntomodulin",P47871
1054,2012,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,2014,-,MMAjun2016_0001,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,mogamulizumab,P51679
1055,1974,Class A (Rhodopsin),small molecule,molindone,drd2_human,DRD2,1974,1974,NRDD372,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1056,1974,Class A (Rhodopsin),small molecule,molindone,drd2_human,DRD2,1974,1974,2425,ADHD,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"spn810 ,zalvari",P14416
1057,1998,Class A (Rhodopsin),small molecule,montelukast,cltr1_human,CYSLTR1,1998,1998,1163,Anti-Asthmatic,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"loratadine + montelukast sodium,claritin + singulair",Q9Y271
1058,1998,Class A (Rhodopsin),small molecule,montelukast,cltr1_human,CYSLTR1,1998,1998,1327,Anti-Asthmatic,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"montelukast sodium,singulair",Q9Y271
1059,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41143
1060,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41145
1061,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P35372
1062,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,MMAmar2016_0055,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P41145
1063,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,MMAmar2016_0056,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P35372
1064,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,MMAmar2016_0057,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"egalet-001, reformulated morphine",P41143
1065,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1013,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P41143
1066,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1013,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P41145
1067,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1013,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"intranasal morphine,rylomine",P35372
1068,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1207,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P41143
1069,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1207,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P41145
1070,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1207,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"m6g, cee 04-410",P35372
1071,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1279,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P41143
1072,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1279,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P41145
1073,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1279,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mh-200, tak-453 sr, morphine hcl,anpec",P35372
1074,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1333,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P41143
1075,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1333,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P41145
1076,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1333,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,avinza",P35372
1077,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P41143
1078,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P41145
1079,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1334,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine sulfate,depodur, depomorphine",P35372
1080,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1335,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P41143
1081,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1335,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P41145
1082,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1335,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"morphine/dextromethorphan,morphidex",P35372
1083,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41143
1084,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41145
1085,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P35372
1086,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41143
1087,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41145
1088,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P35372
1089,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,1903,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,statex,P41145
1090,1984,Class A (Rhodopsin),small molecule,morphine,oprd_human,OPRD1,1984,-,2051,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P41143
1091,1984,Class A (Rhodopsin),small molecule,morphine,oprk_human,OPRK1,1984,-,2051,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P41145
1092,1984,Class A (Rhodopsin),small molecule,morphine,oprm_human,OPRM1,1984,-,2051,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tpm-1/morphine,P35372
1093,0,Class A (Rhodopsin),small molecule,mosapride,5ht4r_human,HTR4,,-,1337,Gastrointestinal reflux disease (GERD),Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mosapride citrate, tak-370,gasmotin",Q13639
1094,0,Class A (Rhodopsin),small molecule,msx-122,cxcr4_human,CXCR4,-,-,1354,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,msx-122,P61073
1095,0,Class A (Rhodopsin),small molecule,mt-1303,s1pr1_human,S1PR1,-,-,MMAmar2016_0211,autoimmune diseases; Multiple Sclerosis; Crohn's disease,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,mt-1303,P21453
1096,2015,Class A (Rhodopsin),small molecule,eluxadoline,oprd_human,OPRD1,2015,2015,1363,irritable bowel syndrome,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mu delta, eluxadoline",P41143
1097,2015,Class A (Rhodopsin),small molecule,eluxadoline,oprm_human,OPRM1,2015,2015,1363,irritable bowel syndrome,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"mu delta, eluxadoline",P35372
1098,1985,Class A (Rhodopsin),small molecule,nabilone,cnr1_human,CNR1,1985,1985,1373,Antiemetics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"nabilone,cesamet",P21554
1099,1985,Class A (Rhodopsin),small molecule,nabilone,cnr2_human,CNR2,1985,1985,1373,Antiemetics,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,"nabilone,cesamet",P34972
1100,1985,Class A (Rhodopsin),small molecule,nabilone,cnr1_human,CNR1,1985,1985,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P21554
1101,1985,Class A (Rhodopsin),small molecule,nabilone,cnr2_human,CNR2,1985,1985,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P34972
1102,1979,Class A (Rhodopsin),small molecule,nadolol,adrb1_human,ADRB1,1979,1979,NRDD376,Anti-Arrhythmia ; Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1103,1979,Class A (Rhodopsin),small molecule,nadolol,adrb2_human,ADRB2,1979,1979,NRDD376,Anti-Arrhythmia ; Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1104,1990,Class A (Rhodopsin),small molecule,nafarelin,gnrhr_human,GNRHR,1990,1990,NRDD377,Antiendometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,P30968
1105,1990,Class A (Rhodopsin),small molecule,nafarelin,gnrr2_human,GNRHR2,1990,1990,NRDD377,Antiendometriosis,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88
1106,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprd_human,OPRD1,1979,1979,1374,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P41143
1107,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprk_human,OPRK1,1979,1979,1374,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P41145
1108,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprm_human,OPRM1,1979,1979,1374,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalbuphine hydrochloride,  pw-4142",P35372
1109,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprd_human,OPRD1,1979,1979,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41143
1110,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprk_human,OPRK1,1979,1979,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41145
1111,1979,Class A (Rhodopsin),small molecule,nalbuphine,oprm_human,OPRM1,1979,1979,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P35372
1112,2013,Class A (Rhodopsin),small molecule,nalmefene,oprd_human,OPRD1,2013,1995,1375,smoking-cessation ; addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P41143
1113,2013,Class A (Rhodopsin),small molecule,nalmefene,oprk_human,OPRK1,2013,1995,1375,smoking-cessation ; addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P41145
1114,2013,Class A (Rhodopsin),small molecule,nalmefene,oprm_human,OPRM1,2013,1995,1375,smoking-cessation ; addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"nalmefene, cph-101",P35372
1115,1995,Class A (Rhodopsin),small molecule,nalmefene ,oprd_human,OPRD1,-,-,2766,pruritus,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P41143
1116,1995,Class A (Rhodopsin),small molecule,nalmefene ,oprk_human,OPRK1,-,-,2766,pruritus,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P41145
1117,1995,Class A (Rhodopsin),small molecule,nalmefene ,oprm_human,OPRM1,-,-,2766,pruritus,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,srd174,P35372
1118,2014,Class A (Rhodopsin),small molecule,naloxegol,oprm_human,OPRM1,2014,-,1419,opioid-induced constipation,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,nktr-118,P35372
1119,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1971,1971,405,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41143
1120,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1971,1971,405,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P41145
1121,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1971,1971,405,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone capsule,nanobup",P35372
1122,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1971,1971,406,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41143
1123,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1971,1971,406,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P41145
1124,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1971,1971,406,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"buprenorphine + naloxone,suboxone",P35372
1125,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1971,1971,MMAmay2016_0645,Analgesics; overdose/drug toxicity,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P35372
1126,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1971,1971,MMAmay2016_0646,Analgesics; overdose/drug toxicity,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P41143
1127,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1971,1971,MMAmay2016_0647,Analgesics; overdose/drug toxicity,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, indivior",P41145
1128,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1971,1971,MMAmar2016_0088,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P35372
1129,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1971,1971,MMAmar2016_0089,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P41143
1130,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1971,1971,MMAmar2016_0090,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",P41145
1131,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1971,1971,MMAmay2016_0517,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P35372
1132,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1971,1971,MMAmay2016_0518,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41145
1133,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1971,1971,MMAmay2016_0921,Analgesics; opioid addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"ox219, buprenorphine + naloxone sublingual tablet",P41143
1134,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1971,1971,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41143
1135,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1971,1971,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P41145
1136,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1971,1971,1733,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ren-213,P35372
1137,1971,Class A (Rhodopsin),small molecule,naloxone,oprm_human,OPRM1,1971,1971,MMAmay2016_0709,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P35372
1138,1971,Class A (Rhodopsin),small molecule,naloxone,oprd_human,OPRD1,1971,1971,MMAmay2016_0710,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41143
1139,1971,Class A (Rhodopsin),small molecule,naloxone,oprk_human,OPRK1,1971,1971,MMAmay2016_0711,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41145
1140,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41143
1141,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P41145
1142,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,122,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",P35372
1143,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,522,Appetite suppressant,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P41143
1144,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,522,Appetite suppressant,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P41145
1145,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,522,Appetite suppressant,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,contrave,P35372
1146,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,MMAfeb2016_0084,addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P35372
1147,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,MMAfeb2016_0085,addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41143
1148,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,MMAfeb2016_0086,addiction,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41145
1149,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41143
1150,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P41145
1151,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,1336,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,morviva,P35372
1152,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41143
1153,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41145
1154,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P35372
1155,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41143
1156,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P41145
1157,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,1686,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-701,P35372
1158,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41143
1159,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41145
1160,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P35372
1161,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,1688,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P41143
1162,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,1688,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P41145
1163,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,1688,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-901,P35372
1164,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,MMAmay2016_0073,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P35372
1165,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,MMAmay2016_0074,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P41143
1166,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,MMAmay2016_0075,Analgesics; for type 1A Charcot-Marie-Tooth disease,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pxt3003, baclofen + naltrexone + sorbitol",P41145
1167,1998,Class A (Rhodopsin),small molecule,naltrexone,oprd_human,OPRD1,1998,1984,2168,substance abuse,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P41143
1168,1998,Class A (Rhodopsin),small molecule,naltrexone,oprk_human,OPRK1,1998,1984,2168,substance abuse,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P41145
1169,1998,Class A (Rhodopsin),small molecule,naltrexone,oprm_human,OPRM1,1998,1984,2168,substance abuse,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,vivitrol,P35372
1170,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1a_human,HTR1A,1998,1998,1381,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P08908
1171,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1b_human,HTR1B,1998,1998,1381,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P28222
1172,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1d_human,HTR1D,1998,1998,1381,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P28221
1173,1998,Class A (Rhodopsin),small molecule,naratriptan,5ht1f_human,HTR1F,1998,1998,1381,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"naratriptan,naramig, amerge",P30939
1174,0,Class A (Rhodopsin),small molecule,nbi-42902,gnrhr_human,GNRHR,-,-,869,postmenopausal symptoms; Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"gnrh receptor antagonist, nbi-42902",P30968
1175,0,Class A (Rhodopsin),small molecule,nbi-42902,gnrr2_human,GNRHR2,-,-,869,postmenopausal symptoms; Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"gnrh receptor antagonist, nbi-42902",Q96P88
1176,0,Class A (Rhodopsin),small molecule,nbi-56418,gnrhr_human,GNRHR,-,-,1388,Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,nbi-56418,P30968
1177,0,Class A (Rhodopsin),small molecule,ncx 1510,hrh1_human,HRH1,-,-,1390,Anti-Allergic,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"ncx 1510, ox-nla",P35367
1178,0,Class A (Rhodopsin),small molecule,ncx116,pf2r_human,PTGFR,-,-,378,Antiglaucomic,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"bol-303259-x, ncx 116, pf-03187207",P43088
1179,2007,Class A (Rhodopsin),small molecule,nebivolol,adrb1_human,ADRB1,-,2007,1394,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nebivolol ,bystolic",P08588
1180,1992,Class A (Rhodopsin),small molecule,nedocromil,cltr1_human,CYSLTR1,1992,1992,NRDD379,Anti-Allergic ; Anti-Asthmatic,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271
1181,1994,Class A (Rhodopsin),small molecule,nefazodone,ada1a_human,ADRA1A,1994,1994,NRDD380,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1182,1994,Class A (Rhodopsin),small molecule,nefazodone,ada1b_human,ADRA1B,1994,1994,NRDD380,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1183,1994,Class A (Rhodopsin),small molecule,nefazodone,5ht2a_human,HTR2A,1994,1994,NRDD380,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1184,0,Class A (Rhodopsin),small molecule,"nelotanserin, apd-125",5ht2a_human,HTR2A,-,-,MMAmar2016_0233,dementia; Parkinson's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"nelotanserin, apd-125",P28223
1185,0,Class A (Rhodopsin),peptide,nemifitide,5ht2a_human,HTR2A,-,-,983,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"inn-00835, nemifitide",P28223
1186,2014,Class A (Rhodopsin),small molecule,netupitant,nk1r_human,TACR1,20142015,2014,MMAmay2016_0499,Antiemetics,Peptide ,,approved,Tachykinin receptors,GPCR;Rhodopsin,established,netupitant + palonosetron,P25103
1187,0,Class A (Rhodopsin),small molecule,ngd-4715,mchr1_human,MCHR1,-,-,1408,Appetite suppressant,Peptide ,,in trial,Melanin-concentrating hormone,GPCR;Rhodopsin,not established,ngd-4715,Q99705
1188,0,Class A (Rhodopsin),small molecule,ngx267,acm1_human,CHRM1,-,-,1410,dry mouth,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ngx267,P11229
1189,0,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,-,-,467,Antidyslipidaemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4
1190,0,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,-,-,467,Antidyslipidaemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019
1191,0,Class A (Rhodopsin),small molecule: combination,niacin,hcar3_human,HCAR3,-,-,MMA2015_0071,Dyslipidemia with low HDL,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,P49019
1192,0,Class A (Rhodopsin),small molecule: combination,niacin,hcar2_human,HCAR2,-,-,MMA2015_0072,Dyslipidemia with low HDL,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,cer627,Q8TDS4
1193,0,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,-,-,1300,Antidyslipidaemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Q8TDS4
1194,0,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,-,-,1300,Antidyslipidaemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",P49019
1195,0,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,-,-,1301,Antidyslipidaemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",Q8TDS4
1196,0,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,-,-,1301,Antidyslipidaemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"mk-0542b, extended release niacin + laropiprant +simvastatin",P49019
1197,0,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,-,-,2468,Antihyperlipidemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"niacin extended-release tablets,niaspan",Q8TDS4
1198,0,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,-,-,2468,Antihyperlipidemic,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"niacin extended-release tablets,niaspan",P49019
1199,0,Class A (Rhodopsin),small molecule,niacin,hcar2_human,HCAR2,-,-,1546,substance abuse deterrant,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",Q8TDS4
1200,0,Class A (Rhodopsin),small molecule,niacin,hcar3_human,HCAR3,-,-,1546,substance abuse deterrant,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P49019
1201,0,Class A (Rhodopsin),small molecule,niacin receptor agonist,hcar2_human,HCAR2,-,-,1412,Anti-atherosclerotic,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,niacin receptor agonist,Q8TDS4
1202,0,Class A (Rhodopsin),small molecule,niacin receptor agonist,hcar3_human,HCAR3,-,-,1412,Anti-atherosclerotic,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,niacin receptor agonist,P49019
1203,0,Class A (Rhodopsin),small molecule,nicergoline,ada1a_human,ADRA1A,-,-,NRDD384,Nootropic ; Vasodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1204,1988,Class A (Rhodopsin),small molecule,nizatidine,hrh2_human,HRH2,1988,1988,NRDD394,GI Anti-Ulcer ; antihistamines,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P25021
1205,0,Class A (Rhodopsin),small molecule polymer conjugate,nktr-181,oprm_human,OPRM1,-,-,1420,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nktr-181,P35372
1206,0,Class B1 (Secretin),protein,nn9924,glp1r_human,GLP1R,-,-,1429,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,nn9924,P43220
1207,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1a_human,ADRA1A,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1208,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1b_human,ADRA1B,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1209,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada1d_human,ADRA1D,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
1210,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2a_human,ADRA2A,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
1211,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2b_human,ADRA2B,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089
1212,1950,Class A (Rhodopsin),small molecule,norepinephrine,ada2c_human,ADRA2C,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825
1213,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb1_human,ADRB1,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1214,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb2_human,ADRB2,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1215,1950,Class A (Rhodopsin),small molecule,norepinephrine,adrb3_human,ADRB3,-,-,NRDD395,Antihypotensive ; Vasoconstrictor,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P13945
1216,0,Class A (Rhodopsin),small molecule,norepinephrine,ada1a_human,ADRA1A,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P35348
1217,0,Class A (Rhodopsin),small molecule,norepinephrine,ada1b_human,ADRA1B,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P35368
1218,0,Class A (Rhodopsin),small molecule,norepinephrine,ada1d_human,ADRA1D,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P25100
1219,0,Class A (Rhodopsin),small molecule,norepinephrine,ada2a_human,ADRA2A,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P08913
1220,0,Class A (Rhodopsin),small molecule,norepinephrine,ada2b_human,ADRA2B,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P18089
1221,0,Class A (Rhodopsin),small molecule,norepinephrine,ada2c_human,ADRA2C,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P18825
1222,0,Class A (Rhodopsin),small molecule,norepinephrine,adrb1_human,ADRB1,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P08588
1223,0,Class A (Rhodopsin),small molecule,norepinephrine,adrb2_human,ADRB2,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P07550
1224,0,Class A (Rhodopsin),small molecule,norepinephrine,adrb3_human,ADRB3,-,-,2273,for prevention of dermatitis during radiotherapy,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,dermx,P13945
1225,0,Class A (Rhodopsin),unknown,not disclosed,oprd_human,OPRD1,-,-,1684,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P41143
1226,0,Class A (Rhodopsin),unknown,not disclosed,oprk_human,OPRK1,-,-,1684,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P41145
1227,0,Class A (Rhodopsin),unknown,not disclosed,oprm_human,OPRM1,-,-,1684,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-202,P35372
1228,0,Class A (Rhodopsin),viral gene delivery,np2 enkephalin,oprd_human,DOR,-,-,2421,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,np2 enkephalin,P41143
1229,0,Class C (Glutamate) ,small molecule,nps-2143,casr_human,CASR,-,-,1441,Anti-osteoporotic,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,nps-2143,P41180
1230,0,Class C (Glutamate) ,small molecule,npsp795,casr_human,CASR,-,-,MMAmar2016_0202,hypocalcaemia,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,npsp795,P41180
1231,0,Class A (Rhodopsin),small molecule,nrp104,ada1b_human,ADRA1B,-,-,2199,ADHD,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,vyvanse,P35368
1232,0,Class A (Rhodopsin),small molecule,nrp290,oprd_human,OPRD1,-,-,1444,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P41143
1233,0,Class A (Rhodopsin),small molecule,nrp290,oprk_human,OPRK1,-,-,1444,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P41145
1234,0,Class A (Rhodopsin),small molecule,nrp290,oprm_human,OPRM1,-,-,1444,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,nrp290,P35372
1235,0,Class A (Rhodopsin),small molecule,ns-304,pi2r_human,PTGIR,-,-,1448,Antihypertensive,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,ns-304,P43119
1236,0,Class A (Rhodopsin),protein,nu206,lgr4_human,LGR4,-,-,2528,gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",Q9BXB1
1237,0,Class A (Rhodopsin),protein,nu206,lgr5_human,LGR5,-,-,2528,gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",O75473
1238,0,Class A (Rhodopsin),small molecule,nxn-188,5ht1b_human,HTR1B,-,-,1460,Anti-migraine,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nxn-188,P28222
1239,0,Class A (Rhodopsin),small molecule,nxn-188,5ht1d_human,HTR1D,-,-,1460,Anti-migraine,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nxn-188,P28221
1240,0,Class A (Rhodopsin),small molecule,obe001,oxyr_human,OXTR,-,-,MMAapril2016_0035,labor and delivery,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,obe001,P30559
1241,0,Class A (Rhodopsin),small molecule,obinepitide,npy2r_human,NPY2R,-,-,2027,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P49146
1242,0,Class A (Rhodopsin),small molecule,obinepitide,npy4r_human,PPYR1,-,-,2027,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P50391
1243,0,Class A (Rhodopsin),small molecule,oc000459 ,pd2r2_human,PD2R2,-,-,1466,Anti-Allergic,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,oc000459,Q9Y5Y4
1244,0,Class A (Rhodopsin),small molecule,oc459,pd2r2_human,GPR44,-,-,MMAmay2016_0684,for allergic rhinitis,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,not established,oc459,Q9Y5Y4
1245,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1988,1988,421,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P30872
1246,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1988,1988,421,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P30874
1247,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1988,1988,421,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,cam-2029,P35346
1248,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1988,1988,981,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P30872
1249,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1988,1988,981,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P30874
1250,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1988,1988,981,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"injectable octreotide acetate,sandostatin lar",P35346
1251,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1988,1988,1470,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P30872
1252,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1988,1988,1470,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P30874
1253,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1988,1988,1470,Antineoplastic,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"octrotide,atrigel",P35346
1254,1988,Class A (Rhodopsin),peptide,octreotide,ssr1_human,SSTR1,1988,1988,1508,Antihypertensive,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate ,octreolin",P30872
1255,1988,Class A (Rhodopsin),peptide,octreotide,ssr2_human,SSTR2,1988,1988,1509,Antihypertensive,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate,octreolin",P30874
1256,1988,Class A (Rhodopsin),peptide,octreotide,ssr5_human,SSTR5,1988,1988,1509,Antihypertensive,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"oral octreotide actetate,octreolin",P35346
1257,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P35348
1258,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P35368
1259,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P08913
1260,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P18089
1261,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alks 3831,P18825
1262,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P11229
1263,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08172
1264,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P20309
1265,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08173
1266,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks 3831,P08912
1267,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21728
1268,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P14416
1269,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P35462
1270,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21917
1271,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,alks 3831,P21918
1272,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,alks 3831,P35367
1273,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P08908
1274,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28222
1275,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28221
1276,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28566
1277,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28223
1278,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28335
1279,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P50406
1280,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P34969
1281,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1996,1996,MMAmay2016_0185,Antipsychotic ; antipsychotic-related metabolic weight gain,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08172
1282,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1996,1996,MMAmay2016_0186,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08173
1283,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1996,1996,MMAmay2016_0187,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08908
1284,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1996,1996,MMAmay2016_0188,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08912
1285,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1996,1996,MMAmay2016_0189,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P08913
1286,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1996,1996,MMAmay2016_0190,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P11229
1287,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1996,1996,MMAmay2016_0191,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P14416
1288,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1996,1996,MMAmay2016_0192,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P18089
1289,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1996,1996,MMAmay2016_0193,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P18825
1290,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1996,1996,MMAmay2016_0194,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P20309
1291,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1996,1996,MMAmay2016_0195,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21728
1292,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1996,1996,MMAmay2016_0196,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21917
1293,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1996,1996,MMAmay2016_0197,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P21918
1294,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1996,1996,MMAmay2016_0198,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28221
1295,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1996,1996,MMAmay2016_0199,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28222
1296,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1996,1996,MMAmay2016_0200,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28223
1297,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1996,1996,MMAmay2016_0201,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28335
1298,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1996,1996,MMAmay2016_0202,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P28566
1299,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1996,1996,MMAmay2016_0203,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P34969
1300,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1996,1996,MMAmay2016_0204,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35348
1301,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1996,1996,MMAmay2016_0205,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35367
1302,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1996,1996,MMAmay2016_0206,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35368
1303,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1996,1996,MMAmay2016_0207,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P35462
1304,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1996,1996,MMAmay2016_0209,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"alks 3831,  olanzapine + alks 33,samidorphan",P50406
1305,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1996,1996,1475,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35348
1306,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1996,1996,1475,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35368
1307,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1996,1996,1475,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08913
1308,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1996,1996,1475,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P18089
1309,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1996,1996,1475,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P18825
1310,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1996,1996,1475,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P11229
1311,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1996,1996,1475,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08172
1312,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1996,1996,1475,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P20309
1313,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1996,1996,1475,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08173
1314,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1996,1996,1475,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08912
1315,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1996,1996,1475,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21728
1316,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1996,1996,1475,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P14416
1317,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1996,1996,1475,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35462
1318,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1996,1996,1475,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21917
1319,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1996,1996,1475,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P21918
1320,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1996,1996,1475,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P35367
1321,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P08908
1322,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28222
1323,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28221
1324,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28566
1325,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28223
1326,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P28335
1327,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P50406
1328,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1996,1996,1475,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",P34969
1329,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35348
1330,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35368
1331,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08913
1332,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P18089
1333,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P18825
1334,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P11229
1335,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08172
1336,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P20309
1337,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08173
1338,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08912
1339,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21728
1340,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P14416
1341,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35462
1342,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21917
1343,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P21918
1344,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1996,1996,1476,Anti-depressant,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P35367
1345,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P08908
1346,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28222
1347,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28221
1348,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28566
1349,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28223
1350,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P28335
1351,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P50406
1352,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1996,1996,1476,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",P34969
1353,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1a_human,ADRA1A,1996,1996,1515,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35348
1354,1996,Class A (Rhodopsin),small molecule,olanzapine,ada1b_human,ADRA1B,1996,1996,1515,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35368
1355,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2a_human,ADRA2A,1996,1996,1515,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08913
1356,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2b_human,ADRA2B,1996,1996,1515,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P18089
1357,1996,Class A (Rhodopsin),small molecule,olanzapine,ada2c_human,ADRA2C,1996,1996,1515,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P18825
1358,1996,Class A (Rhodopsin),small molecule,olanzapine,acm1_human,CHRM1,1996,1996,1515,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P11229
1359,1996,Class A (Rhodopsin),small molecule,olanzapine,acm2_human,CHRM2,1996,1996,1515,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08172
1360,1996,Class A (Rhodopsin),small molecule,olanzapine,acm3_human,CHRM3,1996,1996,1515,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P20309
1361,1996,Class A (Rhodopsin),small molecule,olanzapine,acm4_human,CHRM4,1996,1996,1515,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08173
1362,1996,Class A (Rhodopsin),small molecule,olanzapine,acm5_human,CHRM5,1996,1996,1515,schizophrenia,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08912
1363,1996,Class A (Rhodopsin),small molecule,olanzapine,drd1_human,DRD1,1996,1996,1515,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21728
1364,1996,Class A (Rhodopsin),small molecule,olanzapine,drd2_human,DRD2,1996,1996,1515,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P14416
1365,1996,Class A (Rhodopsin),small molecule,olanzapine,drd3_human,DRD3,1996,1996,1515,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35462
1366,1996,Class A (Rhodopsin),small molecule,olanzapine,drd4_human,DRD4,1996,1996,1515,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21917
1367,1996,Class A (Rhodopsin),small molecule,olanzapine,drd5_human,DRD5,1996,1996,1515,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P21918
1368,1996,Class A (Rhodopsin),small molecule,olanzapine,hrh1_human,HRH1,1996,1996,1515,schizophrenia,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P35367
1369,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1a_human,HTR1A,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P08908
1370,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1b_human,HTR1B,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28222
1371,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1d_human,HTR1D,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28221
1372,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28566
1373,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2a_human,HTR2A,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28223
1374,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht2c_human,HTR2C,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P28335
1375,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht6r_human,HTR6,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P50406
1376,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht7r_human,HTR7,1996,1996,1515,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"orex-003, olanzapine plus zonisamide sr",P34969
1377,2002,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,2002,-,557,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"cs-8663, amlodipine + olmesartan,azor, sevikar",P30556
1378,2002,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,2002,-,1478,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"olmesartan medoxomil (cs-866),benicar",P30556
1379,2002,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,2002,-,1479,Antiglaucomic,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"olmesartan, de-092",P30556
1380,2002,Class A (Rhodopsin),small molecule,olmesartan,agtr1_human,AGTR1,2002,-,2080,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,tribenzor,P30556
1381,2014,Class A (Rhodopsin),small molecule,olodaterol,adrb2_human,ADRB2,2014,2014,MMAmay2016_0592, chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,tiotropium + olodaterol,P07550
1382,1996,Class A (Rhodopsin),small molecule,olopatadine,hrh1_human,HRH1,19962002,1996,1480,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"olopatadine hydrochloride,patanase",P35367
1383,0,Class F (Frizzled),antibody,omp-18r5,fzd7_human,FZD7,-,-,2457,Antineoplastic,Protein ,,in trial,Frizzled,GPCR;Frizzled,not established,omp-18r5,O75084
1384,0,Class A (Rhodopsin),small molecule,opa-6566,aa2ar_human,ADORA2A,-,-,MMAmay2016_0512,Antiglaucomic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,opa-6566,P29274
1385,0,Class A (Rhodopsin),small molecule,opc-14523,5ht1a_human,HTR1A,-,-,1662,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"prs-013, opc-14523",P08908
1386,0,Class A (Rhodopsin),small molecule,opc-14523,pgrc1_human,PGRMC1,-,-,1662,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,not established,"prs-013, opc-14523",O00264
1387,0,Class A (Rhodopsin),small molecule,opc-28326,ada2b_human,ADRA2B,-,-,1501,vasodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,opc-28326,P18089
1388,0,Class A (Rhodopsin),small molecule,opc-28326,ada2c_human,ADRA2C,-,-,1501,vasodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,opc-28326,P18825
1389,2015,Class A (Rhodopsin),small molecule,brexpiprazole,drd2_human,DRD2,2015,2015,1502,Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P14416
1390,2015,Class A (Rhodopsin),small molecule,brexpiprazole,5ht1a_human,HTR1A,2015,2015,1502,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P08908
1391,2015,Class A (Rhodopsin),small molecule,brexpiprazole,5ht2a_human,HTR2A,2015,2015,1502,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P28223
1392,2015,Class A (Rhodopsin),small molecule,brexpiprazole,5ht7r_human,HTR7,2015,2015,1502,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,brexpiprazole,P34969
1393,0,Class A (Rhodopsin),small molecule,opc-51803,v2r_human,AVPR2,-,-,1503,incontinence,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,opc-51803,P30518
1394,1973,Class A (Rhodopsin),small molecule,orciprenaline,adrb2_human,ADRB2,1973,-,NRDD399,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1395,0,Class A (Rhodopsin),small molecule,ordopidine,drd2_human,DRD2,-,-,2422,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,acr325,P14416
1396,0,Class B1 (Secretin),peptide,ormd-0901,glp1r_human,GLP1R,-,-,1519,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"ormd-0901, oral glp-1 analog",P43220
1397,1957,Class A (Rhodopsin),small molecule,orphenadrine,hrh1_human,HRH1,1957,1957,NRDD400,Antiparkinson s; Muscle Relaxants; Central,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1398,0,Class B1 (Secretin),peptide,ostabolin-c,pth1r_human,PTH1R,-,-,1530,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"ostabolin-c,  zt-031",Q03431
1399,0,Class B1 (Secretin),peptide,ostabolin-c,pth2r_human,PTH2R,-,-,1530,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"ostabolin-c,  zt-031",P49190
1400,0,Class A (Rhodopsin),small molecule,ot-730,adrb1_human,ADRB1,-,-,1533,Antiglaucomic,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ot-730,P08588
1401,0,Class A (Rhodopsin),small molecule,ot-730,adrb2_human,ADRB2,-,-,1533,Antiglaucomic,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ot-730,P07550
1402,1983,Class A (Rhodopsin),small molecule,oxprenolol,adrb1_human,ADRB1,,-,NRDD405,Antihypertensive ; Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1403,1983,Class A (Rhodopsin),small molecule,oxprenolol,adrb2_human,ADRB2,,-,NRDD405,Antihypertensive ; Anti-Arrhythmia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1404,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,19752004,1975,14,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P11229
1405,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,19752004,1975,14,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P08172
1406,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,19752004,1975,14,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aa-2010,P20309
1407,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,19752004,1975,190,overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P11229
1408,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,19752004,1975,190,overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P08172
1409,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,19752004,1975,190,overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ap-1034,anturol",P20309
1410,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,19752004,1975,2351,Anti-incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P11229
1411,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,19752004,1975,2351,Anti-incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P08172
1412,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,19752004,1975,2351,Anti-incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dr-3001,P20309
1413,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,19752004,1975,MMAapril2016_0197,overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P11229
1414,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,19752004,1975,MMAapril2016_0198,overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P08172
1415,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,19752004,1975,MMAapril2016_0199,overactive bladder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,jnp-010,P20309
1416,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm1_human,CHRM1,19752004,1975,2067,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P11229
1417,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm2_human,CHRM2,19752004,1975,2067,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P08172
1418,1975,Class A (Rhodopsin),small molecule,oxybutynin,acm3_human,CHRM3,19752004,1975,2067,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",P20309
1419,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,514,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P41143
1420,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,514,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P41145
1421,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,514,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-003, sustained release oxycodone",P35372
1422,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,515,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P41143
1423,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,515,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P41145
1424,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,515,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"col-172, extended-release oxycodone",P35372
1425,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,696,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P41143
1426,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,696,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P41145
1427,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,696,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"eli-154, oxycodone (once daily)",P35372
1428,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,MMAfeb2016_0087,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P35372
1429,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,MMAfeb2016_0088,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41143
1430,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,MMAfeb2016_0089,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,eli-200,P41145
1431,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41143
1432,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P41145
1433,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,1341,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,moxduo,P35372
1434,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,1545,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P41143
1435,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,1545,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P41145
1436,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,1545,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone art, eli216,oxynal",P35372
1437,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,1546,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P41143
1438,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,1546,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P41145
1439,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,1546,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone hcl + niacin,acurox, oxyadf",P35372
1440,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,1547,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P41143
1441,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,1547,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P41145
1442,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,1547,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxycodone, pti-821,remoxy",P35372
1443,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41143
1444,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P41145
1445,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,1687,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"pti-801,oxytrex",P35372
1446,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,MMAmay2016_0706,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P35372
1447,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,MMAmay2016_0707,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41143
1448,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,MMAmay2016_0708,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",P41145
1449,1998,Class A (Rhodopsin),small molecule,oxycodone,oprd_human,OPRD1,1998,-,2068,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P41143
1450,1998,Class A (Rhodopsin),small molecule,oxycodone,oprk_human,OPRK1,1998,-,2068,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P41145
1451,1998,Class A (Rhodopsin),small molecule,oxycodone,oprm_human,OPRM1,1998,-,2068,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,transdermal oxycodone,P35372
1452,0,Class A (Rhodopsin),small molecule,oxycodone xr,oprm_human,OPRM1,-,-,MMAmar2016_0078,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P35372
1453,0,Class A (Rhodopsin),small molecule,oxycodone xr,oprd_human,OPRD1,-,-,MMAmar2016_0079,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P41143
1454,0,Class A (Rhodopsin),small molecule,oxycodone xr,oprk_human,OPRK1,-,-,MMAmar2016_0080,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"rexista, oxycodone xr",P41145
1455,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada1a_human,ADRA1A,1986,-,1491,Analgesics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,oms-103hp,P35348
1456,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada2a_human,ADRA2A,1986,-,1491,Analgesics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,oms-103hp,P08913
1457,1959,Class A (Rhodopsin),small molecule,oxymorphone,oprd_human,OPRD1,1959,-,1548,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxymorphone hydrochloride, en3202,opana, opana er",P41143
1458,1959,Class A (Rhodopsin),small molecule,oxymorphone,oprm_human,OPRM1,1959,-,1548,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"oxymorphone hydrochloride, en3202,opana, opana er",P35372
1459,0,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm1_human,CHRM1,,-,NRDD407,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1460,0,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm2_human,CHRM2,,-,NRDD407,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1461,0,Class A (Rhodopsin),small molecule,oxyphencyclimine,acm3_human,CHRM3,,-,NRDD407,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
1462,0,Class A (Rhodopsin),small molecule,oxyphenonium,acm1_human,CHRM1,,-,NRDD408,Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1463,1980,Class A (Rhodopsin),peptide,oxytocin,oxyr_human,OXTR,1980,-,MMA2016_0022,autism,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"opn-300, intranasal oxytocin",P30559
1464,1980,Class A (Rhodopsin),peptide,oxytocin,oxyr_human,OXTR,1980,-,2014,Analgesics,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ti-001, intranasal oxytocin",P30559
1465,0,Class A (Rhodopsin),peptide,ozarelix,gnrhr_human,GNRHR,-,-,1891,Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"spi-153, d-63153,ozarelix",P30968
1466,0,Class A (Rhodopsin),peptide,ozarelix,gnrr2_human,GNRHR2,-,-,1891,Antineoplastic,Peptide ,,in trial,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"spi-153, d-63153,ozarelix",Q96P88
1467,0,Class A (Rhodopsin),peptide,"p2045, 188re-p2045",ssr2_human,SSTR2,-,-,MMAmay2016_0746,Antineoplastic,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"p2045, 188re-p2045",P30874
1468,0,Class A (Rhodopsin),small molecule,pa101b,gpr35_human,GPR35,-,-,MMAmar2016_0133,autoimmune diseases,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,pa101b,Q9HC97
1469,0,Class A (Rhodopsin),protein,pa-401,cxcr1_human,CXCR1,-,-,1553,Anti-inflammatory ; immunosuppressant,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"pa-401, pa04-001",P25024
1470,0,Class A (Rhodopsin),protein,pa-401,cxcr2_human,CXCR2,-,-,1553,Anti-inflammatory ; immunosuppressant,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"pa-401, pa04-001",P25025
1471,2006,Class A (Rhodopsin),small molecule,paliperidone,drd2_human,DRD2,20062007,2006,1558,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"paliperidone er, paliperidone palmitate",P14416
1472,2006,Class A (Rhodopsin),small molecule,paliperidone,5ht2a_human,HTR2A,20062007,2006,1558,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"paliperidone er, paliperidone palmitate",P28223
1473,0,Class B1 (Secretin),protein,parathyroid hormone,pth1r_human,PTH1R,-,-,377,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"bn-003,capthymone",Q03431
1474,0,Class B1 (Secretin),protein,parathyroid hormone,pth1r_human,PTH1R,-,-,2012,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,thpth,Q03431
1475,0,Class B1 (Secretin),protein,parathyroid hormone,pth2r_human,PTH2R,-,-,2012,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,thpth,P49190
1476,2015,Class B1 (Secretin),protein,parathyroid horomone,pth1r_human,PTHR1,-,-,MMAmay2016_0745,Control hypocalcemia,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"natpara, npsp558, parathyroid horomone",Q03431
1477,0,Class A (Rhodopsin),small molecule,pardoprunox,ada1a_human,ADRA1A,-,-,1563,Antiparkinson,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P35348
1478,0,Class A (Rhodopsin),small molecule,pardoprunox,ada2a_human,ADRA2A,-,-,1563,Antiparkinson,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P08913
1479,0,Class A (Rhodopsin),small molecule,pardoprunox,drd2_human,DRD2,-,-,1563,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P14416
1480,0,Class A (Rhodopsin),small molecule,pardoprunox,drd3_human,DRD3,-,-,1563,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P35462
1481,0,Class A (Rhodopsin),small molecule,pardoprunox,drd4_human,DRD4,-,-,1563,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P21917
1482,0,Class A (Rhodopsin),small molecule,pardoprunox,5ht1a_human,HTR1A,-,-,1563,Antiparkinson,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P08908
1483,0,Class A (Rhodopsin),small molecule,pardoprunox,5ht7r_human,HTR7,-,-,1563,Antiparkinson,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"pardoprunox, slv 308",P34969
1484,2012,Class A (Rhodopsin),peptide,pasireotide,ssr1_human,SSTR1,2012,2012,1567,Antineoplastic ; acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P30872
1485,2012,Class A (Rhodopsin),peptide,pasireotide,ssr2_human,SSTR2,2012,2012,1567,Antineoplastic ; acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P30874
1486,2012,Class A (Rhodopsin),peptide,pasireotide,ssr3_human,SSTR3,2012,2012,1567,Antineoplastic ; acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P32745
1487,2012,Class A (Rhodopsin),peptide,pasireotide,ssr5_human,SSTR5,2012,2012,1567,Antineoplastic ; acromegaly,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"pasireotide, som230",P35346
1488,0,Class B1 (Secretin),protein,pb1023,glp1r_human,GLP1R,-,-,1569,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"pb1023, glp-1-elp-120,glymera",P43220
1489,0,Class A (Rhodopsin),small molecule,pbf-509,aa2ar_human,ADORA2A,-,-,MMAapril2016_0077,Antineoplastic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-509,P29274
1490,0,Class A (Rhodopsin),small molecule,pbf-680,aa1r_human,ADORA1,-,-,MMAmar2016_0115,Anti-Asthmatic,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-680,P30542
1491,0,Class A (Rhodopsin),small molecule,pbf-999,aa1r_human,ADORA1,-,-,MMAapril2016_0022,Huntington's disease,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,pbf-999,P30542
1492,0,Class A (Rhodopsin),small molecule,pd-6735,mtr1a_human,MTNR1A,-,-,1575,Hypnotics and Sedatives,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"pd-6735, ly-156735",P48039
1493,0,Class A (Rhodopsin),small molecule,pd-6735,mtr1b_human,MTNR1B,-,-,1575,Hypnotics and Sedatives,Melatonin ,,in trial,Melatonin,GPCR;Rhodopsin,established,"pd-6735, ly-156735",P49286
1494,0,Class A (Rhodopsin),peptide,pdc31,pf2r_human,PTGFR,-,-,MMAmay2016_0526,pre-term labor; dysmenorrhea,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,pdc31,P43088
1495,1999,Class A (Rhodopsin),small molecule,pemirolast,hrh1_human,HRH1,1999,1999,NRDD416,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1496,1987,Class A (Rhodopsin),small molecule,penbutolol,adrb1_human,ADRB1,1987,1987,NRDD417,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1497,1987,Class A (Rhodopsin),small molecule,penbutolol,adrb2_human,ADRB2,1987,1987,NRDD417,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1498,1974,Class A (Rhodopsin),small molecule,pentagastrin,gasr_human,CCKBR,-,1974,NRDD418,Diagnostic,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32239
1499,1967,Class A (Rhodopsin),small molecule,pentazocine,oprk_human,OPRK1,1967,1967,NRDD419,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145
1500,1967,Class A (Rhodopsin),small molecule,pentazocine,oprm_human,OPRM1,1967,1967,NRDD419,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
1501,1984,Class A (Rhodopsin),small molecule,pentoxifylline,aa1r_human,ADORA1,1984,1984,1586,amyotrophic lateral sclerosis (ALS),Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"pentoxifylline, eht0201",P30542
1502,1984,Class A (Rhodopsin),small molecule,pentoxifylline,aa2ar_human,ADORA2B,1984,1984,1586,amyotrophic lateral sclerosis (ALS),Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"pentoxifylline, eht0201",P29274
1503,0,Class A (Rhodopsin),peptide,peptide yy,npy2r_human,NPY2R,-,-,699,Appetite suppressant,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,eligen pyy-3-36 + glp-1,P49146
1504,1988,Class A (Rhodopsin),small molecule,pergolide,drd1_human,DRD1,1988,-,NRDD422,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1505,1988,Class A (Rhodopsin),small molecule,pergolide,drd2_human,DRD2,1988,-,NRDD422,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1506,1957,Class A (Rhodopsin),small molecule,perphenazine,drd1_human,DRD1,1957,1957,NRDD425,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1507,1957,Class A (Rhodopsin),small molecule,perphenazine,drd2_human,DRD2,1957,1957,NRDD425,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1508,0,Class A (Rhodopsin),small molecule,pf-00610355,adrb2_human,ADRB2,-,-,1591,Bronchodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,pf-00610355,P07550
1509,0,Class A (Rhodopsin),small molecule,phendimetrazine,ada1a_human,ADRA1A,-,-,NRDD427,Appetite suppressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1510,0,Class A (Rhodopsin),small molecule,phendimetrazine,ada1b_human,ADRA1B,-,-,NRDD427,Appetite suppressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1511,0,Class A (Rhodopsin),small molecule,pheniramine,hrh1_human,HRH1,,-,NRDD431,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1512,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1a_human,ADRA1A,1953,1953,NRDD434,Anticonvulsants; Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1513,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2a_human,ADRA2A,1952,1952,NRDD437,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
1514,0,Class A (Rhodopsin),small molecule,phentolamine ,ada1a_human,ADRA1A,-,-,288,sexual dysfunction,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"aviptadil,invicorp",P35348
1515,0,Class A (Rhodopsin),small molecule,phentolamine ,ada2a_human,ADRA2A,-,-,288,sexual dysfunction,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"aviptadil,invicorp",P08913
1516,1952,Class A (Rhodopsin),small molecule,phenylephrine,ada1a_human,ADRA1A,1952,-,1675,incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P35348
1517,1952,Class A (Rhodopsin),small molecule,phenylephrine,ada1b_human,ADRA1B,1952,-,1675,incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P35368
1518,1952,Class A (Rhodopsin),small molecule,phenylephrine,ada1d_human,ADRA1D,1952,-,1675,incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"psd-503, phenylephrine",P25100
1519,0,Class A (Rhodopsin),small molecule,phenylpropanolamine,ada1a_human,ADRA1A,-,-,NRDD439,Appetite Depressants; Nasal Decongestants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1520,0,Class A (Rhodopsin),small molecule,phenylpropanolamine,ada2a_human,ADRA2A,-,-,NRDD439,Appetite Depressants; Nasal Decongestants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
1521,1974,Class A (Rhodopsin),small molecule,pilocarpine,acm1_human,CHRM1,1974,-,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P11229
1522,1974,Class A (Rhodopsin),small molecule,pilocarpine,acm2_human,CHRM2,1974,-,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08172
1523,1974,Class A (Rhodopsin),small molecule,pilocarpine,acm3_human,CHRM3,1974,-,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P20309
1524,2016,Class A (Rhodopsin),small molecule,pimavanserin,5ht2a_human,HTR2A,-,2016,1610,Antiparkinson,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pimavanserin,P28223
1525,1984,Class A (Rhodopsin),small molecule,pimozide,drd2_human,DRD2,1984,1984,NRDD443,Antidyskinetics; Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1526,1982,Class A (Rhodopsin),small molecule,pindolol,adrb1_human,ADRB1,1982,1982,NRDD444,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1527,1982,Class A (Rhodopsin),small molecule,pindolol,adrb2_human,ADRB2,1982,1982,NRDD444,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1528,0,Class A (Rhodopsin),small molecule,pirenzepine,acm1_human,CHRM1,,-,NRDD446,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1529,2008,Class A (Rhodopsin),small molecule,plerixafor,cxcr4_human,CXCR4,20082009,2008,1342,Antineoplastic,Protein ,,approved,Chemokine receptors,GPCR;Rhodopsin,established,mozobil,P61073
1530,0,Class A (Rhodopsin),small molecule,ponesimod,s1pr1_human,S1PR1,-,-,1630,Anti-inflammatory ; multiple sclerosis,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,ponesimod,P21453
1531,0,Class A (Rhodopsin),small molecule,practolol,adrb1_human,ADRB1,,-,NRDD449,Anti-Arrhythmia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08588
1532,1997,Class A (Rhodopsin),small molecule,pramipexole,drd2_human,DRD2,1997,1997,1293,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P14416
1533,1997,Class A (Rhodopsin),small molecule,pramipexole,drd3_human,DRD3,1997,1997,1293,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P35462
1534,1997,Class A (Rhodopsin),small molecule,pramipexole,drd4_human,DRD4,1997,1997,1293,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,mirapex,P21917
1535,1997,Class A (Rhodopsin),small molecule,pramipexole,drd2_human,DRD2,1997,1997,MMAmar2016_0004,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P14416
1536,1997,Class A (Rhodopsin),small molecule,pramipexole,drd4_human,DRD4,1997,1997,MMAmar2016_0005,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P21917
1537,1997,Class A (Rhodopsin),small molecule,pramipexole,drd3_human,DRD3,1997,1997,MMAmar2016_0006,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,p2b001,P35462
1538,2005,Class B1 (Secretin),peptide,pramlintide,calcr_human,CALCR,2005,-,1924,Antidiabetic,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,symlin,P30988
1539,0,Class A (Rhodopsin),small molecule,pranlukast,cltr1_human,CYSLTR1,,-,NRDD451,Anti-Asthmatic,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271
1540,2009,Class A (Rhodopsin),small molecule,prasugrel,p2y12_human,P2RY12,2009,2009,1640,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"prasugrel, cs-747,efient",Q9H244
1541,1976,Class A (Rhodopsin),small molecule,prazosin,ada1a_human,ADRA1A,1976,1976,NRDD453,Antihypertensive ; antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1542,1976,Class A (Rhodopsin),small molecule,prazosin,ada1b_human,ADRA1B,1976,1976,NRDD453,Antihypertensive ; antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1543,1976,Class A (Rhodopsin),small molecule,prazosin,ada1d_human,ADRA1D,1976,1976,NRDD453,Antihypertensive ; antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
1544,0,Class A (Rhodopsin),small molecule,preladenant,aa2ar_human,ADORA2A,-,-,1645,Antiparkinson,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"preladenant, sch-420814",P29274
1545,0,Class A (Rhodopsin),small molecule,pridopidine,drd2_human,DRD2,-,-,1647,Huntington's disease,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,"pridopidine, acr-16,huntexil",P14416
1546,0,Class A (Rhodopsin),antibody,pro 140,ccr5_human,CCR5,-,-,1649,antiviral ; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,pro 140,P51681
1547,0,Class A (Rhodopsin),small molecule,procaterol,adrb2_human,ADRB2,,-,NRDD459,Bronchodilator,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1548,1956,Class A (Rhodopsin),small molecule,prochlorperazine,drd2_human,DRD2,1956,1956,301,Anti-migraine,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"az-001, staccato prochlorperazine",P14416
1549,0,Class A (Rhodopsin),small molecule,prochlorperazine ,drd2_human,DRD2,-,-,395,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"buccal prochlorperazine maleate,emezine",P14416
1550,1955,Class A (Rhodopsin),small molecule,procyclidine,acm1_human,CHRM1,1955,1955,NRDD460,Antidyskinetics; Antiparkinson s,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1551,1955,Class A (Rhodopsin),small molecule,procyclidine,acm2_human,CHRM2,1955,1955,NRDD460,Antidyskinetics; Antiparkinson s,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1552,1955,Class A (Rhodopsin),small molecule,procyclidine,acm4_human,CHRM4,1955,1955,NRDD460,Antidyskinetics; Antiparkinson s,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
1553,0,Class C (Glutamate) ,small molecule,progabide,gabr1_human,GABBR1,-,-,NRDD461,Anticonvulsants,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,-,Q9UBS5
1554,1956,Class A (Rhodopsin),small molecule,promazine,ada1a_human,ADRA1A,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1555,1956,Class A (Rhodopsin),small molecule,promazine,ada1b_human,ADRA1B,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1556,1956,Class A (Rhodopsin),small molecule,promazine,ada1d_human,ADRA1D,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
1557,1956,Class A (Rhodopsin),small molecule,promazine,acm1_human,CHRM1,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1558,1956,Class A (Rhodopsin),small molecule,promazine,acm2_human,CHRM2,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1559,1956,Class A (Rhodopsin),small molecule,promazine,acm3_human,CHRM3,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
1560,1956,Class A (Rhodopsin),small molecule,promazine,acm4_human,CHRM4,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
1561,1956,Class A (Rhodopsin),small molecule,promazine,acm5_human,CHRM5,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
1562,1956,Class A (Rhodopsin),small molecule,promazine,drd1_human,DRD1,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1563,1956,Class A (Rhodopsin),small molecule,promazine,drd2_human,DRD2,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1564,1956,Class A (Rhodopsin),small molecule,promazine,drd4_human,DRD4,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917
1565,1956,Class A (Rhodopsin),small molecule,promazine,hrh1_human,HRH1,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1566,1956,Class A (Rhodopsin),small molecule,promazine,5ht2a_human,HTR2A,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1567,1956,Class A (Rhodopsin),small molecule,promazine,5ht2c_human,HTR2C,1956,1956,NRDD462,Antiemetics; Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
1568,1951,Class A (Rhodopsin),small molecule,promethazine,acm1_human,CHRM1,1951,-,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1569,1951,Class A (Rhodopsin),small molecule,promethazine,acm2_human,CHRM2,1951,-,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1570,1951,Class A (Rhodopsin),small molecule,promethazine,acm3_human,CHRM3,1951,-,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
1571,1951,Class A (Rhodopsin),small molecule,promethazine,acm4_human,CHRM4,1951,-,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
1572,1951,Class A (Rhodopsin),small molecule,promethazine,acm5_human,CHRM5,1951,-,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
1573,1951,Class A (Rhodopsin),small molecule,promethazine,hrh1_human,HRH1,1951,-,NRDD463,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1574,1951,Class A (Rhodopsin),small molecule,promethazine,acm2_human,CHRM2,1951,-,MMAapril2016_0100,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08172
1575,1951,Class A (Rhodopsin),small molecule,promethazine,acm4_human,CHRM4,1951,-,MMAapril2016_0101,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08173
1576,1951,Class A (Rhodopsin),small molecule,promethazine,acm5_human,CHRM5,1951,-,MMAapril2016_0102,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08912
1577,1951,Class A (Rhodopsin),small molecule,promethazine,acm1_human,CHRM1,1951,-,MMAapril2016_0103,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P11229
1578,1951,Class A (Rhodopsin),small molecule,promethazine,acm3_human,CHRM3,1951,-,MMAapril2016_0104,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P20309
1579,1951,Class A (Rhodopsin),small molecule,promethazine,hrh1_human,HRH1,1951,-,MMAapril2016_0105,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P35367
1580,1953,Class A (Rhodopsin),small molecule,propantheline,acm1_human,CHRM1,1953,1953,NRDD464,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1581,0,Class A (Rhodopsin),small molecule,propericiazine,ada1a_human,ADRA1A,-,-,NRDD466,schizophrenia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1582,0,Class A (Rhodopsin),small molecule,propericiazine,ada1b_human,ADRA1B,-,-,NRDD466,schizophrenia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1583,0,Class A (Rhodopsin),small molecule,propericiazine,ada1d_human,ADRA1D,-,-,NRDD466,schizophrenia,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
1584,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1a_human,ADRA1A,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1585,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1b_human,ADRA1B,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1586,1960,Class A (Rhodopsin),small molecule,propiomazine,ada1d_human,ADRA1D,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
1587,1960,Class A (Rhodopsin),small molecule,propiomazine,acm1_human,CHRM1,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1588,1960,Class A (Rhodopsin),small molecule,propiomazine,acm2_human,CHRM2,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1589,1960,Class A (Rhodopsin),small molecule,propiomazine,acm3_human,CHRM3,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
1590,1960,Class A (Rhodopsin),small molecule,propiomazine,acm4_human,CHRM4,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
1591,1960,Class A (Rhodopsin),small molecule,propiomazine,acm5_human,CHRM5,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
1592,1960,Class A (Rhodopsin),small molecule,propiomazine,drd1_human,DRD1,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1593,1960,Class A (Rhodopsin),small molecule,propiomazine,drd2_human,DRD2,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1594,1960,Class A (Rhodopsin),small molecule,propiomazine,drd4_human,DRD4,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917
1595,1960,Class A (Rhodopsin),small molecule,propiomazine,hrh1_human,HRH1,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1596,1960,Class A (Rhodopsin),small molecule,propiomazine,5ht2a_human,HTR2A,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1597,1960,Class A (Rhodopsin),small molecule,propiomazine,5ht2c_human,HTR2C,1960,1960,NRDD467,Hypnotics and Sedatives,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
1598,1957,Class A (Rhodopsin),small molecule,propoxyphene,oprd_human,OPRD1,-,1957,NRDD468,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41143
1599,1957,Class A (Rhodopsin),small molecule,propoxyphene,oprk_human,OPRK1,-,1957,NRDD468,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P41145
1600,1957,Class A (Rhodopsin),small molecule,propoxyphene,oprm_human,OPRM1,-,1957,NRDD468,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,-,P35372
1601,1967,Class A (Rhodopsin),small molecule,propranolol,adrb1_human,ADRB1,1967,1967,2183,cancer cachexia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,vt-122,P08588
1602,0,Class A (Rhodopsin),small molecule,prs-211375,cnr2_human,CNR2,-,-,429,Analgesics,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,cannabinor,P34972
1603,2009,Class A (Rhodopsin),small molecule,prucalopride,5ht4r_human,HTR4,2009,-,1665,motilitant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"prucalopride ,resolor",Q13639
1604,0,Class A (Rhodopsin),small molecule,prx-00023,5ht1a_human,HTR1A,-,-,1666,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-00023,P08908
1605,0,Class A (Rhodopsin),small molecule,prx-07034,5ht6r_human,HTR6,-,-,1667,Anti-obesity ; nootropic,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-07034,P50406
1606,0,Class A (Rhodopsin),small molecule,prx-08066,5ht2b_human,HTR2B,-,-,1668,Antihypertensive,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-08066,P41595
1607,0,Class A (Rhodopsin),small molecule,prx-3140,5ht4r_human,HTR4,-,-,1671,Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,prx-3140,Q13639
1608,0,Class A (Rhodopsin),small molecule,ps433540,agtr1_human,AGTR1,-,-,1673,Antihypertensive,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,ps433540,P30556
1609,0,Class A (Rhodopsin),small molecule,ps433540,agtr2_human,AGTR2,-,-,1673,Antihypertensive,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ps433540,P50052
1610,0,Class A (Rhodopsin),small molecule,ps433540,ednra_human,EDNRA,-,-,1673,Antihypertensive,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,ps433540,P25101
1611,0,Class A (Rhodopsin),small molecule,psd-506,acm2_human,CHRM2,-,-,1676,overactive bladder,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,psd-506,P08172
1612,0,Class A (Rhodopsin),small molecule,psd-506,acm3_human,CHRM3,-,-,1676,overactive bladder,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,psd-506,P20309
1613,1975,Class A (Rhodopsin),small molecule,pseudoephedrine,ada1a_human,ADRA1A,1975,-,789,Anti-Allergic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P35348
1614,1975,Class A (Rhodopsin),small molecule,pseudoephedrine,ada2a_human,ADRA2A,1975,-,789,Anti-Allergic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,fexofenadine + ps/,P08913
1615,0,Class A (Rhodopsin),small molecule,psn602,5ht1a_human,HTR1A,-,-,1678,Anti-obesity,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,psn602,P08908
1616,0,Class A (Rhodopsin),small molecule,psn821,gp119_human,GPR119,-,-,1679,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,psn821,Q8TDV5
1617,0,Class A (Rhodopsin),small molecule,pw2101,adrb2_human,ADRB2,-,-,1690,Antihypertensive,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,pw2101,P07550
1618,0,Class C (Glutamate) ,small molecule,pxt002331,grm4_human,GRM4,-,-,MMAmay2016_0906,Antiparkinson,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,pxt002331,Q14833
1619,0,Class A (Rhodopsin),peptide,pyy3-36,npy2r_human,NPY2R,-,-,1698,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,pyy3-36,P49146
1620,0,Class A (Rhodopsin),small molecule,q-122,cxcr4_human,CXCR4,-,-,MMAmar2016_0157,Anti-inflammatory ; hot flashes,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,q-122,P61073
1621,1997,Class A (Rhodopsin),small molecule,quetiapine,drd2_human,DRD2,1997,1997,1840,Antipsychotic ; Anti-depressant,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,seroquel,P14416
1622,1997,Class A (Rhodopsin),small molecule,quetiapine,5ht2a_human,HTR2A,1997,1997,1840,Antipsychotic ; Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P28223
1623,1997,Class A (Rhodopsin),small molecule,quetiapine,5ht2b_human,HTR2B,1997,1997,1840,Antipsychotic ; Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P41595
1624,1997,Class A (Rhodopsin),small molecule,quetiapine,5ht2c_human,HTR2C,1997,1997,1840,Antipsychotic ; Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,seroquel,P28335
1625,2005,Class A (Rhodopsin),small molecule,ramelteon,mtr1a_human,MTNR1A,2005,2005,1713,insomnia,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"ramelteon, tak-375,rozerem",P48039
1626,2005,Class A (Rhodopsin),small molecule,ramelteon,mtr1b_human,MTNR1B,2005,2005,1713,insomnia,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"ramelteon, tak-375,rozerem",P49286
1627,1977,Class A (Rhodopsin),small molecule,ranitidine,hrh2_human,HRH2,1977,1983,1716,antiulcer,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"ranitidine bismuth citrate,tritec",P25021
1628,1977,Class A (Rhodopsin),small molecule,ranitidine,hrh2_human,HRH2,1977,1983,2238,antiulcer,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,"zantac,ranitidine hydrochloride",P25021
1629,0,Class C (Glutamate) ,small molecule,r-baclofen,gabr1_human,GABBR1,-,-,2222,gastrointestinal reflux disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,xp19986,Q9UBS5
1630,0,Class C (Glutamate) ,small molecule,r-baclofen,gabr2_human,GABBR2,-,-,2222,gastrointestinal reflux disease,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,xp19986,O75899
1631,0,Class A (Rhodopsin),small molecule,"re-021, sparsentan",agtr1_human,AGTR1,-,-,MMAapril2016_0044,kidney disease; nephropathy,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,"re-021, sparsentan",P30556
1632,0,Class A (Rhodopsin),small molecule,"re-021, sparsentan",ednra_human,EDNRA,-,-,MMAapril2016_0045,kidney disease; nephropathy,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"re-021, sparsentan",P25101
1633,0,Class A (Rhodopsin),small molecule,"re-034, cosyntropin, tetracosactid",acthr_human,MC2R,-,-,MMAmar2016_0275,epilepsy,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,"re-034, cosyntropin, tetracosactid",Q01718
1634,0,Class A (Rhodopsin),protein,recombinant human chorionic gonadotropin,lshr_human,LHCGR,-,-,1756,Antineoplastic,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"r-hcg,ovidrel",P22888
1635,0,Class B1 (Secretin),protein,recombinant parathyroid hormone,pth1r_human,PTH1R,-,-,2799,hypoparathyroidism,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"air parathyroid hormone, air pth",Q03431
1636,2008,Class A (Rhodopsin),small molecule,regadenoson,aa2ar_human,ADORA2A,20082010,2008,1726,Diagnostic,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"regadenoson,lexiscan",P29274
1637,0,Class B1 (Secretin),antibody,remd-477,glr_human,GCGR,-,-,MMAapril2016_0214,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,remd-477,P47871
1638,1996,Class A (Rhodopsin),small molecule,remifentanil,oprm_human,OPRM1,1996,1996,1732,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"remifentanil,ultiva",P35372
1639,0,Class A (Rhodopsin),small molecule,remoxipride,drd2_human,DRD2,-,-,NRDD479,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1640,0,Class A (Rhodopsin),small molecule,renzapride,5ht2a_human,HTR2A,-,-,1734,irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P28223
1641,0,Class A (Rhodopsin),small molecule,renzapride,5ht2b_human,HTR2B,-,-,1734,irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P41595
1642,0,Class A (Rhodopsin),small molecule,renzapride,5ht2c_human,HTR2C,-,-,1734,irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,P28335
1643,0,Class A (Rhodopsin),small molecule,renzapride,5ht4r_human,HTR4,-,-,1734,irritable bowel syndrome,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,renzapride,Q13639
1644,0,Class A (Rhodopsin),small molecule,reparixin,cxcr1_human,CXCR1,-,-,MMAmay2016_0551,Antidiabetic; type I diabetes,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,reparixin,P25024
1645,0,Class A (Rhodopsin),small molecule,reparixin,cxcr2_human,CXCR2,-,-,MMAmay2016_0552,Antidiabetic; type I diabetes,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,reparixin,P25025
1646,0,Class A (Rhodopsin),small molecule,rev131,hrh4_human,HRH4,-,-,1745,Anti-Allergic,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,rev131,Q9H3N8
1647,0,Class B1 (Secretin),peptide,rg1068,sctr_human,SCTR,-,-,1749,autism,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"rg1068, synthetic secretin,secreflo",P47872
1648,0,Class A (Rhodopsin),small molecule,ridogrelum,ta2r_human,TBXA2R,-,-,MMAjun2016_0002,for the prevention of systemic thrombo-embolism; adjunctive  to thrombolytic therapy,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,ridogrel,P21731
1649,2007,Class A (Rhodopsin),small molecule,rimonabant,cnr1_human,CNR1,2007,-,1766,Anti-obesity,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,rimonabant,P21554
1650,0,Class A (Rhodopsin),small molecule,risperdal,drd2_human,DRD2,-,-,1770,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,risperdal,P14416
1651,0,Class A (Rhodopsin),small molecule,risperdal,5ht2a_human,HTR2A,-,-,1770,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,risperdal,P28223
1652,1993,Class A (Rhodopsin),small molecule,risperidone,drd2_human,DRD2,1993,1993,NRDD484,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1653,1993,Class A (Rhodopsin),small molecule,risperidone,5ht2a_human,HTR2A,1993,1993,NRDD484,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1654,1987,Class A (Rhodopsin),small molecule,ritodrine,adrb2_human,ADRB2,1987,-,NRDD485,Tocolytic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1655,1998,Class A (Rhodopsin),small molecule,rizatriptan,5ht1b_human,HTR1B,1998,1998,NRDD486,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28222
1656,1998,Class A (Rhodopsin),small molecule,rizatriptan,5ht1d_human,HTR1D,1998,1998,NRDD486,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28221
1657,0,Class A (Rhodopsin),peptide,"rm-493, setmelanotide",mc4r_human,MC4R,-,-,MMAmay2016_0229,Anti-obesity,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,"rm-493, setmelanotide",P32245
1658,0,Class C (Glutamate) ,small molecule,ro4917523,grm5_human,GRM5,-,-,MMAmay2016_0177,Fragile X syndrome,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,ro4917523,P41594
1659,2008,Class A (Rhodopsin),small molecule,rocuronium,acm2_human,CHRM2,2008,1994,1776,Muscle Relaxants,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"rocuronium bromide,esmeron, zemuron, eslax",P08172
1660,2015,Class A (Rhodopsin),small molecule,rolapitant,nk1r_human,TACR1,2015,2015,MMAmay2016_0753,Antiemetics,Peptide ,,approved,Tachykinin receptors,GPCR;Rhodopsin,established,"sch 619734, rolapitant",P25103
1661,0,Class A (Rhodopsin),small molecule,rolofylline,aa1r_human,ADORA1,-,-,1780,congestive heart failure,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,"rolofylline, mk-7418, kw-3902",P30542
1662,0,Class C (Glutamate) ,small molecule,ronacaleret,casr_human,CASR,-,-,1782,Anti-osteoporotic,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"ronacaleret, 751689",P41180
1663,1997,Class A (Rhodopsin),small molecule,ropinirole,drd2_human,DRD2,19972006,1997,1057,restless legs syndrome,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,jzp-7,P14416
1664,1997,Class A (Rhodopsin),small molecule,ropinirole,drd3_human,DRD3,19972006,1997,1057,restless legs syndrome,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,jzp-7,P35462
1665,1997,Class A (Rhodopsin),small molecule,ropinirole,drd2_human,DRD2,19972006,1997,1737,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,requip,P14416
1666,1997,Class A (Rhodopsin),small molecule,ropinirole,drd3_human,DRD3,19972006,1997,1737,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,requip,P35462
1667,2006,Class A (Rhodopsin),small molecule,rotigotine,drd2_human,DRD2,20062007,2007,1404,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P14416
1668,2006,Class A (Rhodopsin),small molecule,rotigotine,drd3_human,DRD3,20062007,2007,1404,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P35462
1669,2006,Class A (Rhodopsin),small molecule,rotigotine,drd4_human,DRD4,20062007,2007,1404,Antiparkinson,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,neupro,P21917
1670,0,Class A (Rhodopsin),small molecule,rpc1063,s1pr1_human,S1PR1,-,-,1790,Multiple Sclerosis,Lipid ,,in trial,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,rpc1063,P21453
1671,0,Class A (Rhodopsin),peptide,rusalatide,par1_human,F2R,-,-,2048,diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",P25116
1672,0,Class A (Rhodopsin),peptide,rusalatide,par3_human,F2RL2,-,-,2048,diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",O00254
1673,0,Class A (Rhodopsin),peptide,rusalatide,par4_human,F2RL3,-,-,2048,diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",Q96RI0
1674,0,Class A (Rhodopsin),small molecule,"rvt-101, sb-742457, gsk 742457",5ht6r_human,HTR6,-,-,MMAmar2016_0106,Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"rvt-101, sb-742457, gsk 742457",P50406
1675,0,Class A (Rhodopsin),small molecule,rx-10045,lt4r1_human,BLT1,-,-,2317,dry eye,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,not established,rx-10045,Q15722
1676,0,Class A (Rhodopsin),small molecule,rx-10045,cml1_human,CMKLR1,-,-,2317,dry eye,Protein ,,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,rx-10045,Q99788
1677,0,Class A (Rhodopsin),antibody,ryi-018,cnr1_human,CNR1,-,-,MMAapril2016_0280,liver disease; nonalcoholic steatohepatitis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,ryi-018,P21554
1678,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1981,-,102,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"albuterol,ventolin",P07550
1679,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1981,-,1021,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ipratropium bromide + albuterol sulfate,duoneb",P07550
1680,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1981,-,1116,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,levalbuterol,P07550
1681,1981,Class A (Rhodopsin),small molecule,salbutamol,adrb2_human,ADRB2,1981,-,1146,symptomatic exophthalmos associated with thyroid-related eye disease,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"lipo-102, salmeterol xinafoate + fluticasone propionate",P07550
1682,1994,Class A (Rhodopsin),small molecule,salmeterol,adrb2_human,ADRB2,1994,1994,61,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,advair/seretide/adoair,P07550
1683,1994,Class A (Rhodopsin),small molecule,salmeterol,adrb2_human,ADRB2,1994,1994,1839,Bronchodilator,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serevent,P07550
1684,0,Class B1 (Secretin),peptide,salmon calcitonin,calcr_human,CALCR,-,-,817,Anti-osteoporotic,Peptide ,,approved,Calcitonin receptors,GPCR;Secretin,established,fortical,P30988
1685,0,Class A (Rhodopsin),small molecule,samidoprhan,oprm_human,MOR,-,-,APR13_0013,addiction,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,alks 3831,P35372
1686,0,Class A (Rhodopsin),small molecule,saprisartan,agtr1_human,AGTR1,-,-,NRDD489,Antihypertensive,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556
1687,0,Class A (Rhodopsin),small molecule,saredutant,nk2r_human,TACR2,-,-,1810,Anti-depressant,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"saredutant, sr 48968",P21452
1688,0,Class A (Rhodopsin),small molecule,sch-527123,cxcr1_human,CXCR1,-,-,1822,chronic obstructive pulmonary disease (COPD),Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"sch-527123, ps-291822, ps-938285",P25024
1689,0,Class A (Rhodopsin),small molecule,sch-527123,cxcr2_human,CXCR2,-,-,1822,chronic obstructive pulmonary disease (COPD),Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,"sch-527123, ps-291822, ps-938285",P25025
1690,1953,Class A (Rhodopsin),small molecule,scopolamine,acm1_human,CHRM1,1953,-,NRDD491,Adjuvants; Anesthesia; Antispasmodics; Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1691,2002,Class B1 (Secretin),peptide,secretin,sctr_human,SCTR,2002,2004,NRDD493,Diagnostic,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,P47872
1692,2015,Class A (Rhodopsin),small molecule,selexipag,pi2r_human,PTGIR,2015,2015,1831,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"selexipag, act-293987",P43119
1693,0,Class B1 (Secretin),peptide,"semaglutide, nn9535 ",glp1r_human,GLP1R,-,-,MMAmay2016_0563,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"semaglutide, nn9535 ",P43220
1694,0,Class A (Rhodopsin),small molecule,sens-111,hrh4_human,HRH4,-,-,MMAapril2016_0282,for vertigo and tinnitus,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,sens-111,Q9H3N8
1695,0,Class A (Rhodopsin),small molecule,ser100,oprx_human,OPRL1,-,-,MMAmay2016_0735,Antihypertensive,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,not established,ser100,P41146
1696,1990,Class B1 (Secretin),peptide,sermorelin,ghrhr_human,GHRHR,1990,1990,NRDD494,Hormone Replacement,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,-,Q02643
1697,0,Class A (Rhodopsin),small molecule,sertindole,ada1a_human,ADRA1A,,-,1838,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P35348
1698,0,Class A (Rhodopsin),small molecule,sertindole,ada1b_human,ADRA1B,,-,1838,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P35368
1699,0,Class A (Rhodopsin),small molecule,sertindole,ada1d_human,ADRA1D,,-,1838,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,serdolect,P25100
1700,0,Class A (Rhodopsin),small molecule,sertindole,drd2_human,DRD2,,-,1838,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,serdolect,P14416
1701,0,Class A (Rhodopsin),small molecule,sertindole,5ht2a_human,HTR2A,,-,1838,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P28223
1702,0,Class A (Rhodopsin),small molecule,sertindole,5ht2c_human,HTR2C,,-,1838,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P28335
1703,0,Class A (Rhodopsin),small molecule,sertindole,5ht6r_human,HTR6,,-,1838,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,serdolect,P50406
1704,2008,Class A (Rhodopsin),small molecule,silodosin,ada1a_human,ADRA1A,20082010,2008,1852,BPH-related urinary symptoms,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,silodosin,P35348
1705,0,Class A (Rhodopsin),small molecule,sitaxsentan,ednra_human,EDNRA,,-,2010,Antihypertensive,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,thelin,P25101
1706,0,Class A (Rhodopsin),small molecule,sofpironium bromide,acm3_human,CHRM3,-,-,MMAmay2016_0805,Anticholinergics; for the√Ç¬†topical treatment of primary axillary hyperhidrosis,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bbi-4000,P20309
1707,0,Class A (Rhodopsin),small molecule,solabegron,adrb3_human,ADRB3,-,-,1874,Antidiabetic; irritable bowel syndrome; antiincontinence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"solabegron, gw 427353",P13945
1708,2004,Class A (Rhodopsin),small molecule,solifenacin,acm1_human,CHRM1,20042009,2004,1876,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P11229
1709,2004,Class A (Rhodopsin),small molecule,solifenacin,acm2_human,CHRM2,20042009,2004,1876,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08172
1710,2004,Class A (Rhodopsin),small molecule,solifenacin,acm3_human,CHRM3,20042009,2004,1876,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P20309
1711,2004,Class A (Rhodopsin),small molecule,solifenacin,acm4_human,CHRM4,20042009,2004,1876,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08173
1712,2004,Class A (Rhodopsin),small molecule,solifenacin,acm5_human,CHRM5,20042009,2004,1876,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"solifenacin succinate, ym-905,vesicare",P08912
1713,2015,Class F (Frizzled),small molecule,sonidegib,smo_human,SMO,2015,2015,1101,Antineoplastic,Protein ,,approved,Frizzled,GPCR;Frizzled,established,lde225,Q99835
1714,0,Class A (Rhodopsin),small molecule,sou-001,ada1a_human,ADRA1A,-,-,1881,incontinence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P35348
1715,0,Class A (Rhodopsin),small molecule,sou-001,ada1b_human,ADRA1B,-,-,1881,incontinence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P35368
1716,0,Class A (Rhodopsin),small molecule,sou-001,ada1d_human,ADRA1D,-,-,1881,incontinence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,"sou-001, drp-001",P25100
1717,0,Class A (Rhodopsin),small molecule,sou-003,v2r_human,AVPR2,-,-,1882,incontinence,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"sou-003, opc-51803",P30518
1718,0,Class A (Rhodopsin),peptide,spi-1620,ednra_human,EDNRA,-,-,1892,adjuvant to chemotherapy,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,spi-1620,P25101
1719,0,Class A (Rhodopsin),peptide,spi-1620,ednrb_human,EDNRB,-,-,1892,adjuvant to chemotherapy,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,spi-1620,P24530
1720,0,Class A (Rhodopsin),peptide,srx-1177,mshr_human,MC1R,-,-,MMAapril2016_0099,Antineoplastic,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,srx-1177,Q01726
1721,0,Class C (Glutamate) ,small molecule,strontium ranelate,casr_human,CASR,-,-,1905,Anti-osteoporotic,Ion ,,in trial,Calcium-sensing receptors,GPCR;Glutamate,established,"strontium ranelate, s12911",P41180
1722,0,Class C (Glutamate) ,small molecule,stx107,grm5_human,GRM5,-,-,1906,Fragile X syndrome,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,established,stx107,P41594
1723,1952,Class A (Rhodopsin),small molecule,succinylcholine,acm1_human,CHRM1,1952,1952,NRDD501,Muscle Relaxants; Skeletal,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1724,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1984,1984,242,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P41143
1725,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1984,1984,242,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P41145
1726,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1984,1984,242,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-01, sufentanil nanotab",P35372
1727,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1984,1984,243,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P41143
1728,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1984,1984,243,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P41145
1729,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1984,1984,243,Analgesics; adjuvant to anesthesia,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"arx-03, sufentanil + triazolam nanotab",P35372
1730,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1984,1984,1909,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P41143
1731,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1984,1984,1909,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P41145
1732,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1984,1984,1909,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil transdermal patch,transdur-sufentanil",P35372
1733,1984,Class A (Rhodopsin),small molecule,sufentanil,oprd_human,OPRD1,1984,1984,1910,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P41143
1734,1984,Class A (Rhodopsin),small molecule,sufentanil,oprk_human,OPRK1,1984,1984,1910,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P41145
1735,1984,Class A (Rhodopsin),small molecule,sufentanil,oprm_human,OPRM1,1984,1984,1910,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"sufentanil,chronogesic",P35372
1736,0,Class A (Rhodopsin),small molecule,sulpiride,drd2_human,DRD2,,-,NRDD504,Antidepressive ; Second-Generation; Antipsychotic,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1737,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1992,1992,MMAapril2016_0106,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P08908
1738,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1992,1992,MMAapril2016_0107,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P28221
1739,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1992,1992,MMAapril2016_0108,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P28222
1740,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1992,1992,MMAapril2016_0109,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"cl-h1t, promethazine + sumatriptan",P30939
1741,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1992,1992,1357,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P08908
1742,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1992,1992,1357,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P28222
1743,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1992,1992,1357,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P28221
1744,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1992,1992,1357,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"mt 400,treximet",P30939
1745,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1992,1992,1438,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P08908
1746,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1992,1992,1438,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P28222
1747,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1992,1992,1438,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P28221
1748,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1992,1992,1438,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"np101,zelrix",P30939
1749,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1992,1992,1914,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P08908
1750,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1992,1992,1914,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P28222
1751,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1992,1992,1914,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P28221
1752,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1992,1992,1914,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,sumatriptan,P30939
1753,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1992,1992,1915,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P08908
1754,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1992,1992,1915,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P28222
1755,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1992,1992,1915,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P28221
1756,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1992,1992,1915,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan, triptan",P30939
1757,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1a_human,HTR1A,1992,1992,1916,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P08908
1758,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1b_human,HTR1B,1992,1992,1916,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P28222
1759,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1d_human,HTR1D,1992,1992,1916,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P28221
1760,1992,Class A (Rhodopsin),small molecule,sumatriptan,5ht1f_human,HTR1F,1992,1992,1916,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"sumatriptan,imitrex",P30939
1761,0,Class A (Rhodopsin),small molecule,surinabant,cnr1_human,CNR1,-,-,1917,smoking-cessation,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"surinabant, sr 147778",P21554
1762,0,Class A (Rhodopsin),small molecule,suvn-502,5ht6r_human,HTR6,-,-,1920,Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,suvn-502,P50406
1763,0,Class A (Rhodopsin),small molecule,suvn-d4010,5ht4r_human,HTR4,-,-,MMAmar2016_0094,Alzheimer's disease,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,suvn-d4010,Q13639
1764,0,Class A (Rhodopsin),small molecule,suvn-g3031,hrh3_human,HRH3,-,-,MMAmar2016_0093,Alzheimer's disease,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,suvn-g3031,Q9Y5N1
1765,2014,Class A (Rhodopsin),small molecule,suvorexant,ox1r_human,HCRTR1,2014,2014,1304,Hypnotics and Sedatives,Peptide ,,approved,Orexin receptors,GPCR;Rhodopsin,established,mk-4305,O43613
1766,2014,Class A (Rhodopsin),small molecule,suvorexant,ox2r_human,HCRTR2,2014,2014,1304,Hypnotics and Sedatives,Peptide ,,approved,Orexin receptors,GPCR;Rhodopsin,established,mk-4305,O43614
1767,0,Class A (Rhodopsin),small molecule,svt-40776,acm3_human,CHRM3,-,-,1921,incontinence,Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,svt-40776,P20309
1768,0,Class A (Rhodopsin),sirna,syl040012,adrb2_human,ADRB2,-,-,1922,Antiglaucomic,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,syl040012,P07550
1769,0,Class A (Rhodopsin),small molecule,syn120,5ht6r_human,HTR6,-,-,MMAapril2016_0309,cognitive disorders,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,syn120,P50406
1770,0,Class A (Rhodopsin),small molecule,syn120,5ht2a_human,HTR2A,-,-,MMAapril2016_0310,cognitive disorders,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,syn120,P28223
1771,0,Class A (Rhodopsin),small molecule,t111,aa2ar_human,ADORA2A,-,-,MMAmay2016_0579,pruritus,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,t111,P29274
1772,0,Class A (Rhodopsin),small molecule,t-62,aa1r_human,ADORA1,-,-,1930,Analgesics,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,t-62,P30542
1773,2012,Class A (Rhodopsin),small molecule,tafluprost,pf2r_human,PTGFR,2012,2012,MMAmay2016_0794,Reduce intraocular pressure,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"taflotan, tapros, zioptan, tafluprost, saflutan, de-085, mk-2452",P43088
1774,0,Class A (Rhodopsin),small molecule,"tak-875, fasiglifam",ffar1_human,FFAR1,-,-,MMAmay2016_0580,Antidiabetic,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,"tak-875, fasiglifam",O14842
1775,0,Class F (Frizzled),small molecule,"taladegib, ly2940680",smo_human,SMO,-,-,MMAmar2016_0177,Antineoplastic,Protein ,,in trial,Frizzled,GPCR;Frizzled,established,"taladegib, ly2940680",Q99835
1776,0,Class A (Rhodopsin),small molecule,talnetant,nk3r_human,TACR3,-,-,1943,schizophrenia,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"talnetant, sb 223412",P29371
1777,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1a_human,ADRA1A,1997,1997,675,benign prostatic hyperplasia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"dutasteride + tamsulosin,jalyn",P35348
1778,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1a_human,ADRA1A,1997,1997,1946,urinary symptoms associated with BPH,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P35348
1779,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1b_human,ADRA1B,1997,1997,1946,urinary symptoms associated with BPH,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P35368
1780,1997,Class A (Rhodopsin),small molecule,tamsulosin,ada1d_human,ADRA1D,1997,1997,1946,urinary symptoms associated with BPH,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tamsulosin, ym-617,harnal, flomax",P25100
1781,2008,Class A (Rhodopsin),small molecule,tapentadol,oprm_human,OPRM1,2008,2008,1950,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,tapentadol,P35372
1782,2008,Class A (Rhodopsin),small molecule,tapentadol,oprm_human,MOR,2008,2008,1951,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tapentadol hydrochloride, cg-5503, r331333",P35372
1783,0,Class A (Rhodopsin),small molecule,taranabant,cnr1_human,CNR1,-,-,1952,Anti-obesity ; smoking-cessation,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"taranabant, mk-0364",P21554
1784,2014,Class A (Rhodopsin),small molecule,tasimelteon,mtr1a_human,MTNR1A,20142015,2014,1956,Hypnotics and Sedatives,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"tasimelteon, vec-162",P48039
1785,2014,Class A (Rhodopsin),small molecule,tasimelteon,mtr1b_human,MTNR1B,20142015,2014,1956,Hypnotics and Sedatives,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"tasimelteon, vec-162",P49286
1786,0,Class A (Rhodopsin),small molecule,tasosartan,agtr1_human,AGTR1,-,-,NRDD509,Antihypertensive,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,-,P30556
1787,0,Class B1 (Secretin),protein,taspoglutide,glp1r_human,GLP1R,-,-,1958,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"taspoglutide, itm-077, r1583, bim-51077",P43220
1788,0,Class A (Rhodopsin),small molecule,tbr-652,ccr5_human,CCR5,-,-,1962,antiviral ; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"tbr-652, tak-652",P51681
1789,0,Class A (Rhodopsin),small molecule,td-1211,oprm_human,OPRM1,-,-,1971,opioid-induced gastrointestinal side-effects,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,td-1211,P35372
1790,0,Class A (Rhodopsin),unknown,td-2749,5ht4r_human,HTR4,-,-,1972,motilitant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,td-2749,Q13639
1791,0,Class A (Rhodopsin),small molecule,td-4208,acm3_human,CHRM3,-,-,MMAmay2016_0081,chronic obstructive pulmonary disease (COPD),Aminergic ,,in trial,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,td-4208,P20309
1792,0,Class A (Rhodopsin),small molecule,tecadenoson,aa1r_human,ADORA1,-,-,1973,Anti-Arrhythmia,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,tecadenoson,P30542
1793,0,Class A (Rhodopsin),small molecule,tedatioxetine,ada1a_human,ADRA1A,-,-,1173,Anti-depressant,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,lu aa24530,P35348
1794,0,Class A (Rhodopsin),small molecule,tedatioxetine,5ht2c_human,HTR2C,-,-,1173,Anti-depressant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa24530,P28335
1795,2012,Class B1 (Secretin),peptide,teduglutide,glp2r_human,GLP2R,2012,2012,2463,short bowel syndrome,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,teduglutide,O95838
1796,2002,Class A (Rhodopsin),small molecule,tegaserod,5ht4r_human,HTR4,2002,2002,1975,motilitant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tegaserod,zelnorm, zelmac",Q13639
1797,1998,Class A (Rhodopsin),small molecule,telmisartan,agtr1_human,AGTR1,1998,1998,1977,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"telmisartan,micardis, micardis hct",P30556
1798,1987,Class A (Rhodopsin),small molecule,terazosin,ada1a_human,ADRA1A,1987,1987,NRDD514,Antineoplastic s; Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1799,1987,Class A (Rhodopsin),small molecule,terazosin,ada1b_human,ADRA1B,1987,1987,NRDD514,Antineoplastic s; Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35368
1800,1987,Class A (Rhodopsin),small molecule,terazosin,ada1d_human,ADRA1D,1987,1987,NRDD514,Antineoplastic s; Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P25100
1801,1974,Class A (Rhodopsin),small molecule,terbutaline,adrb2_human,ADRB2,1974,1974,NRDD515,Bronchodilator ; Tocolytic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P07550
1802,1985,Class A (Rhodopsin),small molecule,terfenadine,hrh1_human,HRH1,,-,NRDD516,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1803,0,Class A (Rhodopsin),small molecule,terguride,5ht2a_human,HTR2A,,-,1981,Antihypertensive,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,terguride,P28223
1804,0,Class A (Rhodopsin),small molecule,terguride,5ht2b_human,HTR2B,,-,1981,Antihypertensive,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,terguride,P41595
1805,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1987,-,MMAmay2016_0763,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"cp046, intranasal teriparatide",Q03431
1806,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1987,-,1983,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide, inhaled air",Q03431
1807,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1987,-,1984,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide, pth1-34 nasal spray",Q03431
1808,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1987,-,1985,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"teriparatide,forteo, forsteo",Q03431
1809,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTH1R,1987,-,2252,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"zt-034, teriparatide nasal spray",Q03431
1810,1987,Class B1 (Secretin),peptide,teriparatide,pth1r_human,PTHR1,1987,-,2252,Anti-osteoporotic,Peptide ,,approved,Parathyroid hormone receptors,GPCR;Secretin,established,"zt-034, teriparatide nasal spray",Q03431
1811,0,Class A (Rhodopsin),small molecule,terlipressin,v1ar_human,AVPR1A,-,-,1986,hepatorenal syndrome,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P37288
1812,0,Class A (Rhodopsin),small molecule,terlipressin,v1br_human,AVPR1B,-,-,1986,hepatorenal syndrome,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P47901
1813,0,Class A (Rhodopsin),small molecule,terlipressin,v2r_human,AVPR2,-,-,1986,hepatorenal syndrome,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"terlipressin,lucassin",P30518
1814,2010,Class B1 (Secretin),peptide,tesamorelin,ghrhr_human,GHRHR,2010,2010,1987,HIV-associated lipodystrophy,Peptide ,,approved,Glucagon receptor family,GPCR;Secretin,established,tesamorelin,Q02643
1815,1985,Class A (Rhodopsin),plant extract,tetrahydrocannabinol,cnr1_human,CNR1,1985,-,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P21554
1816,1985,Class A (Rhodopsin),plant extract,tetrahydrocannabinol,cnr2_human,CNR2,1985,-,1812,Analgesics; neuropathic pain; restlegs legs syndrome,Lipid ,,approved,Cannabinoid receptors,GPCR;Rhodopsin,established,sativex,P34972
1817,0,Class A (Rhodopsin),small molecule,tetrahydrocannabivarin (thcv),cnr1_human,CNR1,-,-,MMAapril2016_0329,Antidiabetic,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,gwp42004,P21554
1818,0,Class A (Rhodopsin),small molecule,tg-0054,cxcr4_human,CXCR4,-,-,2002,adjuvant to stem cell transplantation,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,tg-0054,P61073
1819,0,Class B1 (Secretin),peptide,th0318,glp1r_human,GLP1R,-,-,2008,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,th0318,P43220
1820,0,Class A (Rhodopsin),small molecule,thc:cbd oral formulation,cnr1_human,CNR1,-,-,MMAapril2016_0119,Multiple Sclerosis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,thc:cbd oral formulation,P21554
1821,0,Class A (Rhodopsin),small molecule,thc:cbd oral formulation,cnr2_human,CNR2,-,-,MMAapril2016_0120,Multiple Sclerosis,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,thc:cbd oral formulation,P34972
1822,1976,Class A (Rhodopsin),small molecule,theophylline,aa1r_human,ADORA1,1976,-,53,Bronchodilator,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P30542
1823,1976,Class A (Rhodopsin),small molecule,theophylline,aa2ar_human,ADORA2A,1976,-,53,Bronchodilator,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P29274
1824,1976,Class A (Rhodopsin),small molecule,theophylline,aa2br_human,ADORA2B,1976,-,53,Bronchodilator,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adc4022, low-dose inhaled theophylline",P29275
1825,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm1_human,CHRM1,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1826,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm2_human,CHRM2,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1827,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm3_human,CHRM3,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
1828,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm4_human,CHRM4,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
1829,1961,Class A (Rhodopsin),small molecule,thiethylperazine,acm5_human,CHRM5,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08912
1830,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd1_human,DRD1,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1831,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd2_human,DRD2,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1832,1961,Class A (Rhodopsin),small molecule,thiethylperazine,drd4_human,DRD4,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21917
1833,1961,Class A (Rhodopsin),small molecule,thiethylperazine,hrh1_human,HRH1,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1834,1961,Class A (Rhodopsin),small molecule,thiethylperazine,5ht2a_human,HTR2A,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1835,1961,Class A (Rhodopsin),small molecule,thiethylperazine,5ht2c_human,HTR2C,1961,1961,NRDD519,Antiemetics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28335
1836,1962,Class A (Rhodopsin),small molecule,thioridazine,ada1a_human,ADRA1A,1962,1962,NRDD521,schizophrenia,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1837,1962,Class A (Rhodopsin),small molecule,thioridazine,drd1_human,DRD1,1962,1962,NRDD521,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1838,1962,Class A (Rhodopsin),small molecule,thioridazine,drd2_human,DRD2,1962,1962,NRDD521,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1839,1962,Class A (Rhodopsin),small molecule,thioridazine,5ht2a_human,HTR2A,1962,1962,NRDD521,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P28223
1840,1998,Class A (Rhodopsin),protein,thyrotropin alfa,tshr_human,TSHR,-,1998,NRDD522,Diagnostic,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P16473
1841,2010,Class A (Rhodopsin),small molecule,ticagrelor,p2y12_human,P2RY12,20102011,2011,2015,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,ticagrelor,Q9H244
1842,1991,Class A (Rhodopsin),small molecule,ticlopidine,p2y12_human,P2RY12,1991,1991,NRDD525,Platelet Aggregation Inhibitors,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,-,Q9H244
1843,1981,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,1981,1978,386,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P08588
1844,1981,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,1981,1978,386,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"brimonidine tartrate/timolol maleate,combigan",P07550
1845,1981,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,1981,1978,1095,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P08588
1846,1981,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,1981,1978,1095,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"latanoprost + timolol,xalcom, xalacom",P07550
1847,1981,Class A (Rhodopsin),small molecule,timolol,adrb1_human,ADRB1,1981,1978,2071,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P08588
1848,1981,Class A (Rhodopsin),small molecule,timolol,adrb2_human,ADRB2,1981,1978,2071,Antiglaucomic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P07550
1849,2004,Class A (Rhodopsin),small molecule,tiotropium,acm2_human,CHRM2,2004,2004,MMAmay2016_0589,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P08172
1850,2004,Class A (Rhodopsin),small molecule,tiotropium,acm1_human,CHRM1,2004,2004,MMAmay2016_0590,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P11229
1851,2004,Class A (Rhodopsin),small molecule,tiotropium,acm3_human,CHRM3,2004,2004,MMAmay2016_0591,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tiotropium + olodaterol,P20309
1852,2004,Class A (Rhodopsin),small molecule,tiotropium,acm1_human,CHRM1,2004,2004,2019,cystic fibrosis; chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P11229
1853,2004,Class A (Rhodopsin),small molecule,tiotropium,acm2_human,CHRM2,2004,2004,2019,cystic fibrosis; chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P08172
1854,2004,Class A (Rhodopsin),small molecule,tiotropium,acm3_human,CHRM3,2004,2004,2019,cystic fibrosis; chronic obstructive pulmonary disorder (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tiotropium bromide,spiriva",P20309
1855,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2a_human,ADRA2A,1996,1996,1458,skeletal muscular spasticity,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P08913
1856,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2b_human,ADRA2B,1996,1996,1458,skeletal muscular spasticity,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P18089
1857,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2c_human,ADRA2C,1996,1996,1458,skeletal muscular spasticity,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"nvd-422, tizanidine oral spray",P18825
1858,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2a_human,ADRA2A,1996,1996,2021,Muscle Relaxants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P08913
1859,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2b_human,ADRA2B,1996,1996,2021,Muscle Relaxants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P18089
1860,1996,Class A (Rhodopsin),small molecule,tizanidine,ada2c_human,ADRA2C,1996,1996,2021,Muscle Relaxants,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"tizanidine hydrochloride,zanaflex",P18825
1861,0,Class A (Rhodopsin),small molecule,tm30339,npy4r_human,PPYR1,-,-,2028,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,tm30339,P50391
1862,0,Class A (Rhodopsin),small molecule,tm38837,cnr1_human,CNR1,-,-,2029,Anti-obesity,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,tm38837,P21554
1863,1948,Class A (Rhodopsin),small molecule,tolazoline,ada1a_human,ADRA1A,1948,-,NRDD530,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1864,1998,Class A (Rhodopsin),small molecule,tolterodine,acm1_human,CHRM1,1998,1998,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P11229
1865,1998,Class A (Rhodopsin),small molecule,tolterodine,acm2_human,CHRM2,1998,1998,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08172
1866,1998,Class A (Rhodopsin),small molecule,tolterodine,acm3_human,CHRM3,1998,1998,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P20309
1867,1998,Class A (Rhodopsin),small molecule,tolterodine,acm4_human,CHRM4,1998,1998,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08173
1868,1998,Class A (Rhodopsin),small molecule,tolterodine,acm5_human,CHRM5,1998,1998,2013,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,thvd-201,P08912
1869,0,Class A (Rhodopsin),small molecule,tolterodine ,acm1_human,CHRM1,-,-,2036,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P11229
1870,0,Class A (Rhodopsin),small molecule,tolterodine ,acm2_human,CHRM2,-,-,2036,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08172
1871,0,Class A (Rhodopsin),small molecule,tolterodine ,acm3_human,CHRM3,-,-,2036,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P20309
1872,0,Class A (Rhodopsin),small molecule,tolterodine ,acm4_human,CHRM4,-,-,2036,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08173
1873,0,Class A (Rhodopsin),small molecule,tolterodine ,acm5_human,CHRM5,-,-,2036,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"tolterodine extended release capsules,detrol la",P08912
1874,2009,Class A (Rhodopsin),small molecule,tolvaptan,v2r_human,AVPR2,2009,2009,2037,Antihypertensive,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"tolvaptan, opc-41061,samsca",P30518
1875,0,Class A (Rhodopsin),small molecule,tonabersat,5ht1d_human,HTR1D,-,-,2038,Anti-migraine,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tonabersat,P28221
1876,0,Class A (Rhodopsin),small molecule,tozadenant,aa2ar_human,ADORA2A,-,-,1926,Antiparkinson,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,syn-115,P29274
1877,0,Class A (Rhodopsin),antisense oligo,tpi-asm8,ccr3_human,CCR3,-,-,2049,Anti-Asthmatic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,tpi-asm8,P51677
1878,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,19952003,1995,MMAmay2016_0676,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,e-58425,P28335
1879,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,19952003,1995,MMAmay2016_0678,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,e-58425,P35372
1880,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,19952003,1995,MMAmay2016_0679,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,e-58425,P41145
1881,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,19952003,1995,1685,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pti-601,P28335
1882,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,19952003,1995,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P41145
1883,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,19952003,1995,1685,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pti-601,P35372
1884,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,19952003,1995,2055,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P28335
1885,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,19952003,1995,2055,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P41145
1886,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,19952003,1995,2055,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol extended-release,raliva er",P35372
1887,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,19952003,1995,2056,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P28335
1888,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,19952003,1995,2056,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P41145
1889,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,19952003,1995,2056,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol hydrochloride,ultram",P35372
1890,1995,Class A (Rhodopsin),small molecule,tramadol,5ht2c_human,HTR2C,19952003,1995,2057,Analgesics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P28335
1891,1995,Class A (Rhodopsin),small molecule,tramadol,oprk_human,OPRK1,19952003,1995,2057,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P41145
1892,1995,Class A (Rhodopsin),small molecule,tramadol,oprm_human,OPRM1,19952003,1995,2057,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,"tramadol,tridural, ryzolt",P35372
1893,2001,Class A (Rhodopsin),small molecule,travoprost,pf2r_human,PTGFR,2001,2001,2071,Antiglaucomic,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"travoprost + timolol,extravan, duotrav",P43088
1894,1981,Class A (Rhodopsin),small molecule,trazodone,5ht1a_human,HTR1A,1981,1981,MMAmay2016_0460,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P08908
1895,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2a_human,HTR2A,1981,1981,MMAmay2016_0461,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P28223
1896,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2c_human,HTR2C,1981,1981,MMAmay2016_0462,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"lorexys, sip-104, bupropion/trazodone",P28335
1897,1981,Class A (Rhodopsin),small molecule,trazodone,5ht1a_human,HTR1A,1981,1981,2072,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P08908
1898,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2a_human,HTR2A,1981,1981,2072,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P28223
1899,1981,Class A (Rhodopsin),small molecule,trazodone,5ht2c_human,HTR2C,1981,1981,2072,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trazodone extended release, dds-04a,oleptro",P28335
1900,0,Class A (Rhodopsin),small molecule,trelanserin,5ht1b_human,HTR1B,-,-,2074,intermittent claudication,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trelanserin, sl 65.0472",P28222
1901,0,Class A (Rhodopsin),small molecule,trelanserin,5ht2a_human,HTR2A,-,-,2074,intermittent claudication,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"trelanserin, sl 65.0472",P28223
1902,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2002,2002,NRDD537,Antihypertensive ; Antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,-,Q9H244
1903,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,2002,2002,MMA2016_0038,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"transcon treprostinil, subcutaneous injection",P43119
1904,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2002,2002,MMA2016_0040,Antihypertensive,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"transcon treprostinil, subcutaneous injection",Q9H244
1905,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2002,2002,2767,Antihypertensive,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"treprostinil inhaled/oral,tyvaso, viveta",Q9H244
1906,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,2002,2002,2767,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"treprostinil inhaled/oral,tyvaso, viveta",P43119
1907,2002,Class A (Rhodopsin),small molecule,treprostinil,p2y12_human,P2RY12,2002,2002,2768,Antihypertensive,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"treprostinil subcutaneous/intravenous,remodulin",Q9H244
1908,2002,Class A (Rhodopsin),small molecule,treprostinil,pi2r_human,PTGIR,2002,2002,2768,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"treprostinil subcutaneous/intravenous,remodulin",P43119
1909,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm1_human,CHRM1,-,1954,NRDD540,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1910,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm2_human,CHRM2,-,1954,NRDD540,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1911,1954,Class A (Rhodopsin),small molecule,tridihexethyl,acm3_human,CHRM3,-,1954,NRDD540,GI Anti-Ulcer ; anticholinergic; Antispasmodics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P20309
1912,1959,Class A (Rhodopsin),small molecule,trifluoperazine,ada1a_human,ADRA1A,1959,1959,NRDD541,Antiemetics; Antipsychotic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,-,P35348
1913,1959,Class A (Rhodopsin),small molecule,trifluoperazine,drd2_human,DRD2,1959,1959,NRDD541,Antiemetics; Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1914,1957,Class A (Rhodopsin),small molecule,triflupromazine,acm1_human,CHRM1,1957,-,NRDD542,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1915,1957,Class A (Rhodopsin),small molecule,triflupromazine,acm2_human,CHRM2,1957,-,NRDD542,Antiemetics; Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08172
1916,1957,Class A (Rhodopsin),small molecule,triflupromazine,drd1_human,DRD1,1957,-,NRDD542,Antiemetics; Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
1917,1957,Class A (Rhodopsin),small molecule,triflupromazine,drd2_human,DRD2,1957,-,NRDD542,Antiemetics; Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
1918,1957,Class A (Rhodopsin),small molecule,triflupromazine,5ht2b_human,HTR2B,1957,-,NRDD542,Antiemetics; Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,-,P41595
1919,1949,Class A (Rhodopsin),small molecule,trihexyphenidyl,acm1_human,CHRM1,1949,-,NRDD543,Antiparkinson,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P11229
1920,0,Class A (Rhodopsin),small molecule,trimeprazine,hrh1_human,HRH1,-,-,NRDD545,Antipruritics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1921,1948,Class A (Rhodopsin),small molecule,tripelennamine,hrh1_human,HRH1,1948,1948,NRDD550,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1922,1982,Class A (Rhodopsin),small molecule,triprolidine,hrh1_human,HRH1,1982,-,NRDD551,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,-,P35367
1923,2001,Class A (Rhodopsin),peptide,triptorelin pamoate,gnrhr_human,GNRHR,2001,2000,2084,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",P30968
1924,2001,Class A (Rhodopsin),peptide,triptorelin pamoate,gnrr2_human,GNRHR2,2001,2000,2084,Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Q96P88
1925,1960,Class A (Rhodopsin),small molecule,tropicamide,acm4_human,CHRM4,1960,1960,NRDD552,Diagnostic ; Mydriatics,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,-,P08173
1926,2004,Class A (Rhodopsin),small molecule,trospium,acm1_human,CHRM1,2004,-,2086,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P11229
1927,2004,Class A (Rhodopsin),small molecule,trospium,acm2_human,CHRM2,2004,-,2086,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08172
1928,2004,Class A (Rhodopsin),small molecule,trospium,acm3_human,CHRM3,2004,-,2086,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P20309
1929,2004,Class A (Rhodopsin),small molecule,trospium,acm4_human,CHRM4,2004,-,2086,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08173
1930,2004,Class A (Rhodopsin),small molecule,trospium,acm5_human,CHRM5,2004,-,2086,incontinence,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"trospium chloride,sanctura",P08912
1931,2004,Class A (Rhodopsin),small molecule,trospium chloride,acm1_human,CHRM1,-,2004,2350,chronic pulmonary obstructive disorder,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,alks,P11229
1932,0,Class A (Rhodopsin),protein,trv120027,agtr1_human,AGTR1,-,-,2279,Antihypertensive,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,established,trv120027,P30556
1933,0,Class A (Rhodopsin),small molecule,trv130,oprm_human,OPRM1,-,-,MMAmay2016_0607,Analgesics; post-operative pain,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,trv130,P35372
1934,0,Class A (Rhodopsin),small molecule,trv734,oprk_human,OPRK1,-,-,MMAapril2016_0140,Analgesics,Peptide ,,in trial,Opioid receptors,GPCR;Rhodopsin,established,trv734,P41145
1935,0,Class C (Glutamate) ,unknown,"ts-032, pf-4802540",grm2_human,GRM2,-,-,2090,schizophrenia,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ts-032, pf-4802540",Q14416
1936,0,Class C (Glutamate) ,unknown,"ts-032, pf-4802540",grm3_human,GRM3,-,-,2090,schizophrenia,Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,"ts-032, pf-4802540",Q14832
1937,0,Class A (Rhodopsin),injectible islet neogenesis therapy,tt-223,gasr_human,CCKBR,-,-,2092,Antidiabetic; injectable islet neogenesis therapy for diabetes,Peptide ,,in trial,Cholecystokinin receptors,GPCR;Rhodopsin,established,tt-223,P32239
1938,0,Class B1 (Secretin),injectible islet neogenesis therapy,tt-223,glp1r_human,GLP1R,-,-,2092,Antidiabetic; injectable islet neogenesis therapy for diabetes,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,tt-223,P43220
1939,0,Class B1 (Secretin),peptide,tt-401,glr_human,GCGR,-,-,MMAmay2016_0612,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,tt-401,P47871
1940,0,Class B1 (Secretin),peptide,tt-401,glp1r_human,GLP1R,-,-,MMAmay2016_0613,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,tt-401,P43220
1941,0,Class B1 (Secretin),small molecule,ttp054,glp1r_human,GLP1R,-,-,MMAmay2016_0113,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,ttp054,P43220
1942,0,Class B1 (Secretin),small molecule,ttp273,glp1r_human,GLP1R,-,-,MMAmar2016_0255,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,ttp273,P43220
1943,0,Class A (Rhodopsin),peptide,"txa127, angiotensin (1-7)",mas_human,MAS1,-,-,MMAmay2016_0617,for stem cell engraftment and thrombocytopenia,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"txa127, angiotensin (1-7)",P04201
1944,0,Class A (Rhodopsin),small molecule,tzp-101,ghsr_human,GHSR,-,-,2095,gastroparesis,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,tzp-101,Q92847
1945,0,Class A (Rhodopsin),small molecule,tzp-102,ghsr_human,GHSR,-,-,2096,gastroparesis,Peptide ,,in trial,Ghrelin receptors,GPCR;Rhodopsin,not established,tzp-102,Q92847
1946,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,20132014,-,MMAmar2016_0193,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P08172
1947,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,20132014,-,MMAmar2016_0194,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P20309
1948,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,20132014,-,MMAmay2016_0713,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"incruse ellipta,  umeclidinium bromide",P08172
1949,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,20132014,-,MMAmay2016_0714,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,"incruse ellipta,  umeclidinium bromide",P20309
1950,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm2_human,CHRM2,20132014,-,MMAmay2016_0618,Bronchodilator ; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,umeclidinium + vilanterol,P08172
1951,2013,Class A (Rhodopsin),small molecule,umeclidinium,acm3_human,CHRM3,20132014,-,MMAmay2016_0618,Bronchodilator ; COPD,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,umeclidinium + vilanterol,P20309
1952,0,Class B1 (Secretin),peptide,urocortin 2,crfr2_human,CRHR2,-,-,2105,congestive heart failure,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"urocortin 2, 358-086-15",Q13324
1953,1986,Class A (Rhodopsin),protein,urofollitropin,fshr_human,FSHR,-,-,NRDD554,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945
1954,0,Class A (Rhodopsin),small molecule,v24343,cnr1_human,CNR1,-,-,2112,Anti-obesity,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,v24343,P21554
1955,0,Class A (Rhodopsin),small molecule,v81444,aa2ar_human,ADORA2A,-,-,MMAmay2016_0766,Antiparkinson,Nucleotide ,,in trial,Adenosine receptors,GPCR;Rhodopsin,established,v81444,P29274
1956,0,Class A (Rhodopsin),small molecule,va106483,v2r_human,AVPR2,-,-,2115,BPH-related urinary symptoms,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va106483,P30518
1957,0,Class A (Rhodopsin),small molecule,va111913,v1ar_human,AVPR1A,-,-,2116,dysmenorrhea,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P37288
1958,0,Class A (Rhodopsin),small molecule,va111913,v1br_human,AVPR1B,-,-,2116,dysmenorrhea,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P47901
1959,0,Class A (Rhodopsin),small molecule,va111913,v2r_human,AVPR2,-,-,2116,dysmenorrhea,Peptide ,,in trial,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,va111913,P30518
1960,2012,Class A (Rhodopsin),small molecule,valsartan,agtr1_human,AGTR1,2012,2015,MMAmay2016_0742,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,sacubitril + valsartan,P30556
1961,2012,Class A (Rhodopsin),small molecule,valsartan,agtr1_human,AGTR1,2012,2015,2122,Antihypertensive,Peptide ,,approved,Angiotensin receptors,GPCR;Rhodopsin,established,"valsartan,diovan",P30556
1962,0,Class A (Rhodopsin),small molecule,vapitadine,hrh1_human,HRH1,-,-,2123,Anti-Allergic,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"vapitadine dihydrochloride,hivenyl",P35367
1963,0,Class A (Rhodopsin),small molecule,vapreotide,ssr2_human,SSTR2,,-,2124,liver cirrhosis-related variceal bleeding,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"vapreotide, debio 8609,sanvar, docrised",P30874
1964,0,Class A (Rhodopsin),small molecule,vapreotide,ssr5_human,SSTR5,,-,2124,liver cirrhosis-related variceal bleeding,Peptide ,,approved,Somatostatin receptors,GPCR;Rhodopsin,established,"vapreotide, debio 8609,sanvar, docrised",P35346
1965,0,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr1_human,VIPR1,-,-,288,sexual dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Secretin,not established,"aviptadil,invicorp",P32241
1966,0,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr2_human,VIPR2,-,-,288,sexual dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"aviptadil,invicorp",P41587
1967,0,Class B1 (Secretin),peptide,"vasomera, pb1046",vipr2_human,VIPR2,-,-,MMAmay2016_0630,Antihypertensive,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"vasomera, pb1046",P41587
1968,0,Class A (Rhodopsin),peptide,vasopressin,v1ar_human,AVPR1A,,-,NRDD560,Antidiuretic,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P37288
1969,0,Class A (Rhodopsin),peptide,vasopressin,v1br_human,AVPR1B,,-,NRDD560,Antidiuretic,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P47901
1970,0,Class A (Rhodopsin),peptide,vasopressin,v2r_human,AVPR2,,-,NRDD560,Antidiuretic,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,-,P30518
1971,0,Class A (Rhodopsin),small molecule,velneperit,npy5r_human,NPY5R,-,-,2144,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"velneperit, s-2367",Q15761
1972,0,Class A (Rhodopsin),small molecule,velusetrag,5ht4r_human,HTR4,-,-,2145,motilitant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"velusetrag, td-5108",Q13639
1973,0,Class B1 (Secretin),small molecule,"verucerfont, nbi-77860",crfr1_human,CRHR1,-,-,MMA2016_0047,Congenital Adrenal Hyperplasia,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"verucerfont, nbi-77860",P34998
1974,0,Class A (Rhodopsin),small molecule,vestipitant,nk1r_human,TACR1,-,-,2148,tinnitus; hypnotic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vestipitant, gw 597599",P25103
1975,0,Class B1 (Secretin),small molecule,viaderm-glp1 agonist,glp1r_human,GLP1R,-,-,MMAmay2016_0133,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,viaderm-glp1 agonist,P43220
1976,0,Class A (Rhodopsin),small molecule,vicriviroc,ccr5_human,CCR5,-,-,2157,antiviral ; HIV,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,vicriviroc,P51681
1977,2009,Class C (Glutamate) ,small molecule,vigabatrin,gabr1_human,GABBR1,2009,2009,2159,addiction,Amino acid ,,approved,GABAB receptors,GPCR;Glutamate,established,"vigabatrin is a selective, irreversible enzyme-activated gaba transaminase inhibitor. gaba (gamma-aminobutyric acid) is a n/",Q9UBS5
1978,2013,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,2013,2013,MMAmar2016_0195,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",P07550
1979,2013,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,2013,2013,MMAmay2016_0779,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,fluticasone furoate and vilanterol inhalation powder,P07550
1980,2013,Class A (Rhodopsin),small molecule,vilanterol,adrb2_human,ADRB2,2013,-,MMAmay2016_0619,chronic obstructive pulmonary disease (COPD),Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,umeclidinium bromide (gsk573719) + vilanterol,P07550
1981,2011,Class A (Rhodopsin),small molecule,vilazodone ,5ht1a_human,HTR1A,2011,2011,2160,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"vilazodone hydrochloride, sb 659746a",P08908
1982,2012,Class F (Frizzled),small molecule,vismodegib,smo_human,SMO,20122013,2012,2822,Antineoplastic,Protein ,,approved,Frizzled,GPCR;Frizzled,established,"gdc-0449, hedgehog pathway inhibitor",Q99835
1983,0,Class A (Rhodopsin),small molecule,vofopitant,nk1r_human,TACR1,-,-,2170,post-traumatic stress disorder; hypnotic,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vofopitant, gr-205171",P25103
1984,0,Class A (Rhodopsin),small molecule,volinanserin,5ht2a_human,HTR2A,-,-,2172,Hypnotics and Sedatives,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,volinanserin,P28223
1985,2014,Class A (Rhodopsin),small molecule,vorapaxar,par1_human,F2R,2014,2014,2175,cardiovascular disease,Peptide ,,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",P25116
1986,2014,Class A (Rhodopsin),small molecule,vorapaxar,par3_human,F2RL2,2014,2014,2175,cardiovascular disease,Peptide ,,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",O00254
1987,2014,Class A (Rhodopsin),small molecule,vorapaxar,par4_human,F2RL3,2014,2014,2175,cardiovascular disease,Peptide ,,approved,Proteinase-activated receptors,GPCR;Rhodopsin,established,"vorapaxar , sch-530348",Q96RI0
1988,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht1a_human,HTR1A,2013,2013,1171,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P08908
1989,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht1b_human,HTR1B,2013,2013,1171,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P28222
1990,2013,Class A (Rhodopsin),small molecule,vortioxetine,5ht7r_human,HTR7,2013,2013,1171,Anti-depressant,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lu aa21004,P34969
1991,0,Class A (Rhodopsin),small molecule,"vpd-737, serlopitant",nk1r_human,TACR1,-,-,MMAmay2016_0635,pruritus,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,established,"vpd-737, serlopitant",P25103
1992,0,Class A (Rhodopsin),small molecule,vr-147,5ht1b_human,HTR1B,-,-,2179,Anti-migraine,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vr-147,P28222
1993,0,Class A (Rhodopsin),small molecule,vr-147,5ht1d_human,HTR1D,-,-,2179,Anti-migraine,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vr-147,P28221
1994,0,Class B1 (Secretin),peptide,vrs-859,glp1r_human,GLP1R,-,-,2182,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,vrs-859,P43220
1995,0,Class A (Rhodopsin),small molecule,vsn16r,gpr55_human,GPR55,-,-,MMAmay2016_0803,Antispasmodics;  for spatisity related to multiple sclerosis,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,vsn16r,Q9Y2T6
1996,0,Class A (Rhodopsin),small molecule,x4p-001,cxcr4_human,CXCR4,-,-,MMAapril2016_0220,Antineoplastic ; renal cell carcinoma,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,x4p-001,P61073
1997,0,Class A (Rhodopsin),small molecule,xaliproden,5ht1a_human,HTR1A,-,-,2200,neuroprotectant,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"xaliproden, sr 57746a",P08908
1998,0,Class A (Rhodopsin),small molecule,xp21279,drd1_human,DRD1,-,-,2223,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21728
1999,0,Class A (Rhodopsin),small molecule,xp21279,drd2_human,DRD2,-,-,2223,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P14416
2000,0,Class A (Rhodopsin),small molecule,xp21279,drd3_human,DRD3,-,-,2223,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P35462
2001,0,Class A (Rhodopsin),small molecule,xp21279,drd4_human,DRD4,-,-,2223,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21917
2002,0,Class A (Rhodopsin),small molecule,xp21279,drd5_human,DRD5,-,-,2223,Antiparkinson,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,xp21279,P21918
2003,0,Class A (Rhodopsin),small molecule,ykp10811,5ht4r_human,HTR4,-,-,MMAmay2016_0641,for chronic or functional constipation,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ykp10811,Q13639
2004,0,Class A (Rhodopsin),unknown,ykp-1358,drd2_human,DRD2,-,-,2226,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,ykp-1358,P14416
2005,0,Class A (Rhodopsin),unknown,ykp-1358,5ht2a_human,HTR2A,-,-,2226,schizophrenia,Aminergic ,,in trial,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ykp-1358,P28223
2006,0,Class A (Rhodopsin),small molecule,ym-178,adrb3_human,ADRB3,-,-,2229,overactive bladder,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,ym-178,P13945
2007,2012,Class A (Rhodopsin),small molecule,mirabegron,adrb3_human,ADRB3,2012,2012,MMAmay2016_0790,incontinence,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,"ym178, mirabegron",P13945
2008,0,Class A (Rhodopsin),small molecule,ym-598,ednra_human,EDNRA,-,-,2230,Antineoplastic,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,ym-598,P25101
2009,0,Class A (Rhodopsin),small molecule,yohimbine,ada2a_human,ADRA2A,,-,NRDD564,Mydriatics; Anti-impotence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P08913
2010,0,Class A (Rhodopsin),small molecule,yohimbine,ada2b_human,ADRA2B,,-,NRDD564,Mydriatics; Anti-impotence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18089
2011,0,Class A (Rhodopsin),small molecule,yohimbine,ada2c_human,ADRA2C,,-,NRDD564,Mydriatics; Anti-impotence,Aminergic ,,in trial,Adrenoceptors,GPCR;Rhodopsin,established,-,P18825
2012,0,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr1_human,SSTR1,-,-,2232,Antineoplastic,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P30872
2013,0,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr2_human,SSTR2,-,-,2232,Antineoplastic,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P30874
2014,0,Class A (Rhodopsin),peptide,yttrium-90 edotreotide,ssr5_human,SSTR5,-,-,2232,Antineoplastic,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,"yttrium-90 edotreotide,onalta",P35346
2015,1996,Class A (Rhodopsin),small molecule,zafirlukast,cltr1_human,CYSLTR1,1996,1996,2235,Anti-Asthmatic,Lipid ,,approved,Leukotriene receptors,GPCR;Rhodopsin,established,"zafirlukast,accolate",Q9Y271
2016,0,Class A (Rhodopsin),small molecule,zibotentan,ednra_human,EDNRA,-,-,2241,Antineoplastic,Peptide ,,in trial,Endothelin receptors,GPCR;Rhodopsin,established,"zibotentan, zd-4054, azd-4054",P25101
2017,0,Class A (Rhodopsin),small molecule,zicronapine,drd4_human,DRD4,-,-,1176,schizophrenia,Aminergic ,,in trial,Dopamine receptors,GPCR;Rhodopsin,established,lu-31130,P21917
2018,2001,Class A (Rhodopsin),small molecule,ziprasidone ,drd2_human,DRD2,2001,2001,2243,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",P14416
2019,2001,Class A (Rhodopsin),small molecule,ziprasidone ,5ht2a_human,HTR2A,2001,2001,2243,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",P28223
2020,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1a_human,HTR1A,1997,1997,2246,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P08908
2021,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1b_human,HTR1B,1997,1997,2246,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P28222
2022,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1d_human,HTR1D,1997,1997,2246,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P28221
2023,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1f_human,HTR1F,1997,1997,2246,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,"zolmitriptan,zomig",P30939
2024,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1a_human,HTR1A,1997,1997,MMAapril2016_0110,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P08908
2025,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1d_human,HTR1D,1997,1997,MMAapril2016_0111,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P28221
2026,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1b_human,HTR1B,1997,1997,MMAapril2016_0112,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P28222
2027,1997,Class A (Rhodopsin),small molecule,zolmitriptan,5ht1f_human,HTR1F,1997,1997,MMAapril2016_0113,Anti-migraine,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,zp-triptan,P30939
2028,0,Class B1 (Secretin),peptide,zp1848,glp2r_human,GLP2R,-,-,2251,Crohn's disease,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1848,O95838
2029,0,Class A (Rhodopsin),small molecule,"zpl-389, zpl-3893787",hrh4_human,HRH4,-,-,MMAmar2016_0120,Anti-inflammatory ; atopic dermatitis,Aminergic ,,in trial,Histamine receptors,GPCR;Rhodopsin,established,"zpl-389, zpl-3893787",Q9H3N8
2030,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd1_human,DRD1,,-,NRDD567,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21728
2031,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd2_human,DRD2,,-,NRDD567,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P14416
2032,1962,Class A (Rhodopsin),small molecule,zuclopenthixol,drd5_human,DRD5,,-,NRDD567,schizophrenia,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,-,P21918
2033,0,Class B1 (Secretin),peptide,zyd1,glp1r_human,GLP1R,-,-,2256,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zyd1,P43220
2034,0,Class A (Rhodopsin),small molecule,zyn002,cnr1_human,CNR1,-,-,MMAapril2016_0296,Anticonvulsants; Antiepileptics,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,zyn002,P21554
2035,0,Class A (Rhodopsin),small molecule,zyn002,cnr2_human,CNR2,-,-,MMAapril2016_0297,Anticonvulsants; Antiepileptics,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,zyn002,P34972
2036,0,Class A (Rhodopsin),small molecule,ergoloid,5ht1a_human,HTR1A,-,-,ASH_Sep2016_0,cardiovascular disease,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ergoloid,P08908
2037,2015,Class A (Rhodopsin),unknown,aripiprazole lauroxil,5ht1a_human,HTR1A,-,2015,ASH_Sep2016_1,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P08908
2038,0,Class A (Rhodopsin),small molecule,lecozotan,5ht1a_human,HTR1A,-,-,ASH_Sep2016_2,Alzheimer's disease,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,lecozotan,P08908
2039,0,Class A (Rhodopsin),small molecule,piclozotan,5ht1a_human,HTR1A,-,-,ASH_Sep2016_3,stroke,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,piclozotan,P08908
2040,0,Class A (Rhodopsin),small molecule,naluzotan,5ht1a_human,HTR1A,-,-,ASH_Sep2016_4,temporal lobe epilepsy,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,naluzotan,P08908
2041,0,Class A (Rhodopsin),small molecule,gsk163090,5ht1a_human,HTR1A,-,-,ASH_Sep2016_5,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P08908
2042,2002,Class A (Rhodopsin),small molecule,eletriptan,5ht1b_human,HTR1B,2002,2002,ASH_Sep2016_6,Anti-migraine,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eletriptan,P28222
2043,0,Class A (Rhodopsin),small molecule,ergoloid,5ht1b_human,HTR1B,-,-,ASH_Sep2016_7,cardiovascular disease,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ergoloid,P28222
2044,0,Class A (Rhodopsin),small molecule,gsk163090,5ht1b_human,HTR1B,-,-,ASH_Sep2016_8,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P28222
2045,0,Class A (Rhodopsin),small molecule,gsk163090,5ht1d_human,HTR1D,-,-,ASH_Sep2016_9,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,gsk163090,P28221
2046,1996,Class A (Rhodopsin),small molecule,olanzapine,5ht1e_human,HTR1E,1996,1996,APR13_0013,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,alks 3831,P28566
2047,2002,Class A (Rhodopsin),small molecule,eletriptan,5ht1f_human,HTR1F,2002,2002,ASH_Sep2016_10,Anti-migraine,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,eletriptan,P30939
2048,2001,Class A (Rhodopsin),small molecule,almotriptan,5ht1f_human,HTR1F,2001,2001,ASH_Sep2016_11,Anti-migraine,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,almotriptan,P30939
2049,1974,Class A (Rhodopsin),small molecule,molindone,5ht2a_human,HTR2A,1974,1974,ASH_Sep2016_12,schizophrenia,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,molindone,P28223
2050,1967,Class A (Rhodopsin),small molecule,haloperidol,5ht2a_human,HTR2A,1967,1967,ASH_Sep2016_13,conduct disorder,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,haloperidol,P28223
2051,2015,Class A (Rhodopsin),unknown,aripiprazole lauroxil,5ht2a_human,HTR2A,-,2015,ASH_Sep2016_14,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P28223
2052,1979,Class A (Rhodopsin),small molecule,trimipramine,5ht2a_human,HTR2A,1979,1979,ASH_Sep2016_15,unipolar depression,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trimipramine,P28223
2053,1957,Class A (Rhodopsin),small molecule,chlorpromazine,5ht2a_human,HTR2A,1957,1957,ASH_Sep2016_16,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P28223
2054,1970,Class A (Rhodopsin),small molecule,droperidol,5ht2a_human,HTR2A,1970,-,ASH_Sep2016_17,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,droperidol,P28223
2055,1959,Class A (Rhodopsin),small molecule,trifluoperazine,5ht2a_human,HTR2A,1959,1959,ASH_Sep2016_18,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P28223
2056,1967,Class A (Rhodopsin),small molecule,thiothixene,5ht2a_human,HTR2A,1967,1967,ASH_Sep2016_19,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thiothixene,P28223
2057,1984,Class A (Rhodopsin),small molecule,pimozide,5ht2a_human,HTR2A,1984,1984,ASH_Sep2016_20,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pimozide,P28223
2058,0,Class A (Rhodopsin),small molecule,haloperidol decanoate,5ht2a_human,HTR2A,-,-,ASH_Sep2016_21,psychosis,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P28223
2059,0,Class A (Rhodopsin),small molecule,vabicaserin,5ht2a_human,HTR2A,-,-,ASH_Sep2016_22,schizophrenia,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P28223
2060,0,Class A (Rhodopsin),small molecule,tedatioxetine,5ht2a_human,HTR2A,-,-,ASH_Sep2016_23,unipolar depression,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,tedatioxetine,P28223
2061,0,Class A (Rhodopsin),small molecule,temanogrel,5ht2a_human,HTR2A,-,-,ASH_Sep2016_24,acute coronary syndrome,Aminergic ,1.0,Phase I,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,temanogrel,P28223
2062,1962,Class A (Rhodopsin),small molecule,methysergide,5ht2b_human,HTR2B,1962,1962,ASH_Sep2016_25,Anti-migraine,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methysergide,P41595
2063,1946,Class A (Rhodopsin),small molecule,methylergonovine,5ht2b_human,HTR2B,1946,-,ASH_Sep2016_26,hemorrhage,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methylergonovine,P41595
2064,0,Class A (Rhodopsin),small molecule,vabicaserin,5ht2b_human,HTR2B,-,-,ASH_Sep2016_27,schizophrenia,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P41595
2065,1993,Class A (Rhodopsin),small molecule,risperidone,5ht2c_human,HTR2C,1993,1993,ASH_Sep2016_28,schizophrenia,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,risperidone,P28335
2066,1996,Class A (Rhodopsin),small molecule,mirtazapine,5ht2c_human,HTR2C,1996,1996,ASH_Sep2016_29,unipolar depression,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,mirtazapine,P28335
2067,0,Class A (Rhodopsin),small molecule,ziprasidone,5ht2c_human,HTR2C,-,-,ASH_Sep2016_30,schizophrenia,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ziprasidone,P28335
2068,1975,Class A (Rhodopsin),small molecule,loxapine,5ht2c_human,HTR2C,1975,1975,ASH_Sep2016_31,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,loxapine,P28335
2069,1977,Class A (Rhodopsin),small molecule,cyclobenzaprine,5ht2c_human,HTR2C,1977,1977,ASH_Sep2016_32,spasticity,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cyclobenzaprine,P28335
2070,1994,Class A (Rhodopsin),small molecule,nefazodone,5ht2c_human,HTR2C,1994,1994,ASH_Sep2016_33,unipolar depression,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,nefazodone,P28335
2071,1962,Class A (Rhodopsin),small molecule,thioridazine,5ht2c_human,HTR2C,1962,1962,ASH_Sep2016_34,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thioridazine,P28335
2072,0,Class A (Rhodopsin),small molecule,methixene,5ht2c_human,HTR2C,,-,ASH_Sep2016_35,Antiparkinson,Aminergic ,4.0,Phase IV,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,methixene,P28335
2073,1959,Class A (Rhodopsin),small molecule,trifluoperazine,5ht2c_human,HTR2C,1959,1959,ASH_Sep2016_36,psychosis,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P28335
2074,1979,Class A (Rhodopsin),small molecule,trimipramine,5ht2c_human,HTR2C,1979,1979,ASH_Sep2016_37,unipolar depression,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,trimipramine,P28335
2075,0,Class A (Rhodopsin),small molecule,esmirtazapine,5ht2c_human,HTR2C,-,-,ASH_Sep2016_38,insomnia,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,esmirtazapine,P28335
2076,0,Class A (Rhodopsin),small molecule,vabicaserin,5ht2c_human,HTR2C,-,-,ASH_Sep2016_39,schizophrenia,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,vabicaserin,P28335
2077,1979,Class A (Rhodopsin),small molecule,metoclopramide,5ht4r_human,HTR4,1979,1979,ASH_Sep2016_40,pregnancy,Aminergic ,4.0,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,metoclopramide,Q13639
2078,0,Class A (Rhodopsin),small molecule,naronapride,5ht4r_human,HTR4,-,-,ASH_Sep2016_41,constipation,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,naronapride,Q13639
2079,2009,Class A (Rhodopsin),small molecule,asenapine,5ht5a_human,HTR5A,20092010,2009,250,schizophrenia,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,asenapine,P47898
2080,0,Class A (Rhodopsin),small molecule,idalopirdine,5ht6r_human,HTR6,-,-,ASH_Sep2016_42,Alzheimer's disease,Aminergic ,3.0,Phase III,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,idalopirdine,P50406
2081,0,Class A (Rhodopsin),small molecule,cerlapirdine,5ht6r_human,HTR6,-,-,ASH_Sep2016_43,Alzheimer's disease,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,cerlapirdine,P50406
2082,0,Class A (Rhodopsin),small molecule,intepirdine,5ht6r_human,HTR6,-,-,ASH_Sep2016_44,Alzheimer's disease,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,intepirdine,P50406
2083,0,Class A (Rhodopsin),small molecule,pf-05212377,5ht6r_human,HTR6,-,-,ASH_Sep2016_45,Alzheimer's disease,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pf-05212377,P50406
2084,0,Class A (Rhodopsin),small molecule,ly2590443,5ht7r_human,HTR7,-,-,ASH_Sep2016_46,Anti-migraine,Aminergic ,2.0,Phase II,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,ly2590443,P34969
2085,1956,Class A (Rhodopsin),small molecule,mepenzolate,acm1_human,CHRM1,-,1956,ASH_Sep2016_47,digestive system disease,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mepenzolate,P11229
2086,0,Class A (Rhodopsin),small molecule,diphemanil,acm1_human,CHRM1,-,-,ASH_Sep2016_48,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,diphemanil,P11229
2087,0,Class A (Rhodopsin),small molecule,methixene,acm1_human,CHRM1,,-,ASH_Sep2016_49,Antiparkinson,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methixene,P11229
2088,0,Class A (Rhodopsin),small molecule,methscopolamine,acm1_human,CHRM1,-,-,ASH_Sep2016_50,cycloplegia,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methscopolamine,P11229
2089,0,Class A (Rhodopsin),small molecule,isopropamide,acm1_human,CHRM1,-,-,ASH_Sep2016_51,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,isopropamide,P11229
2090,0,Class A (Rhodopsin),small molecule,hexocyclium,acm1_human,CHRM1,-,-,ASH_Sep2016_52,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,hexocyclium,P11229
2091,2007,Class A (Rhodopsin),small molecule,fesoterodine,acm2_human,CHRM2,20072008,2008,ASH_Sep2016_53,prostate adenocarcinoma,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,fesoterodine,P08172
2092,2004,Class A (Rhodopsin),small molecule,darifenacin,acm2_human,CHRM2,2004,2004,ASH_Sep2016_54,overactive bladder,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,darifenacin,P08172
2093,1953,Class A (Rhodopsin),small molecule,propantheline,acm2_human,CHRM2,1953,1953,ASH_Sep2016_55,digestive system disease,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,propantheline,P08172
2094,0,Class A (Rhodopsin),small molecule,batefenterol,acm2_human,CHRM2,-,-,ASH_Sep2016_56,chronic obstructive pulmonary disease (COPD),Aminergic ,2.0,Phase II,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,batefenterol,P08172
2095,1948,Class A (Rhodopsin),small molecule,bethanechol,acm2_human,CHRM2,1948,-,ASH_Sep2016_57,eosinophilic esophagitis,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bethanechol,P08172
2096,2015,Class A (Rhodopsin),unknown,aripiprazole lauroxil,drd2_human,DRD2,-,2015,ASH_Sep2016_58,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,aripiprazole lauroxil,P14416
2097,1957,Class A (Rhodopsin),small molecule,chlorpromazine,drd2_human,DRD2,1957,1957,ASH_Sep2016_59,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P14416
2098,0,Class A (Rhodopsin),small molecule,ergoloid,drd2_human,DRD2,-,-,ASH_Sep2016_60,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P14416
2099,0,Class A (Rhodopsin),small molecule,fluphenazine decanoate,drd2_human,DRD2,-,-,ASH_Sep2016_61,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,fluphenazine decanoate,P14416
2100,1979,Class A (Rhodopsin),small molecule,trimipramine,drd2_human,DRD2,1979,1979,ASH_Sep2016_62,unipolar depression,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,trimipramine,P14416
2101,0,Class A (Rhodopsin),small molecule,levomepromazine,drd2_human,DRD2,,-,ASH_Sep2016_63,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P14416
2102,1980,Class A (Rhodopsin),small molecule,amoxapine,drd2_human,DRD2,1980,1980,ASH_Sep2016_64,unipolar depression,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P14416
2103,0,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd2_human,DRD2,-,-,ASH_Sep2016_65,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P14416
2104,0,Class A (Rhodopsin),small molecule,fluphenazine enanthate,drd2_human,DRD2,-,-,ASH_Sep2016_66,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,fluphenazine enanthate,P14416
2105,1967,Class A (Rhodopsin),small molecule,thiothixene,drd2_human,DRD2,1967,1967,ASH_Sep2016_67,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,thiothixene,P14416
2106,1973,Class A (Rhodopsin),small molecule,acetylcholine,acm3_human,CHRM3,-,1973,ASH_Sep2016_68,Antiglaucomic,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acetylcholine,P20309
2107,1953,Class A (Rhodopsin),small molecule,propantheline,acm3_human,CHRM3,1953,1953,ASH_Sep2016_69,digestive system disease,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,propantheline,P20309
2108,1960,Class A (Rhodopsin),small molecule,tropicamide,acm3_human,CHRM3,1960,1960,ASH_Sep2016_70,myopia,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,tropicamide,P20309
2109,1961,Class A (Rhodopsin),small molecule,glycopyrrolate,acm3_human,CHRM3,19612012,1961,ASH_Sep2016_71,obstructive lung disease,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,glycopyrrolate,P20309
2110,1986,Class A (Rhodopsin),small molecule,ipratropium,acm3_human,CHRM3,1986,1986,ASH_Sep2016_72,chronic obstructive pulmonary disease (COPD),Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ipratropium,P20309
2111,1974,Class A (Rhodopsin),small molecule,cyclopentolate,acm3_human,CHRM3,1974,-,ASH_Sep2016_73,cycloplegia,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,cyclopentolate,P20309
2112,0,Class A (Rhodopsin),small molecule,isopropamide,acm3_human,CHRM3,-,-,ASH_Sep2016_74,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,isopropamide,P20309
2113,0,Class A (Rhodopsin),small molecule,methscopolamine,acm3_human,CHRM3,-,-,ASH_Sep2016_75,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methscopolamine,P20309
2114,0,Class A (Rhodopsin),small molecule,oxyphenonium,acm3_human,CHRM3,,-,ASH_Sep2016_76,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,oxyphenonium,P20309
2115,1950,Class A (Rhodopsin),small molecule,dicyclomine,acm3_human,CHRM3,1950,1950,ASH_Sep2016_77,digestive system disease,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dicyclomine,P20309
2116,0,Class A (Rhodopsin),small molecule,hexocyclium,acm3_human,CHRM3,-,-,ASH_Sep2016_78,digestive system disease,Aminergic ,4.0,Phase IV,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,hexocyclium,P20309
2117,1956,Class A (Rhodopsin),small molecule,mepenzolate,acm3_human,CHRM3,-,1956,ASH_Sep2016_79,digestive system disease,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,mepenzolate,P20309
2118,1972,Class A (Rhodopsin),small molecule,carbachol,acm3_human,CHRM3,1972,1972,ASH_Sep2016_80,Antiglaucomic,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,carbachol,P20309
2119,1986,Class A (Rhodopsin),small molecule,methacholine,acm3_human,CHRM3,-,1986,ASH_Sep2016_81,Anti-Asthmatic,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,methacholine,P20309
2120,0,Class A (Rhodopsin),small molecule,batefenterol,acm3_human,CHRM3,-,-,ASH_Sep2016_82,chronic obstructive pulmonary disease (COPD),Aminergic ,2.0,Phase II,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,batefenterol,P20309
2121,1948,Class A (Rhodopsin),small molecule,bethanechol,acm3_human,CHRM3,1948,-,ASH_Sep2016_83,eosinophilic esophagitis,Aminergic ,4.0,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,bethanechol,P20309
2122,2012,Class A (Rhodopsin),small molecule,aclidinium,acm4_human,CHRM4,2012,2012,44,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08173
2123,2012,Class A (Rhodopsin),small molecule,aclidinium,acm5_human,CHRM5,2012,2012,44,Bronchodilator,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,aclidinium,P08912
2124,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1a_human,ADRA1A,-,-,ASH_Sep2016_84,Antihypertensive,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P35348
2125,0,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1a_human,ADRA1A,-,-,ASH_Sep2016_85,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P35348
2126,0,Class A (Rhodopsin),small molecule,naphazoline,ada1a_human,ADRA1A,-,-,ASH_Sep2016_86,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P35348
2127,1960,Class A (Rhodopsin),small molecule,ergotamine,ada1a_human,ADRA1A,1960,-,ASH_Sep2016_87,Anti-migraine,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P35348
2128,0,Class A (Rhodopsin),small molecule,dipivefrin,ada1a_human,ADRA1A,-,-,ASH_Sep2016_88,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P35348
2129,1979,Class A (Rhodopsin),small molecule,trimipramine,ada1a_human,ADRA1A,1979,1979,ASH_Sep2016_89,unipolar depression,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P35348
2130,0,Class A (Rhodopsin),small molecule,mephentermine,ada1b_human,ADRA1B,,-,ASH_Sep2016_90,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P35368
2131,1995,Class A (Rhodopsin),small molecule,carvedilol,ada1b_human,ADRA1B,1995,1995,ASH_Sep2016_91,Antihypertensive,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P35368
2132,1954,Class A (Rhodopsin),small molecule,metaraminol,ada1b_human,ADRA1B,1954,-,ASH_Sep2016_92,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,metaraminol,P35368
2133,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1b_human,ADRA1B,-,-,ASH_Sep2016_93,Antihypertensive,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P35368
2134,0,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1b_human,ADRA1B,-,-,ASH_Sep2016_94,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P35368
2135,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1b_human,ADRA1B,1953,1953,ASH_Sep2016_95,adrenal gland pheochromocytoma,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P35368
2136,0,Class A (Rhodopsin),small molecule,naphazoline,ada1b_human,ADRA1B,-,-,ASH_Sep2016_96,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P35368
2137,1948,Class A (Rhodopsin),small molecule,tolazoline,ada1b_human,ADRA1B,1948,-,ASH_Sep2016_97,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P35368
2138,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada1b_human,ADRA1B,1986,-,ASH_Sep2016_98,Antiglaucomic,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P35368
2139,1960,Class A (Rhodopsin),small molecule,ergotamine,ada1b_human,ADRA1B,1960,-,ASH_Sep2016_99,Anti-migraine,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P35368
2140,0,Class A (Rhodopsin),small molecule,ergoloid,ada1b_human,ADRA1B,-,-,ASH_Sep2016_100,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P35368
2141,1979,Class A (Rhodopsin),small molecule,trimipramine,ada1b_human,ADRA1B,1979,1979,ASH_Sep2016_101,unipolar depression,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P35368
2142,1952,Class A (Rhodopsin),small molecule,phentolamine,ada1b_human,ADRA1B,1952,1952,ASH_Sep2016_102,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P35368
2143,0,Class A (Rhodopsin),small molecule,dipivefrin,ada1b_human,ADRA1B,-,-,ASH_Sep2016_103,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P35368
2144,1996,Class A (Rhodopsin),small molecule,midodrine,ada1d_human,ADRA1D,1996,1996,ASH_Sep2016_104,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,midodrine,P25100
2145,0,Class A (Rhodopsin),small molecule,mephentermine,ada1d_human,ADRA1D,,-,ASH_Sep2016_105,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P25100
2146,0,Class A (Rhodopsin),small molecule,dipivefrin,ada1d_human,ADRA1D,-,-,ASH_Sep2016_106,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P25100
2147,1995,Class A (Rhodopsin),small molecule,carvedilol,ada1d_human,ADRA1D,1995,1995,ASH_Sep2016_107,Antihypertensive,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P25100
2148,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada1d_human,ADRA1D,-,-,ASH_Sep2016_108,Antihypertensive,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P25100
2149,0,Class A (Rhodopsin),small molecule,ergoloid,ada1d_human,ADRA1D,-,-,ASH_Sep2016_109,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P25100
2150,1954,Class A (Rhodopsin),small molecule,metaraminol,ada1d_human,ADRA1D,1954,-,ASH_Sep2016_110,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,metaraminol,P25100
2151,0,Class A (Rhodopsin),small molecule,naphazoline,ada1d_human,ADRA1D,-,-,ASH_Sep2016_111,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P25100
2152,1960,Class A (Rhodopsin),small molecule,ergotamine,ada1d_human,ADRA1D,1960,-,ASH_Sep2016_112,Anti-migraine,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P25100
2153,1948,Class A (Rhodopsin),small molecule,tolazoline,ada1d_human,ADRA1D,1948,-,ASH_Sep2016_113,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P25100
2154,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada1d_human,ADRA1D,1953,1953,ASH_Sep2016_114,adrenal gland pheochromocytoma,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P25100
2155,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada1d_human,ADRA1D,1986,-,ASH_Sep2016_115,allergic conjunctivitis,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P25100
2156,1984,Class A (Rhodopsin),small molecule,labetalol,ada1d_human,ADRA1D,1984,1984,ASH_Sep2016_116,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P25100
2157,1952,Class A (Rhodopsin),small molecule,phentolamine,ada1d_human,ADRA1D,1952,1952,ASH_Sep2016_117,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P25100
2158,1979,Class A (Rhodopsin),small molecule,trimipramine,ada1d_human,ADRA1D,1979,1979,ASH_Sep2016_118,unipolar depression,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,trimipramine,P25100
2159,0,Class A (Rhodopsin),small molecule,methoxamine,ada1d_human,ADRA1D,,-,ASH_Sep2016_119,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,methoxamine,P25100
2160,0,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada1d_human,ADRA1D,-,-,ASH_Sep2016_120,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P25100
2161,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2a_human,ADRA2A,-,-,ASH_Sep2016_121,Antihypertensive,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P08913
2162,0,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2a_human,ADRA2A,-,-,ASH_Sep2016_122,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P08913
2163,0,Class A (Rhodopsin),small molecule,mephentermine,ada2a_human,ADRA2A,,-,ASH_Sep2016_123,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P08913
2164,1960,Class A (Rhodopsin),small molecule,ergotamine,ada2a_human,ADRA2A,1960,-,ASH_Sep2016_124,Anti-migraine,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P08913
2165,1948,Class A (Rhodopsin),small molecule,tolazoline,ada2a_human,ADRA2A,1948,-,ASH_Sep2016_125,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P08913
2166,0,Class A (Rhodopsin),small molecule,naphazoline,ada2a_human,ADRA2A,-,-,ASH_Sep2016_126,eye allergy,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P08913
2167,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2a_human,ADRA2A,1953,1953,ASH_Sep2016_127,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P08913
2168,1984,Class A (Rhodopsin),small molecule,labetalol,ada2a_human,ADRA2A,1984,1984,ASH_Sep2016_128,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P08913
2169,0,Class A (Rhodopsin),small molecule,naphazoline,ada2b_human,ADRA2B,-,-,ASH_Sep2016_129,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P18089
2170,1999,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2b_human,ADRA2B,1999,-,ASH_Sep2016_130,Analgesics,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,dexmedetomidine,P18089
2171,1996,Class A (Rhodopsin),small molecule,mirtazapine,ada2b_human,ADRA2B,1996,1996,ASH_Sep2016_131,unipolar depression,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,mirtazapine,P18089
2172,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada2b_human,ADRA2B,1986,-,ASH_Sep2016_132,dry eye,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P18089
2173,1986,Class A (Rhodopsin),small molecule,guanfacine,ada2b_human,ADRA2B,1986,1986,ASH_Sep2016_133,attention deficit hyperactivity disorder,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,guanfacine,P18089
2174,1948,Class A (Rhodopsin),small molecule,tolazoline,ada2b_human,ADRA2B,1948,-,ASH_Sep2016_134,arthralgia,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P18089
2175,1987,Class A (Rhodopsin),small molecule,apraclonidine,ada2b_human,ADRA2B,1987,1987,ASH_Sep2016_135,Antiglaucomic,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,apraclonidine,P18089
2176,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2b_human,ADRA2B,1953,1953,ASH_Sep2016_136,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P18089
2177,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2b_human,ADRA2B,1952,1952,ASH_Sep2016_137,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P18089
2178,1984,Class A (Rhodopsin),small molecule,labetalol,ada2b_human,ADRA2B,1984,1984,ASH_Sep2016_138,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P18089
2179,0,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2b_human,ADRA2B,-,-,ASH_Sep2016_139,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P18089
2180,1960,Class A (Rhodopsin),small molecule,ergotamine,ada2b_human,ADRA2B,1960,-,ASH_Sep2016_140,Anti-migraine,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P18089
2181,0,Class A (Rhodopsin),small molecule,ergoloid,ada2b_human,ADRA2B,-,-,ASH_Sep2016_141,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P18089
2182,1962,Class A (Rhodopsin),small molecule,methyldopa,ada2b_human,ADRA2B,1962,1962,ASH_Sep2016_142,Antihypertensive,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,methyldopa,P18089
2183,0,Class A (Rhodopsin),small molecule,dipivefrin,ada2b_human,ADRA2B,-,-,ASH_Sep2016_143,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P18089
2184,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2b_human,ADRA2B,-,-,ASH_Sep2016_144,Antihypertensive,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P18089
2185,0,Class A (Rhodopsin),small molecule,mephentermine,ada2b_human,ADRA2B,,-,ASH_Sep2016_145,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P18089
2186,0,Class A (Rhodopsin),small molecule,esmirtazapine,ada2b_human,ADRA2B,-,-,ASH_Sep2016_146,menopause,Aminergic ,3.0,Phase III,Adrenoceptors,GPCR;Rhodopsin,established,esmirtazapine,P18089
2187,1982,Class A (Rhodopsin),small molecule,guanabenz,ada2b_human,ADRA2B,1982,1982,ASH_Sep2016_147,For treatment of Multiple Sclerosis,Aminergic ,1.0,in trial,Adrenoceptors,GPCR;Rhodopsin,established,guanabenz,P18089
2188,1996,Class A (Rhodopsin),small molecule,mirtazapine,ada2c_human,ADRA2C,1996,1996,ASH_Sep2016_148,unipolar depression,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,mirtazapine,P18825
2189,1999,Class A (Rhodopsin),small molecule,dexmedetomidine,ada2c_human,ADRA2C,1999,-,ASH_Sep2016_149,Antineoplastic,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,dexmedetomidine,P18825
2190,0,Class A (Rhodopsin),small molecule,naphazoline,ada2c_human,ADRA2C,-,-,ASH_Sep2016_150,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,naphazoline,P18825
2191,1986,Class A (Rhodopsin),small molecule,oxymetazoline,ada2c_human,ADRA2C,1986,-,ASH_Sep2016_151,dry eye,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,oxymetazoline,P18825
2192,1986,Class A (Rhodopsin),small molecule,guanfacine,ada2c_human,ADRA2C,1986,1986,ASH_Sep2016_152,obstructive sleep apnea,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,guanfacine,P18825
2193,1953,Class A (Rhodopsin),small molecule,phenoxybenzamine,ada2c_human,ADRA2C,1953,1953,ASH_Sep2016_153,adrenal gland pheochromocytoma,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phenoxybenzamine,P18825
2194,1948,Class A (Rhodopsin),small molecule,tolazoline,ada2c_human,ADRA2C,1948,-,ASH_Sep2016_154,arthralgia,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,tolazoline,P18825
2195,0,Class A (Rhodopsin),small molecule,ergoloid,ada2c_human,ADRA2C,-,-,ASH_Sep2016_155,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,ergoloid,P18825
2196,1984,Class A (Rhodopsin),small molecule,labetalol,ada2c_human,ADRA2C,1984,1984,ASH_Sep2016_156,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P18825
2197,1962,Class A (Rhodopsin),small molecule,methyldopa,ada2c_human,ADRA2C,1962,1962,ASH_Sep2016_157,Antihypertensive,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,methyldopa,P18825
2198,1960,Class A (Rhodopsin),small molecule,ergotamine,ada2c_human,ADRA2C,1960,-,ASH_Sep2016_158,Anti-migraine,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergotamine,P18825
2199,0,Class A (Rhodopsin),small molecule,tetrahydrozoline,ada2c_human,ADRA2C,-,-,ASH_Sep2016_159,nasal obstruction,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,tetrahydrozoline,P18825
2200,0,Class A (Rhodopsin),small molecule,rauwolfia serpentina,ada2c_human,ADRA2C,-,-,ASH_Sep2016_160,Antihypertensive,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,rauwolfia serpentina,P18825
2201,0,Class A (Rhodopsin),small molecule,mephentermine,ada2c_human,ADRA2C,,-,ASH_Sep2016_161,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P18825
2202,1987,Class A (Rhodopsin),small molecule,apraclonidine,ada2c_human,ADRA2C,1987,1987,ASH_Sep2016_162,Antiglaucomic,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,apraclonidine,P18825
2203,1952,Class A (Rhodopsin),small molecule,phentolamine,ada2c_human,ADRA2C,1952,1952,ASH_Sep2016_163,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,phentolamine,P18825
2204,0,Class A (Rhodopsin),small molecule,dipivefrin,ada2c_human,ADRA2C,-,-,ASH_Sep2016_164,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P18825
2205,0,Class A (Rhodopsin),small molecule,esmirtazapine,ada2c_human,ADRA2C,-,-,ASH_Sep2016_165,insomnia,Aminergic ,3.0,Phase III,Adrenoceptors,GPCR;Rhodopsin,established,esmirtazapine,P18825
2206,1982,Class A (Rhodopsin),small molecule,guanabenz,ada2c_human,ADRA2C,1982,1982,ASH_Sep2016_166,Antineoplastic,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,guanabenz,P18825
2207,0,Class A (Rhodopsin),small molecule,dipivefrin,adrb1_human,ADRB1,-,-,ASH_Sep2016_167,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P08588
2208,1992,Class A (Rhodopsin),small molecule,sotalol,adrb1_human,ADRB1,1992,1992,ASH_Sep2016_168,atrial fibrillation,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,sotalol,P08588
2209,1974,Class A (Rhodopsin),small molecule,dopamine,adrb1_human,ADRB1,1974,1974,ASH_Sep2016_169,hypotension,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,dopamine,P08588
2210,1989,Class A (Rhodopsin),small molecule,propafenone,adrb1_human,ADRB1,1989,1989,ASH_Sep2016_170,cardiac arrhythmia,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,propafenone,P08588
2211,0,Class A (Rhodopsin),small molecule,mephentermine,adrb1_human,ADRB1,,-,ASH_Sep2016_171,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P08588
2212,2007,Class A (Rhodopsin),small molecule,nebivolol,adrb2_human,ADRB2,-,2007,ASH_Sep2016_172,Antihypertensive,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,nebivolol,P07550
2213,1981,Class A (Rhodopsin),small molecule,albuterol,adrb2_human,ADRB2,-,1981,ASH_Sep2016_173,chronic obstructive pulmonary disease (COPD),Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,albuterol,P07550
2214,0,Class A (Rhodopsin),small molecule,levosalbutamol,adrb2_human,ADRB2,-,-,ASH_Sep2016_174,Anti-Asthmatic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,levosalbutamol,P07550
2215,1973,Class A (Rhodopsin),small molecule,metaproterenol,adrb2_human,ADRB2,-,1973,ASH_Sep2016_175,Anti-Asthmatic,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,metaproterenol,P07550
2216,1988,Class A (Rhodopsin),small molecule,carteolol,adrb2_human,ADRB2,1988,1988,ASH_Sep2016_176,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,carteolol,P07550
2217,1989,Class A (Rhodopsin),small molecule,propafenone,adrb2_human,ADRB2,1989,1989,ASH_Sep2016_177,atrial fibrillation,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,propafenone,P07550
2218,1967,Class A (Rhodopsin),small molecule,propranolol,adrb2_human,ADRB2,1967,1967,ASH_Sep2016_178,Antihypertensive,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,propranolol,P07550
2219,1978,Class A (Rhodopsin),small molecule,dobutamine,adrb2_human,ADRB2,1978,1978,ASH_Sep2016_179,heart failure,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,dobutamine,P07550
2220,1992,Class A (Rhodopsin),small molecule,sotalol,adrb2_human,ADRB2,1992,1992,ASH_Sep2016_180,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,sotalol,P07550
2221,1986,Class A (Rhodopsin),small molecule,pirbuterol,adrb2_human,ADRB2,1986,1986,ASH_Sep2016_181,obstructive lung disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,pirbuterol,P07550
2222,0,Class A (Rhodopsin),small molecule,isoetharine,adrb2_human,ADRB2,-,-,ASH_Sep2016_182,obstructive lung disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,isoetharine,P07550
2223,1984,Class A (Rhodopsin),small molecule,bitolterol,adrb2_human,ADRB2,-,1984,ASH_Sep2016_183,obstructive lung disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,bitolterol,P07550
2224,1986,Class A (Rhodopsin),small molecule,esmolol,adrb2_human,ADRB2,1986,1986,ASH_Sep2016_184,tinnitus,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,esmolol,P07550
2225,0,Class A (Rhodopsin),small molecule,dipivefrin,adrb2_human,ADRB2,-,-,ASH_Sep2016_185,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P07550
2226,0,Class A (Rhodopsin),small molecule,mephentermine,adrb2_human,ADRB2,,-,ASH_Sep2016_186,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P07550
2227,0,Class A (Rhodopsin),small molecule,carmoterol,adrb2_human,ADRB2,-,-,ASH_Sep2016_187,chronic obstructive pulmonary disease (COPD),Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,carmoterol,P07550
2228,0,Class A (Rhodopsin),small molecule,batefenterol,adrb2_human,ADRB2,-,-,ASH_Sep2016_188,chronic obstructive pulmonary disease (COPD),Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,batefenterol,P07550
2229,0,Class A (Rhodopsin),small molecule,bedoradrine,adrb2_human,ADRB2,-,-,ASH_Sep2016_189,Anti-Asthmatic,Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,bedoradrine,P07550
2230,0,Class A (Rhodopsin),small molecule,abediterol,adrb2_human,ADRB2,-,-,ASH_Sep2016_190,Anti-Asthmatic,Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,abediterol,P07550
2231,0,Class A (Rhodopsin),small molecule,azd3199,adrb2_human,ADRB2,-,-,ASH_Sep2016_191,chronic obstructive pulmonary disease (COPD),Aminergic ,2.0,Phase II,Adrenoceptors,GPCR;Rhodopsin,established,azd3199,P07550
2232,1995,Class A (Rhodopsin),small molecule,carvedilol,adrb3_human,ADRB3,1995,1995,ASH_Sep2016_192,Antihypertensive,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,carvedilol,P13945
2233,0,Class A (Rhodopsin),small molecule,isoproterenol,adrb3_human,ADRB3,-,-,ASH_Sep2016_193,Anti-Asthmatic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,isoproterenol,P13945
2234,1988,Class A (Rhodopsin),small molecule,carteolol,adrb3_human,ADRB3,1988,1988,ASH_Sep2016_194,Antiglaucomic,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,carteolol,P13945
2235,1984,Class A (Rhodopsin),small molecule,labetalol,adrb3_human,ADRB3,1984,1984,ASH_Sep2016_195,cardiovascular disease,Aminergic ,4.0,approved,Adrenoceptors,GPCR;Rhodopsin,established,labetalol,P13945
2236,0,Class A (Rhodopsin),small molecule,mephentermine,adrb3_human,ADRB3,,-,ASH_Sep2016_196,cardiovascular disease,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,mephentermine,P13945
2237,0,Class A (Rhodopsin),small molecule,dipivefrin,adrb3_human,ADRB3,-,-,ASH_Sep2016_197,Antiglaucomic,Aminergic ,4.0,Phase IV,Adrenoceptors,GPCR;Rhodopsin,established,dipivefrin,P13945
2238,0,Class A (Rhodopsin),small molecule,ergoloid,drd1_human,DRD1,-,-,ASH_Sep2016_198,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21728
2239,1984,Class A (Rhodopsin),small molecule,pimozide,drd1_human,DRD1,1984,1984,ASH_Sep2016_199,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21728
2240,1980,Class A (Rhodopsin),small molecule,amoxapine,drd1_human,DRD1,1980,1980,ASH_Sep2016_200,unipolar depression,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21728
2241,1970,Class A (Rhodopsin),small molecule,droperidol,drd3_human,DRD3,1970,-,ASH_Sep2016_201,vomiting,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,droperidol,P35462
2242,1967,Class A (Rhodopsin),small molecule,haloperidol,drd3_human,DRD3,1967,1967,ASH_Sep2016_202,gastroparesis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol,P35462
2243,1959,Class A (Rhodopsin),small molecule,trifluoperazine,drd3_human,DRD3,1959,1959,ASH_Sep2016_203,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P35462
2244,1957,Class A (Rhodopsin),small molecule,chlorpromazine,drd3_human,DRD3,1957,1957,ASH_Sep2016_204,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P35462
2245,1962,Class A (Rhodopsin),small molecule,thioridazine,drd3_human,DRD3,1962,1962,ASH_Sep2016_205,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioridazine,P35462
2246,0,Class A (Rhodopsin),small molecule,ergoloid,drd3_human,DRD3,-,-,ASH_Sep2016_206,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P35462
2247,1975,Class A (Rhodopsin),small molecule,loxapine,drd3_human,DRD3,1975,1975,ASH_Sep2016_207,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,loxapine,P35462
2248,1956,Class A (Rhodopsin),small molecule,promazine,drd3_human,DRD3,1956,1956,ASH_Sep2016_208,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,promazine,P35462
2249,1988,Class A (Rhodopsin),small molecule,pergolide,drd3_human,DRD3,1988,-,ASH_Sep2016_209,Antiparkinson,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P35462
2250,1980,Class A (Rhodopsin),small molecule,amoxapine,drd3_human,DRD3,1980,1980,ASH_Sep2016_210,unipolar depression,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P35462
2251,1984,Class A (Rhodopsin),small molecule,pimozide,drd3_human,DRD3,1984,1984,ASH_Sep2016_211,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P35462
2252,0,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd3_human,DRD3,-,-,ASH_Sep2016_212,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P35462
2253,0,Class A (Rhodopsin),small molecule,levomepromazine,drd3_human,DRD3,,-,ASH_Sep2016_213,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P35462
2254,1967,Class A (Rhodopsin),small molecule,haloperidol,drd4_human,DRD4,1967,1967,ASH_Sep2016_214,schizophrenia,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol,P21917
2255,0,Class A (Rhodopsin),small molecule,ergoloid,drd4_human,DRD4,-,-,ASH_Sep2016_215,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21917
2256,1978,Class A (Rhodopsin),small molecule,bromocriptine,drd4_human,DRD4,1978,2009,ASH_Sep2016_216,growth hormone excess,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,bromocriptine,P21917
2257,1959,Class A (Rhodopsin),small molecule,trifluoperazine,drd4_human,DRD4,1959,1959,ASH_Sep2016_217,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,trifluoperazine,P21917
2258,1997,Class A (Rhodopsin),small molecule,ropinirole,drd4_human,DRD4,19972006,1997,ASH_Sep2016_218,Antiparkinson,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,ropinirole,P21917
2259,1962,Class A (Rhodopsin),small molecule,thioridazine,drd4_human,DRD4,1962,1962,ASH_Sep2016_219,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioridazine,P21917
2260,1957,Class A (Rhodopsin),small molecule,chlorpromazine,drd4_human,DRD4,1957,1957,ASH_Sep2016_220,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,chlorpromazine,P21917
2261,1980,Class A (Rhodopsin),small molecule,amoxapine,drd4_human,DRD4,1980,1980,ASH_Sep2016_221,unipolar depression,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21917
2262,1984,Class A (Rhodopsin),small molecule,pimozide,drd4_human,DRD4,1984,1984,ASH_Sep2016_222,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21917
2263,1975,Class A (Rhodopsin),small molecule,loxapine,drd4_human,DRD4,1975,1975,ASH_Sep2016_223,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,loxapine,P21917
2264,1970,Class A (Rhodopsin),small molecule,droperidol,drd4_human,DRD4,1970,-,ASH_Sep2016_224,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,droperidol,P21917
2265,0,Class A (Rhodopsin),small molecule,levomepromazine,drd4_human,DRD4,,-,ASH_Sep2016_225,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,levomepromazine,P21917
2266,1988,Class A (Rhodopsin),small molecule,pergolide,drd4_human,DRD4,1988,-,ASH_Sep2016_226,Antiparkinson,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P21917
2267,0,Class A (Rhodopsin),small molecule,haloperidol decanoate,drd4_human,DRD4,-,-,ASH_Sep2016_227,psychosis,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,haloperidol decanoate,P21917
2268,1980,Class A (Rhodopsin),small molecule,amoxapine,drd5_human,DRD5,1980,1980,ASH_Sep2016_228,unipolar depression,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,amoxapine,P21918
2269,0,Class A (Rhodopsin),small molecule,ergoloid,drd5_human,DRD5,-,-,ASH_Sep2016_229,cardiovascular disease,Aminergic ,4.0,Phase IV,Dopamine receptors,GPCR;Rhodopsin,established,ergoloid,P21918
2270,1984,Class A (Rhodopsin),small molecule,pimozide,drd5_human,DRD5,1984,1984,ASH_Sep2016_230,psychosis,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,pimozide,P21918
2271,1988,Class A (Rhodopsin),small molecule,pergolide,drd5_human,DRD5,1988,-,ASH_Sep2016_231,Antiparkinson,Aminergic ,4.0,approved,Dopamine receptors,GPCR;Rhodopsin,established,pergolide,P21918
2272,0,Class A (Rhodopsin),small molecule,antazoline,hrh1_human,HRH1,,-,ASH_Sep2016_232,atrial fibrillation,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,antazoline,P35367
2273,1948,Class A (Rhodopsin),small molecule,tolazoline,hrh1_human,HRH1,1948,-,ASH_Sep2016_233,cardiovascular disease,Aminergic ,4.0,approved,Histamine receptors,GPCR;Rhodopsin,established,tolazoline,P35367
2274,1979,Class A (Rhodopsin),small molecule,trimipramine,hrh1_human,HRH1,1979,1979,ASH_Sep2016_234,unipolar depression,Aminergic ,4.0,approved,Histamine receptors,GPCR;Rhodopsin,established,trimipramine,P35367
2275,0,Class A (Rhodopsin),small molecule,acrivastine,hrh1_human,HRH1,-,-,ASH_Sep2016_235,Anti-Allergic,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,acrivastine,P35367
2276,0,Class A (Rhodopsin),small molecule,pyrilamine,hrh1_human,HRH1,,-,ASH_Sep2016_236,pruritus,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,pyrilamine,P35367
2277,0,Class A (Rhodopsin),small molecule,esmirtazapine,hrh1_human,HRH1,-,-,ASH_Sep2016_237,insomnia,Aminergic ,3.0,Phase III,Histamine receptors,GPCR;Rhodopsin,established,esmirtazapine,P35367
2278,0,Class A (Rhodopsin),small molecule,dexchlorpheniramine,hrh1_human,HRH1,-,-,ASH_Sep2016_238,sunburn,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,dexchlorpheniramine,P35367
2279,0,Class A (Rhodopsin),small molecule,histamine,hrh1_human,HRH1,-,-,ASH_Sep2016_239,Anti-migraine,Aminergic ,4.0,Phase IV,Histamine receptors,GPCR;Rhodopsin,established,histamine,P35367
2280,1951,Class A (Rhodopsin),small molecule,methantheline,hrh2_human,HRH2,-,1951,ASH_Sep2016_240,digestive system disease,Aminergic ,4.0,approved,Histamine receptors,GPCR;Rhodopsin,established,methantheline,P25021
2281,1948,Class A (Rhodopsin),small molecule,tolazoline,hrh2_human,HRH2,1948,-,ASH_Sep2016_241,arthralgia,Aminergic ,4.0,approved,Histamine receptors,GPCR;Rhodopsin,established,tolazoline,P25021
2282,0,Class A (Rhodopsin),small molecule,pitolisant,hrh3_human,HRH3,-,-,ASH_Sep2016_242,Antiparkinson,Aminergic ,3.0,Phase III,Histamine receptors,GPCR;Rhodopsin,established,pitolisant,Q9Y5N1
2283,0,Class A (Rhodopsin),small molecule,bavisant,hrh3_human,HRH3,-,-,ASH_Sep2016_243,attention deficit hyperactivity disorder,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,bavisant,Q9Y5N1
2284,0,Class A (Rhodopsin),small molecule,pf-03654764,hrh3_human,HRH3,-,-,ASH_Sep2016_244,allergic rhinitis,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,pf-03654764,Q9Y5N1
2285,0,Class A (Rhodopsin),small molecule,pf-03654746,hrh3_human,HRH3,-,-,ASH_Sep2016_245,allergic rhinitis,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,pf-03654746,Q9Y5N1
2286,0,Class A (Rhodopsin),small molecule,irdabisant,hrh3_human,HRH3,-,-,ASH_Sep2016_246,cognitive impairment,Aminergic ,1.0,Phase I,Histamine receptors,GPCR;Rhodopsin,established,irdabisant,Q9Y5N1
2287,0,Class A (Rhodopsin),small molecule,toreforant,hrh4_human,HRH4,-,-,ASH_Sep2016_247,Anti-Asthmatic,Aminergic ,2.0,Phase II,Histamine receptors,GPCR;Rhodopsin,established,toreforant,Q9H3N8
2288,1976,Class A (Rhodopsin),small molecule,amphetamine,taar1_human,TAAR1,1976,-,413,cognitive dysfunction; ADHD,Aminergic ,,approved,Trace amine receptors,GPCR;Rhodopsin,established,"c105, levo-amphetamine sulfate",Q96RJ0
2289,2011,Class A (Rhodopsin),small molecule,azilsartan medoxomil,agtr1_human,AGTR1,2011,-,ASH_Sep2016_248,Antihypertensive,Peptide ,4.0,approved,Angiotensin receptors,GPCR;Rhodopsin,established,azilsartan medoxomil,P30556
2290,1998,Class A (Rhodopsin),small molecule,candesartan cilexetil,agtr1_human,AGTR1,-,1998,ASH_Sep2016_249,Antihypertensive,Peptide ,4.0,approved,Angiotensin receptors,GPCR;Rhodopsin,established,candesartan cilexetil,P30556
2291,2002,Class A (Rhodopsin),small molecule,olmesartan medoxomil,agtr1_human,AGTR1,-,2002,ASH_Sep2016_250,cardiovascular disease,Peptide ,4.0,approved,Angiotensin receptors,GPCR;Rhodopsin,established,olmesartan medoxomil,P30556
2292,0,Class A (Rhodopsin),small molecule,ema401,agtr2_human,AGTR2,-,-,MMAmay2016_0377,peripheral neuropathic pain; post herpetic neuralgia,Peptide ,,in trial,Angiotensin receptors,GPCR;Rhodopsin,not established,ema401,P50052
2293,0,Class A (Rhodopsin),peptide,apelin,apj_human,APLNR,-,-,MMAjun2016_0045,Cardiovascular disorders; Insulin sensitivity,Peptide ,,in trial,Apelin receptors,GPCR;Rhodopsin,not established,apelin,P35414
2294,0,Class A (Rhodopsin),small molecule,anatibant,bkrb2_human,BDKRB2,-,-,177,traumatic brain injury,Peptide ,,in trial,Bradykinin receptors,GPCR;Rhodopsin,established,anatibant,P30411
2295,0,Class A (Rhodopsin),small molecule,ceruletide,cckar_human,CCKAR,,-,NRDD085,Diagnostic,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32238
2296,1974,Class A (Rhodopsin),small molecule,pentagastrin,gasr_human,CCKBR,-,1974,NRDD418,Diagnostic,Peptide ,,approved,Cholecystokinin receptors,GPCR;Rhodopsin,established,-,P32239
2297,0,Class A (Rhodopsin),small molecule,ccx168,c5ar1_human,C5AR1,-,-,448,Anti-inflammatory ; for treatment for autoimmune disease,Peptide ,,in trial,Complement peptide receptors,GPCR;Rhodopsin,not established,ccx168,P21730
2298,0,Class A (Rhodopsin),small molecule,tezosentan,ednra_human,EDNRA,-,-,ASH_Sep2016_251,heart failure,Peptide ,3.0,Phase III,Endothelin receptors,GPCR;Rhodopsin,established,tezosentan,P25101
2299,0,Class A (Rhodopsin),small molecule,tezosentan,ednrb_human,EDNRB,-,-,ASH_Sep2016_252,heart failure,Peptide ,3.0,Phase III,Endothelin receptors,GPCR;Rhodopsin,established,tezosentan,P24530
2300,0,Class A (Rhodopsin),small molecule,darusentan,ednrb_human,EDNRB,-,-,ASH_Sep2016_253,Antihypertensive,Peptide ,3.0,Phase III,Endothelin receptors,GPCR;Rhodopsin,established,darusentan,P24530
2301,0,Class A (Rhodopsin),small molecule,ulimorelin,ghsr_human,GHSR,-,-,ASH_Sep2016_254,digestive system disease,Peptide ,3.0,Phase III,Ghrelin receptors,GPCR;Rhodopsin,not established,ulimorelin,Q92847
2302,1989,Class A (Rhodopsin),protein,goserelin,gnrhr_human,GNRHR,1989,1989,ASH_Sep2016_255,Antineoplastic,Peptide ,4.0,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,goserelin,P30968
2303,1999,Class A (Rhodopsin),protein,ganirelix acetate,gnrhr_human,GNRHR,-,1999,ASH_Sep2016_256,infertility,Peptide ,4.0,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,ganirelix acetate,P30968
2304,0,Class A (Rhodopsin),small molecule,elagolix,gnrhr_human,GNRHR,-,-,ASH_Sep2016_257,endometriosis,Peptide ,3.0,Phase III,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,elagolix,P30968
2305,0,Class A (Rhodopsin),small molecule,relugolix,gnrhr_human,GNRHR,-,-,ASH_Sep2016_258,endometriosis,Peptide ,2.0,Phase II,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,relugolix,P30968
2306,1976,Class A (Rhodopsin),small molecule,danazol,gnrr2_human,GNRHR2,-,1976,NRDD139,Antiendometriosis; Antineoplastic,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,-,Q96P88
2307,0,Class A (Rhodopsin),small molecule,ngd-4715,mchr1_human,MCHR1,-,-,1408,Appetite suppressant,Peptide ,,in trial,Melanin-concentrating hormone,GPCR;Rhodopsin,not established,ngd-4715,Q99705
2308,0,Class A (Rhodopsin),protein,modimelanotide,mshr_human,MC1R,-,-,ASH_Sep2016_259,acute kidney injury,Peptide ,2.0,Phase II,Melanocortin receptors,GPCR;Rhodopsin,not established,modimelanotide,Q01726
2309,1955,Class A (Rhodopsin),protein,corticotropin,acthr_human,MC2R,1955,1950,NRDD127,Diagnostic,Peptide ,,approved,Melanocortin receptors,GPCR;Rhodopsin,established,-,Q01718
2310,0,Class A (Rhodopsin),protein,bremelanotide,mc3r_human,MC3R,-,-,ASH_Sep2016_260,sexual dysfunction,Peptide ,3.0,Phase III,Melanocortin receptors,GPCR;Rhodopsin,not established,bremelanotide,P41968
2311,0,Class A (Rhodopsin),protein,modimelanotide,mc3r_human,MC3R,-,-,ASH_Sep2016_261,acute kidney injury,Peptide ,2.0,Phase II,Melanocortin receptors,GPCR;Rhodopsin,not established,modimelanotide,P41968
2312,0,Class A (Rhodopsin),small molecule,ap-1034,mc4r_human,MC4R,-,-,189,Anti-obesity,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap1030,P32245
2313,0,Class A (Rhodopsin),peptide,ap214,mc5r_human,MC5R,-,-,2538,post-surgical kidney injury,Peptide ,,in trial,Melanocortin receptors,GPCR;Rhodopsin,not established,ap214,P33032
2314,0,Class A (Rhodopsin),small molecule,camicinal,mtlr_human,MLNR,-,-,ASH_Sep2016_262,gastroparesis,Peptide ,2.0,Phase II,Motilin receptors,GPCR;Rhodopsin,not established,camicinal,O43193
2315,0,Class A (Rhodopsin),small molecule,obinepitide,npy2r_human,NPY2R,-,-,2027,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P49146
2316,0,Class A (Rhodopsin),small molecule,obinepitide,npy4r_human,PPYR1,-,-,2027,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"tm30338,obinepitide",P50391
2317,0,Class A (Rhodopsin),small molecule,velneperit,npy5r_human,NPY5R,-,-,2144,Anti-obesity,Peptide ,,in trial,Neuropeptide Y receptors,GPCR;Rhodopsin,not established,"velneperit, s-2367",Q15761
2318,0,Class A (Rhodopsin),small molecule,odelepran,oprd_human,OPRD1,-,-,ASH_Sep2016_263,alcohol dependence,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P41143
2319,0,Class A (Rhodopsin),small molecule,cebranopadol,oprd_human,OPRD1,-,-,ASH_Sep2016_264,diabetic neuropathy,Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P41143
2320,2013,Class A (Rhodopsin),small molecule,hydrocodone,oprk_human,OPRK1,2013,-,ASH_Sep2016_265,Analgesics,Peptide ,4.0,approved,Opioid receptors,GPCR;Rhodopsin,established,hydrocodone,P41145
2321,1959,Class A (Rhodopsin),small molecule,oxymorphone,oprk_human,OPRK1,1959,-,ASH_Sep2016_266,opiate dependence,Peptide ,4.0,approved,Opioid receptors,GPCR;Rhodopsin,established,oxymorphone,P41145
2322,0,Class A (Rhodopsin),small molecule,cebranopadol,oprk_human,OPRK1,-,-,ASH_Sep2016_267,diabetic neuropathy,Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P41145
2323,0,Class A (Rhodopsin),small molecule,odelepran,oprk_human,OPRK1,-,-,ASH_Sep2016_268,alcohol dependence,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P41145
2324,1958,Class A (Rhodopsin),small molecule,dihydrocodeine,oprm_human,OPRM1,1958,-,ASH_Sep2016_269,Analgesics,Peptide ,4.0,approved,Opioid receptors,GPCR;Rhodopsin,established,dihydrocodeine,P35372
2325,1942,Class A (Rhodopsin),small molecule,meperidine,oprm_human,OPRM1,-,1942,ASH_Sep2016_270,Analgesics,Peptide ,4.0,approved,Opioid receptors,GPCR;Rhodopsin,established,meperidine,P35372
2326,1978,Class A (Rhodopsin),small molecule,difenoxin,oprm_human,OPRM1,1978,-,ASH_Sep2016_271,recurrent infection of the gastrointestinal tract,Peptide ,4.0,approved,Opioid receptors,GPCR;Rhodopsin,established,difenoxin,P35372
2327,0,Class A (Rhodopsin),small molecule,axelopran,oprm_human,OPRM1,-,-,ASH_Sep2016_272,constipation,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,axelopran,P35372
2328,0,Class A (Rhodopsin),small molecule,cebranopadol,oprm_human,OPRM1,-,-,ASH_Sep2016_273,"osteoarthritis, knee",Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,established,cebranopadol,P35372
2329,0,Class A (Rhodopsin),small molecule,methylsamidorphan,oprm_human,OPRM1,-,-,ASH_Sep2016_274,constipation,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,methylsamidorphan,P35372
2330,0,Class A (Rhodopsin),small molecule,odelepran,oprm_human,OPRM1,-,-,ASH_Sep2016_275,alcohol dependence,Peptide ,2.0,Phase II,Opioid receptors,GPCR;Rhodopsin,established,odelepran,P35372
2331,0,Class A (Rhodopsin),small molecule,cebranopadol,oprx_human,OPRL1,-,-,ASH_Sep2016_276,Analgesics,Peptide ,3.0,Phase III,Opioid receptors,GPCR;Rhodopsin,not established,cebranopadol,P41146
2332,0,Class A (Rhodopsin),small molecule,sb-649868,ox1r_human,HCRTR1,-,-,ASH_Sep2016_277,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,sb-649868,O43613
2333,0,Class A (Rhodopsin),small molecule,lemborexant,ox1r_human,HCRTR1,-,-,ASH_Sep2016_278,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,lemborexant,O43613
2334,0,Class A (Rhodopsin),small molecule,sb-649868,ox2r_human,HCRTR2,-,-,ASH_Sep2016_279,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,sb-649868,O43614
2335,0,Class A (Rhodopsin),small molecule,lemborexant,ox2r_human,HCRTR2,-,-,ASH_Sep2016_280,insomnia,Peptide ,2.0,Phase II,Orexin receptors,GPCR;Rhodopsin,established,lemborexant,O43614
2336,0,Class A (Rhodopsin),small molecule,rigosertib,par1_human,F2R,-,-,ASH_Sep2016_281,refractory anemia with excess blasts,Peptide ,3.0,Phase III,Proteinase-activated receptors,GPCR;Rhodopsin,established,rigosertib,P25116
2337,0,Class A (Rhodopsin),small molecule,atopaxar,par1_human,F2R,-,-,ASH_Sep2016_282,acute coronary syndrome,Peptide ,2.0,Phase II,Proteinase-activated receptors,GPCR;Rhodopsin,established,atopaxar,P25116
2338,0,Class A (Rhodopsin),peptide,rusalatide,par3_human,F2RL2,-,-,2048,diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",O00254
2339,0,Class A (Rhodopsin),peptide,rusalatide,par4_human,F2RL3,-,-,2048,diabetic foot ulcers,Peptide ,,in trial,Proteinase-activated receptors,GPCR;Rhodopsin,established,"tp-508,chrysalin",Q96RI0
2340,0,Class A (Rhodopsin),small molecule,dg3173,ssr1_human,SSTR1,-,-,632,hormone replacement,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,dg3173,P30872
2341,2001,Class A (Rhodopsin),protein,lanreotide,ssr2_human,SSTR2,20012007,2007,ASH_Sep2016_283,Antineoplastic,Peptide ,4.0,approved,Somatostatin receptors,GPCR;Rhodopsin,established,lanreotide,P30874
2342,1988,Class A (Rhodopsin),protein,octreotide,ssr3_human,SSTR3,1988,1988,ASH_Sep2016_284,growth hormone excess,Peptide ,4.0,approved,Somatostatin receptors,GPCR;Rhodopsin,established,octreotide,P32745
2343,1988,Class A (Rhodopsin),protein,octreotide,ssr4_human,SSTR4,1988,1988,ASH_Sep2016_285,growth hormone excess,Peptide ,4.0,approved,Somatostatin receptors,GPCR;Rhodopsin,established,octreotide,P31391
2344,0,Class A (Rhodopsin),small molecule,bim23a760,ssr5_human,SSTR5,-,-,358,Antineoplastic ; treatment for acromegaly,Peptide ,,in trial,Somatostatin receptors,GPCR;Rhodopsin,established,bim23a760,P35346
2345,0,Class A (Rhodopsin),small molecule,tradipitant,nk1r_human,TACR1,-,-,ASH_Sep2016_286,alcohol dependence,Peptide ,2.0,Phase II,Tachykinin receptors,GPCR;Rhodopsin,established,tradipitant,P25103
2346,0,Class A (Rhodopsin),small molecule,orvepitant,nk1r_human,TACR1,-,-,ASH_Sep2016_287,unipolar depression,Peptide ,2.0,Phase II,Tachykinin receptors,GPCR;Rhodopsin,established,orvepitant,P25103
2347,0,Class A (Rhodopsin),small molecule,saredutant,nk2r_human,TACR2,-,-,1810,Anti-depressant,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"saredutant, sr 48968",P21452
2348,0,Class A (Rhodopsin),small molecule,"mle4901,  azd4901",nk3r_human,TACR3,-,-,MMAapril2016_0263,for Polycystic Ovarian Syndrome,Peptide ,,in trial,Tachykinin receptors,GPCR;Rhodopsin,not established,"mle4901,  azd4901",P29371
2349,0,Class A (Rhodopsin),protein,selepressin,v1ar_human,AVPR1A,-,-,ASH_Sep2016_288,septic shock,Peptide ,2.0,Phase II,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,selepressin,P37288
2350,1978,Class A (Rhodopsin),peptide,desmopressin,v1br_human,AVPR1B,-,1978,1537,incontinence,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"ox 19, sublingual desmopressin",P47901
2351,2005,Class A (Rhodopsin),small molecule,conivaptan,v2r_human,AVPR2,2005,2005,519,hyponatremia,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,"conivaptan, ym-087,vaprisol",P30518
2352,0,Class A (Rhodopsin),small molecule,retosiban,oxyr_human,OXTR,-,-,ASH_Sep2016_289,premature birth,Peptide ,3.0,Phase III,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,retosiban,P30559
2353,0,Class A (Rhodopsin),protein,barusiban,oxyr_human,OXTR,-,-,ASH_Sep2016_290,infertility,Peptide ,2.0,Phase II,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,barusiban,P30559
2354,0,Class A (Rhodopsin),small molecule,epelsiban,oxyr_human,OXTR,-,-,ASH_Sep2016_291,premature ejaculation,Peptide ,2.0,Phase II,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,epelsiban,P30559
2355,0,Class A (Rhodopsin),small molecule,ccx832,cml1_human,CMKLR1,-,-,451,Anti-inflammatory ; for treatment for autoimmune disease,Protein ,,in trial,Chemerin receptor,GPCR;Rhodopsin,not established,ccx832,Q99788
2356,0,Class A (Rhodopsin),small molecule,ccx354,ccr1_human,CCR1,-,-,450,Anti-inflammatory ; DMARD,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,ccx354,P32246
2357,0,Class A (Rhodopsin),small molecule,cenicriviroc,ccr2_human,CCR2,-,-,ASH_Sep2016_292,antiviral ; HIV,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,cenicriviroc,P41597
2358,0,Class A (Rhodopsin),antisense oligo,tpi-asm8,ccr3_human,CCR3,-,-,2049,Anti-Asthmatic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,tpi-asm8,P51677
2359,2012,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,2014,-,MMAjun2016_0001,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,not established,mogamulizumab,P51679
2360,0,Class A (Rhodopsin),small molecule,cenicriviroc,ccr5_human,CCR5,-,-,ASH_Sep2016_293,antiviral ; HIV,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,established,cenicriviroc,P51681
2361,0,Class A (Rhodopsin),small molecule,vercirnon,ccr9_human,CCR9,-,-,ASH_Sep2016_294,crohn's disease,Protein ,3.0,Phase III,Chemokine receptors,GPCR;Rhodopsin,not established,vercirnon,P51686
2362,0,Class A (Rhodopsin),small molecule,navarixin,cxcr1_human,CXCR1,-,-,ASH_Sep2016_295,chronic obstructive pulmonary disease (COPD),Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,navarixin,P25024
2363,0,Class A (Rhodopsin),small molecule,ladarixin,cxcr1_human,CXCR1,-,-,ASH_Sep2016_296,bullous pemphigoid,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,ladarixin,P25024
2364,0,Class A (Rhodopsin),small molecule,danirixin,cxcr2_human,CXCR2,-,-,ASH_Sep2016_297,chronic obstructive pulmonary disease (COPD),Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,danirixin,P25025
2365,0,Class A (Rhodopsin),small molecule,ladarixin,cxcr2_human,CXCR2,-,-,ASH_Sep2016_298,bullous pemphigoid,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,ladarixin,P25025
2366,0,Class A (Rhodopsin),small molecule,navarixin,cxcr2_human,CXCR2,-,-,ASH_Sep2016_299,chronic obstructive pulmonary disease (COPD),Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,navarixin,P25025
2367,0,Class A (Rhodopsin),small molecule,elubrixin,cxcr2_human,CXCR2,-,-,ASH_Sep2016_300,ulcerative colitis,Protein ,2.0,Phase II,Chemokine receptors,GPCR;Rhodopsin,not established,elubrixin,P25025
2368,0,Class A (Rhodopsin),antibody,"alx- 0651, biparatopic nanobody",cxcr4_human,CXCR4,-,-,MMAmay2016_0267,Antineoplastic,Protein ,,in trial,Chemokine receptors,GPCR;Rhodopsin,established,"alx- 0651, biparatopic nanobody",P61073
2369,2000,Class A (Rhodopsin),protein,choriogonadotropin alfa,fshr_human,FSHR,-,-,NRDD099,Fertility,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P23945
2370,0,Class A (Rhodopsin),protein,"gonadotropin, chorionic",lshr_human,LHCGR,-,-,ASH_Sep2016_301,infertility,Protein ,4.0,Phase IV,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,"gonadotropin, chorionic",P22888
2371,1998,Class A (Rhodopsin),protein,thyrotropin alfa,tshr_human,TSHR,-,1998,NRDD522,Diagnostic,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,-,P16473
2372,0,Class A (Rhodopsin),small molecule,"tak-875, fasiglifam",ffar1_human,FFAR1,-,-,MMAmay2016_0580,Antidiabetic,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,"tak-875, fasiglifam",O14842
2373,0,Class A (Rhodopsin),small molecule,glpg0974,ffar2_human,FFAR2,-,-,MMAmay2016_0156,Anti-inflammatory ; neutrophil driven inflammation; ulcerative colitis,Lipid ,,in trial,Free fatty acid receptors,GPCR;Rhodopsin,not established,glpg0974,O15552
2374,0,Class A (Rhodopsin),small molecule,amelubant,lt4r1_human,BLT1,-,-,ASH_Sep2016_302,chronic obstructive pulmonary disease (COPD),Lipid ,2.0,Phase II,Leukotriene receptors,GPCR;Rhodopsin,not established,amelubant,Q15722
2375,0,Class A (Rhodopsin),small molecule,cinalukast,cltr1_human,CYSLTR1,-,-,NRDD106,Anti-Asthmatic,Lipid ,,in trial,Leukotriene receptors,GPCR;Rhodopsin,established,-,Q9Y271
2376,0,Class A (Rhodopsin),small molecule,am-152,lpar1_human,LPAR1,-,-,144,Anti-inflammatory ; antifibrotic,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,am-152,Q92633
2377,0,Class A (Rhodopsin),small molecule,mc-1,lpar4_human,LPAR4,-,-,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,Q99677
2378,0,Class A (Rhodopsin),small molecule,mc-1,lpar6_human,LPAR6,-,-,1227,cardioprotectant,Lipid ,,in trial,Lysophospholipid (LPA) receptors,GPCR;Rhodopsin,not established,mc-4232,P43657
2379,0,Class A (Rhodopsin),enzyme,asfotase alfa,s1pr1_human,S1PR1,-,-,ASH_Sep2016_303,hypophosphatasia,Lipid ,4.0,Phase IV,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,asfotase alfa,P21453
2380,0,Class A (Rhodopsin),small molecule,siponimod,s1pr1_human,S1PR1,-,-,ASH_Sep2016_304,chronic progressive multiple sclerosis,Lipid ,3.0,Phase III,Lysophospholipid (S1P) receptors,GPCR;Rhodopsin,established,siponimod,P21453
2381,0,Class A (Rhodopsin),small molecule,ibipinabant,cnr1_human,CNR1,-,-,ASH_Sep2016_305,Antidiabetic,Lipid ,2.0,Phase II,Cannabinoid receptors,GPCR;Rhodopsin,established,ibipinabant,P21554
2382,0,Class A (Rhodopsin),small molecule,drinabant,cnr1_human,CNR1,-,-,ASH_Sep2016_306,schizophrenia,Lipid ,2.0,Phase II,Cannabinoid receptors,GPCR;Rhodopsin,established,drinabant,P21554
2383,0,Class A (Rhodopsin),small molecule,ajulemic acid,cnr2_human,CNR2,-,-,2361,Analgesics;neuropathic pain,Lipid ,,in trial,Cannabinoid receptors,GPCR;Rhodopsin,established,"ip 751, ct-3",P34972
2384,0,Class A (Rhodopsin),small molecule,vsn16r,gpr55_human,GPR55,-,-,MMAmay2016_0803,Antispasmodics;  for spatisity related to multiple sclerosis,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,vsn16r,Q9Y2T6
2385,0,Class A (Rhodopsin),small molecule,apd597,gp119_human,GPR119,-,-,2469,Antidiabetic,Lipid ,,in trial,"GPR18, GPR55 and GPR119",GPCR;Rhodopsin,not established,apd597,Q8TDV5
2386,0,Class A (Rhodopsin),small molecule,vidupiprant,pd2r_human,PTGDR,-,-,ASH_Sep2016_307,Anti-Asthmatic,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,vidupiprant,Q13258
2387,0,Class A (Rhodopsin),small molecule,fevipiprant,pd2r2_human,GPR44,-,-,ASH_Sep2016_308,Anti-Asthmatic,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,fevipiprant,Q9Y5Y4
2388,0,Class A (Rhodopsin),small molecule,setipiprant,pd2r2_human,GPR44,-,-,ASH_Sep2016_309,seasonal allergic rhinitis,Lipid ,3.0,Phase III,Prostanoid receptors,GPCR;Rhodopsin,not established,setipiprant,Q9Y5Y4
2389,0,Class A (Rhodopsin),small molecule,vidupiprant,pd2r2_human,GPR44,-,-,ASH_Sep2016_310,Anti-Asthmatic,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,vidupiprant,Q9Y5Y4
2390,0,Class A (Rhodopsin),small molecule,azd1981,pd2r2_human,GPR44,-,-,ASH_Sep2016_311,Anti-Asthmatic,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,not established,azd1981,Q9Y5Y4
2391,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r1_human,PTGER1,-,-,29,dental ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P34995
2392,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r2_human,PTGER2,-,-,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P43116
2393,1988,Class A (Rhodopsin),small molecule,misoprostol,pe2r3_human,PTGER3,1988,1988,ASH_Sep2016_312,hemorrhage,Lipid ,4.0,approved,Prostanoid receptors,GPCR;Rhodopsin,established,misoprostol,P43115
2394,0,Class A (Rhodopsin),peptide,"ac-100,dentonin",pe2r4_human,PTGER4,-,-,29,periodontal ossificant,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"ac-100,dentonin",P35408
2395,0,Class A (Rhodopsin),small molecule,latanoprostene bunod,pf2r_human,PTGFR,-,-,ASH_Sep2016_313,increased intraocular pressure,Lipid ,3.0,Phase III,Prostanoid receptors,GPCR;Rhodopsin,established,latanoprostene bunod,P43088
2396,0,Class A (Rhodopsin),small molecule,ralinepag,pi2r_human,PTGIR,-,-,ASH_Sep2016_314,Antihypertensive,Lipid ,2.0,Phase II,Prostanoid receptors,GPCR;Rhodopsin,established,ralinepag,P43119
2397,0,Class A (Rhodopsin),small molecule,"boxaban, hepatoren, vasculan, ifetroban",ta2r_human,TBXA2R,-,-,MMAjun2016_0011,Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,Lipid ,,in trial,Prostanoid receptors,GPCR;Rhodopsin,established,"boxaban, hepatoren, vasculan, ifetroban",P21731
2398,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1a_human,MTNR1A,2009,-,87,Anti-depressant,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine, ago178c, s-20098,valdoxan, thymanax",P48039
2399,2009,Class A (Rhodopsin),small molecule,agomelatine,mtr1b_human,MTNR1B,2009,-,86,Anti-depressant,Melatonin ,,approved,Melatonin,GPCR;Rhodopsin,established,"agomelatine , ago178c, s-20098,valdoxan, thymanax",P49286
2400,1989,Class A (Rhodopsin),small molecule,adenosine,aa1r_human,ADORA1,1989,1989,2267,Analgesics,Nucleotide ,,approved,Adenosine receptors,GPCR;Rhodopsin,established,"adenogesic, adenosine (intravenous)",P30542
2401,0,Class A (Rhodopsin),small molecule,apadenoson,aa2ar_human,ADORA2A,-,-,ASH_Sep2016_315,atrial fibrillation,Nucleotide ,3.0,Phase III,Adenosine receptors,GPCR;Rhodopsin,established,apadenoson,P29274
2402,1984,Class A (Rhodopsin),small molecule,pentoxifylline,aa2br_human,ADORA2B,1984,1984,ASH_Sep2016_316,irritable bowel syndrome,Nucleotide ,4.0,approved,Adenosine receptors,GPCR;Rhodopsin,established,pentoxifylline,P29275
2403,1999,Class A (Rhodopsin),small molecule,caffeine,aa2br_human,ADORA2B,1999,-,ASH_Sep2016_317,coronary artery disease,Nucleotide ,4.0,approved,Adenosine receptors,GPCR;Rhodopsin,established,caffeine,P29275
2404,1976,Class A (Rhodopsin),small molecule,theophylline,aa3r_human,ADORA3,1976,-,ASH_Sep2016_318,Anti-Asthmatic,Nucleotide ,4.0,approved,Adenosine receptors,GPCR;Rhodopsin,established,theophylline,P0DMS8
2405,1999,Class A (Rhodopsin),small molecule,caffeine,aa3r_human,ADORA3,1999,-,ASH_Sep2016_319,atherosclerosis,Nucleotide ,4.0,approved,Adenosine receptors,GPCR;Rhodopsin,established,caffeine,P0DMS8
2406,0,Class A (Rhodopsin),small molecule,cf101,aa3r_human,ADORA3,-,-,ASH_Sep2016_320,keratoconjunctivitis sicca,Nucleotide ,3.0,Phase III,Adenosine receptors,GPCR;Rhodopsin,established,cf101,P0DMS8
2407,0,Class A (Rhodopsin),small molecule,mc-1,p2ry1_human,P2RY1,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P47900
2408,0,Class A (Rhodopsin),small molecule,denufosol,p2ry2_human,P2RY2,-,-,614,cystic fibrosis,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,"denufosol tetrasodium, ins37217 respiratory",P41231
2409,0,Class A (Rhodopsin),small molecule,mc-1,p2ry4_human,P2RY4,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,P51582
2410,0,Class A (Rhodopsin),small molecule,gc021109,p2ry6_human,P2RY6,-,-,MMAfeb2016_0055,Alzheimer's disease,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,gc021109,Q15077
2411,0,Class A (Rhodopsin),small molecule,mc-1,p2y11_human,P2RY11,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q96G91
2412,2015,Class A (Rhodopsin),small molecule,cangrelor,p2y12_human,P2RY12,2015,2015,428,antithrombotic,Nucleotide ,,approved,P2Y receptors,GPCR;Rhodopsin,established,"cangrelor, ar69931",Q9H244
2413,0,Class A (Rhodopsin),small molecule,mc-1,p2y13_human,P2RY13,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q9BPV8
2414,0,Class A (Rhodopsin),small molecule,mc-1,p2y14_human,P2RY14,-,-,1227,cardioprotectant,Nucleotide ,,in trial,P2Y receptors,GPCR;Rhodopsin,not established,mc-4232,Q15391
2415,0,Class A (Rhodopsin),small molecule,int-767,gpbar_human,GPBAR1,-,-,MMAapril2016_0196,Treatment of liver fibrosis,Steroid ,,in trial,Bile acid receptors,GPCR;Rhodopsin,not established,int-767,Q8TDU6
2416,0,Class A (Rhodopsin),small molecule,ari-3037mo,hcar2_human,HCAR2,-,-,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,Q8TDS4
2417,0,Class A (Rhodopsin),small molecule,ari-3037mo,hcar3_human,HCAR3,-,-,226,Vitamin B analog; for treatment for hyperlipidemia,Alicarboxylic acid ,,in trial,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,ari-3037mo,P49019
2418,0,Class A (Rhodopsin),small molecule,pa101b,gpr35_human,GPR35,-,-,MMAmar2016_0133,autoimmune diseases,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,pa101b,Q9HC97
2419,0,Class A (Rhodopsin),small molecule,glpg1205,gpr84_human,GPR84,-,-,MMAapril2016_0323,for ulcerative colitis; IBS,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,glpg1205,Q9NQS5
2420,0,Class A (Rhodopsin),protein,nu206,lgr4_human,LGR4,-,-,2528,gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",Q9BXB1
2421,0,Class A (Rhodopsin),protein,nu206,lgr5_human,LGR5,-,-,2528,gastrointestinal disease,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"nu206, r-spondin1",O75473
2422,0,Class A (Rhodopsin),peptide,"txa127, angiotensin (1-7)",mas_human,MAS1,-,-,MMAmay2016_0617,for stem cell engraftment and thrombocytopenia,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,"txa127, angiotensin (1-7)",P04201
2423,0,Class A (Rhodopsin),small molecule,mc-1,p2ry8_human,P2RY8,-,-,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,Q86VZ1
2424,0,Class A (Rhodopsin),small molecule,mc-1,p2y10_human,P2RY10,-,-,1227,cardioprotectant,Orphan ,,in trial,Class A orphans,GPCR;Rhodopsin,not established,mc-4232,O00398
2425,0,Class B1 (Secretin),protein,calcitonin salmon recombinant,calcr_human,CALCR,-,-,ASH_Sep2016_321,osteitis deformans,Peptide ,4.0,Phase IV,Calcitonin receptors,GPCR;Secretin,established,calcitonin salmon recombinant,P30988
2426,2005,Class B1 (Secretin),protein,pramlintide acetate,calcr_human,CALCR,-,2005,ASH_Sep2016_322,Antidiabetic,Peptide ,4.0,approved,Calcitonin receptors,GPCR;Secretin,established,pramlintide acetate,P30988
2427,1978,Class B1 (Secretin),protein,calcitonin salmon,calcr_human,CALCR,1978,-,ASH_Sep2016_323,postmenopausal osteoporosis,Peptide ,4.0,approved,Calcitonin receptors,GPCR;Secretin,established,calcitonin salmon,P30988
2428,0,Class B1 (Secretin),protein,calcitonin human,calcr_human,CALCR,-,-,ASH_Sep2016_324,parathyroid disease,Peptide ,4.0,Phase IV,Calcitonin receptors,GPCR;Secretin,established,calcitonin human,P30988
2429,0,Class B1 (Secretin),protein,davalintide,calcr_human,CALCR,-,-,ASH_Sep2016_325,Anti-obesity,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,established,davalintide,P30988
2430,0,Class B1 (Secretin),small molecule,telcagepant,calrl_human,CALCRL,-,-,ASH_Sep2016_326,Anti-migraine,Peptide ,3.0,Phase III,Calcitonin receptors,GPCR;Secretin,not established,telcagepant,Q16602
2431,0,Class B1 (Secretin),small molecule,ubrogepant,calrl_human,CALCRL,-,-,ASH_Sep2016_327,Anti-migraine,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,not established,ubrogepant,Q16602
2432,0,Class B1 (Secretin),protein,davalintide,calrl_human,CALCRL,-,-,ASH_Sep2016_328,Anti-obesity,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,not established,davalintide,Q16602
2433,0,Class B1 (Secretin),small molecule,rimegepant,calrl_human,CALCRL,-,-,ASH_Sep2016_329,Anti-migraine,Peptide ,2.0,Phase II,Calcitonin receptors,GPCR;Secretin,not established,rimegepant,Q16602
2434,0,Class B1 (Secretin),small molecule,emicerfont,crfr1_human,CRHR1,-,-,ASH_Sep2016_330,irritable bowel syndrome,Peptide ,2.0,Phase II,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,emicerfont,P34998
2435,0,Class B1 (Secretin),small molecule,pexacerfont,crfr1_human,CRHR1,-,-,ASH_Sep2016_331,anxiety,Peptide ,3.0,Phase III,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,pexacerfont,P34998
2436,0,Class B1 (Secretin),peptide,corticotropin-releasing factor,crfr2_human,CRHR2,-,-,528,peritumoral brain edema,Peptide ,,in trial,Corticotropin-releasing factor receptors,GPCR;Secretin,not established,"corticotropin-releasing factor,xerecept",Q13324
2437,0,Class B1 (Secretin),small molecule,akl-0707,ghrhr_human,GHRH,-,-,96,hormone replacement,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"akl-0707, ghrh analog",Q02643
2438,0,Class B1 (Secretin),peptide,mar701,gipr_human,GIPR,-,-,1217,Antidiabetic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,not established,mar701,P48546
2439,2014,Class B1 (Secretin),protein,dulaglutide,glp1r_human,GLP1R,2014,-,ASH_Sep2016_332,Antidiabetic,Peptide ,4.0,approved,Glucagon receptor family,GPCR;Secretin,established,dulaglutide,P43220
2440,0,Class B1 (Secretin),peptide,elsiglutide,glp2r_human,GLP2R,-,-,2464,Antidiuretic,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,zp1846,O95838
2441,0,Class B1 (Secretin),small molecule,mk-0893,glr_human,GCGR,-,-,ASH_Sep2016_333,Antidiabetic,Peptide ,2.0,Phase II,Glucagon receptor family,GPCR;Secretin,established,mk-0893,P47871
2442,0,Class B1 (Secretin),protein,glucagon hydrochloride recombinant,glr_human,GCGR,-,-,ASH_Sep2016_334,hypoglycemia,Peptide ,4.0,Phase IV,Glucagon receptor family,GPCR;Secretin,established,glucagon hydrochloride recombinant,P47871
2443,0,Class B1 (Secretin),peptide,rg1068,sctr_human,SCTR,-,-,1749,autism,Peptide ,,in trial,Glucagon receptor family,GPCR;Secretin,established,"rg1068, synthetic secretin,secreflo",P47872
2444,0,Class B1 (Secretin),small molecule,768974,pth1r_human,PTH1R,-,-,10,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,"768974, parathyroid hormone analog",Q03431
2445,0,Class B1 (Secretin),protein,alx1-11,pth2r_human,PTH2R,-,-,1646,Anti-osteoporotic,Peptide ,,in trial,Parathyroid hormone receptors,GPCR;Secretin,established,preos,P49190
2446,0,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr1_human,VIPR1,-,-,288,sexual dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Secretin,not established,"aviptadil,invicorp",P32241
2447,0,Class B1 (Secretin),peptide,vasoactive intestinal peptide,vipr2_human,VIPR2,-,-,288,sexual dysfunction,Peptide ,,in trial,VIP and PACAP receptors,GPCR;Rhodopsin,not established,"aviptadil,invicorp",P41587
2448,0,Class C (Glutamate) ,small molecule,adx71441,gabr2_human,GABBR2,-,-,MMAmay2016_0244,neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,O75899
2449,2004,Class C (Glutamate) ,small molecule,cinacalcet,casr_human,CASR,2004,2004,NRDD105,Calcimimetics,Ion ,,approved,Calcium-sensing receptors,GPCR;Glutamate,established,-,P41180
2450,0,Class C (Glutamate) ,small molecule,adx71441,gabr1_human,GABBR1,-,-,MMAmay2016_0243,neurologic disorders,Amino acid ,,in trial,GABAB receptors,GPCR;Glutamate,established,adx71441,Q9UBS5
2451,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm1_human,GRM1,-,-,MMAmar2016_0121,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q13255
2452,0,Class C (Glutamate) ,small molecule,pomaglumetad methionil,grm2_human,GRM2,-,-,ASH_Sep2016_335,schizophrenia,Amino acid ,3.0,Phase III,Metabotropic glutamate receptors,GPCR;Glutamate,not established,pomaglumetad methionil,Q14416
2453,0,Class C (Glutamate) ,small molecule,decoglurant,grm2_human,GRM2,-,-,ASH_Sep2016_336,unipolar depression,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,not established,decoglurant,Q14416
2454,0,Class C (Glutamate) ,small molecule,pomaglumetad methionil,grm3_human,GRM3,-,-,ASH_Sep2016_337,schizophrenia,Amino acid ,3.0,Phase III,Metabotropic glutamate receptors,GPCR;Glutamate,not established,pomaglumetad methionil,Q14832
2455,0,Class C (Glutamate) ,small molecule,decoglurant,grm3_human,GRM3,-,-,ASH_Sep2016_338,unipolar depression,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,not established,decoglurant,Q14832
2456,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm4_human,GRM4,-,-,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14833
2457,0,Class C (Glutamate) ,small molecule,dipraglurant,grm5_human,GRM5,-,-,ASH_Sep2016_339,Antiparkinson,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,established,dipraglurant,P41594
2458,0,Class C (Glutamate) ,small molecule,mavoglurant,grm5_human,GRM5,-,-,ASH_Sep2016_340,obsessive-compulsive disorder,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,established,mavoglurant,P41594
2459,0,Class C (Glutamate) ,small molecule,basimglurant,grm5_human,GRM5,-,-,ASH_Sep2016_341,fragile x syndrome,Amino acid ,2.0,Phase II,Metabotropic glutamate receptors,GPCR;Glutamate,established,basimglurant,P41594
2460,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm6_human,GRM6,-,-,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O15303
2461,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm7_human,GRM7,-,-,MMAmar2016_0124,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,Q14831
2462,0,Class C (Glutamate) ,small molecule,fasoracetam monohydrate,grm8_human,GRM8,-,-,MMAmar2016_0125,attention deficit hyperactivity disorder (ADHD),Amino acid ,,in trial,Metabotropic glutamate receptors,GPCR;Glutamate,not established,nfc-1,O00222
2463,0,Class F (Frizzled),antibody,omp-18r5,fzd7_human,FZD7,-,-,2457,Antineoplastic,Protein ,,in trial,Frizzled,GPCR;Frizzled,not established,omp-18r5,O75084
2464,0,Class F (Frizzled),small molecule,patidegib,smo_human,SMO,-,-,ASH_Sep2016_342,primary myelofibrosis,Protein ,2.0,Phase II,Frizzled,GPCR;Frizzled,established,patidegib,Q99835
2465,0,Class F (Frizzled),small molecule,glasdegib,smo_human,SMO,-,-,ASH_Sep2016_343,Antineoplastic,Protein ,2.0,Phase II,Frizzled,GPCR;Frizzled,established,glasdegib,Q99835
2466,0,Class F (Frizzled),small molecule,tak-441,smo_human,SMO,-,-,ASH_Sep2016_344,basal cell carcinoma,Protein ,1.0,Phase I,Frizzled,GPCR;Frizzled,established,tak-441,Q99835
2467,1924,Class B1 (Secretin),peptide,abaloparatide,pth1r_human,PTHR1,-,-,ASH_Sep2016_345,Anti-osteoporotic,Peptide,3.0,Phase III,Parathyroid hormone receptors,GPCR;Secretin,established,Abaloparatide,Q03431
2468,0,Class A (Rhodopsin),small molecule,suramin,p2ry2_human,P2RY2,,-,ASH_Oct2016_346,African trypanosomiasis,Nucleotide ,,approved,P2Y,GPCR;Rhodopsin,established,Suramin,P41231
2469,0,Class A (Rhodopsin),small molecule,metiamide,hrh2_human,HRH2,-,-,ASH_Oct2016_348,acid reducer,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,metiamide,P25021
2470,0,Class A (Rhodopsin),small molecule,metiamide,hrh2_human,HRH2,-,-,ASH_Oct2016_349,acid reducer,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,metiamide,P25021
2471,1942,Class A (Rhodopsin),small molecule,pethidine,oprk_human,OPRK1,1942,-,ASH_Oct2016_350,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,pethidine,P41145
2472,0,Class A (Rhodopsin),small molecule,ketobemidone,oprk_human,OPRK1,-,-,ASH_Oct2016_351,Analgesics,Peptide ,,approved,Opioid receptors,GPCR;Rhodopsin,established,ketobemidone,P41145
2473,0,Class A (Rhodopsin),small molecule,ketobemidone,oprd_human,OPRD1,-,-,ASH_Oct2016_352,Analgesics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,ketobemidone,P41143
2474,0,Class A (Rhodopsin),small molecule,ethylmorphine,oprm_human,OPRM1,-,-,ASH_Oct2016_353,Analgesics,Aminergic ,,Approved,Histamine receptors,GPCR;Rhodopsin,established,ethylmorphine,P35372
2475,0,Class A (Rhodopsin),small molecule,ketobemidone,oprm_human,OPRM1,-,-,ASH_Oct2016_354,Analgesics,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,ketobemidone,P35372
2476,0,Class A (Rhodopsin),small molecule,phenindamine,hrh1_human,HRH1,-,-,ASH_Oct2016_355,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,phenindamine,P35367
2477,0,Class A (Rhodopsin),small molecule,chloropyramine,hrh1_human,HRH1,-,-,ASH_Oct2016_356,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,chloropyramine,P35367
2478,0,Class A (Rhodopsin),small molecule,dimetindene,hrh1_human,HRH1,-,-,ASH_Oct2016_357,Anti-Allergic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,dimetindene,P35367
2479,0,Class A (Rhodopsin),small molecule,chlorcyclizine,hrh1_human,HRH1,-,-,ASH_Oct2016_358,Anti-Allergic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,chlorcyclizine,P35367
2480,0,Class A (Rhodopsin),small molecule,bilastine,hrh1_human,HRH1,-,-,ASH_Oct2016_359,Anti-Allergic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,bilastine,P35367
2481,0,Class A (Rhodopsin),small molecule,dimetindene,acm2_human,CHRM2,-,-,ASH_Oct2016_360,Anti-Allergic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,dimetindene,P08172
2482,1979,Class A (Rhodopsin),small molecule,isoetarine,adrb1_human,ADRB1,1979,-,ASH_Oct2016_361,Anti-Asthmatic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,isoetarine,P08588
2483,0,Class A (Rhodopsin),small molecule,butriptyline,hrh1_human,HRH1,-,-,ASH_Oct2016_363,Anti-depressant,Peptide ,,approved,Endothelin receptors,GPCR;Rhodopsin,established,butriptyline,P35367
2484,0,Class A (Rhodopsin),small molecule,butriptyline,5ht2a_human,HTR2A,-,-,ASH_Oct2016_365,Anti-depressant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,butriptyline,P28223
2485,0,Class A (Rhodopsin),small molecule,bromopride,drd2_human,DRD2,-,-,ASH_Oct2016_366,Antiemetics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,bromopride,P14416
2486,0,Class A (Rhodopsin),small molecule,ergonovine,ada1a_human,ADRA1A,-,-,ASH_Oct2016_367,antihaemorrhagic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,ergonovine,P35348
2487,0,Class A (Rhodopsin),small molecule,sitaxentan,ednra_human,EDNRA,-,-,ASH_Oct2016_368,Antihypertensive,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,sitaxentan,P25101
2488,0,Class A (Rhodopsin),small molecule,bupranolol,adrb1_human,ADRB1,,-,ASH_Oct2016_369,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,bupranolol,P08588
2489,0,Class A (Rhodopsin),small molecule,celiprolol,adrb1_human,ADRB1,,-,ASH_Oct2016_370,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,celiprolol,P08588
2490,0,Class A (Rhodopsin),small molecule,bopindolol,adrb1_human,ADRB1,-,-,ASH_Oct2016_371,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,bopindolol,P08588
2491,0,Class A (Rhodopsin),small molecule,celiprolol,adrb2_human,ADRB2,,-,ASH_Oct2016_372,Antihypertensive,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,celiprolol,P07550
2492,0,Class A (Rhodopsin),small molecule,isothipendyl,hrh1_human,HRH1,-,-,ASH_Oct2016_373,antipruritic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,isothipendyl,P35367
2493,0,Class A (Rhodopsin),small molecule,thioproperazine,ada1b_human,ADRA1B,-,-,ASH_Oct2016_374,Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thioproperazine,P35368
2494,2006,Class A (Rhodopsin),small molecule,benperidol,ada1a_human,ADRA1A,2006,-,ASH_Oct2016_375,Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,benperidol,P35348
2495,0,Class A (Rhodopsin),small molecule,thioproperazine,ada1a_human,ADRA1A,-,-,ASH_Oct2016_376,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioproperazine,P35348
2496,0,Class A (Rhodopsin),small molecule,flupentixol,5ht2a_human,HTR2A,,-,ASH_Oct2016_377,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,flupentixol,P28223
2497,1980,Class A (Rhodopsin),small molecule,pipotiazine,5ht2a_human,HTR2A,1980,-,ASH_Oct2016_378,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,pipotiazine,P28223
2498,0,Class A (Rhodopsin),small molecule,acepromazine,5ht2a_human,HTR2A,-,-,ASH_Oct2016_379,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,acepromazine,P28223
2499,0,Class A (Rhodopsin),small molecule,thioproperazine,5ht2a_human,HTR2A,-,-,ASH_Oct2016_380,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,thioproperazine,P28223
2500,0,Class A (Rhodopsin),small molecule,flupentixol,drd1_human,DRD1,,-,ASH_Oct2016_381,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,flupentixol,P21728
2501,1980,Class A (Rhodopsin),small molecule,pipotiazine,drd1_human,DRD1,1980,-,ASH_Oct2016_382,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,pipotiazine,P21728
2502,0,Class A (Rhodopsin),small molecule,acepromazine,drd1_human,DRD1,-,-,ASH_Oct2016_383,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,acepromazine,P21728
2503,2006,Class A (Rhodopsin),small molecule,benperidol,drd2_human,DRD2,2006,-,ASH_Oct2016_384,Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,benperidol,P14416
2504,0,Class A (Rhodopsin),small molecule,flupentixol,drd2_human,DRD2,,-,ASH_Oct2016_385,Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,flupentixol,P14416
2505,1980,Class A (Rhodopsin),small molecule,pipotiazine,drd2_human,DRD2,1980,-,ASH_Oct2016_386,Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pipotiazine,P14416
2506,0,Class A (Rhodopsin),small molecule,acepromazine,drd2_human,DRD2,-,-,ASH_Oct2016_387,Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,acepromazine,P14416
2507,0,Class A (Rhodopsin),small molecule,thioproperazine,drd2_human,DRD2,-,-,ASH_Oct2016_388,Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,thioproperazine,P14416
2508,0,Class A (Rhodopsin),small molecule,flupentixol,acm1_human,CHRM1,,-,ASH_Oct2016_389,Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,flupentixol,P11229
2509,1980,Class A (Rhodopsin),small molecule,pipotiazine,5ht1a_human,HTR1A,1980,-,ASH_Oct2016_390,Antipsychotic,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,pipotiazine,P08908
2510,0,Class A (Rhodopsin),small molecule,acepromazine,5ht1a_human,HTR1A,-,-,ASH_Oct2016_391,Antipsychotic,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,acepromazine,P08908
2511,0,Class A (Rhodopsin),small molecule,thioproperazine,5ht1a_human,HTR1A,-,-,ASH_Oct2016_392,Antipsychotic,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,thioproperazine,P08908
2512,0,Class A (Rhodopsin),small molecule,flupentixol,5ht2a_human,HTR2A,,-,ASH_Oct2016_393,Antipsychotic,Aminergic ,,approved,Dopamine receptors,GPCR;Rhodopsin,established,flupentixol,P28223
2513,0,Class A (Rhodopsin),small molecule,hyoscyamine,acm1_human,CHRM1,-,-,ASH_Oct2016_394,Antispasmodics,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,hyoscyamine,P11229
2514,0,Class A (Rhodopsin),small molecule,alverine,5ht1a_human,HTR1A,-,-,ASH_Oct2016_395,Antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alverine,P08908
2515,0,Class A (Rhodopsin),small molecule,hyoscyamine,acm2_human,CHRM2,-,-,ASH_Oct2016_396,Antispasmodics,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,hyoscyamine,P08172
2516,0,Class A (Rhodopsin),small molecule,clofedanol,hrh1_human,HRH1,-,-,ASH_Oct2016_397,antitussive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,clofedanol,P35367
2517,0,Class A (Rhodopsin),small molecule,captodiame,drd3_human,DRD3,-,-,ASH_Oct2016_399,anxiolytic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,captodiame,P35462
2518,0,Class A (Rhodopsin),small molecule,captodiame,5ht2c_human,HTR2C,-,-,ASH_Oct2016_400,anxiolytic,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,captodiame,P28335
2519,0,Class A (Rhodopsin),small molecule,isoprenaline,adrb3_human,ADRB3,,-,ASH_Oct2016_401,cardiovascular ; Anti-Asthmatic ,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,isoprenaline,P13945
2520,0,Class A (Rhodopsin),small molecule,isoprenaline,adrb1_human,ADRB1,,-,ASH_Oct2016_402,cardiovascular ; Anti-Asthmatic ,Peptide ,,approved,Thyrotropin-releasing hormone receptors,GPCR;Rhodopsin,established,isoprenaline,p08588
2521,0,Class B1 (Secretin),small molecule,isoprenaline,adrb2_human,ADRB2,,-,ASH_Oct2016_403,cardiovascular ; Anti-Asthmatic ,Peptide ,,approved,Corticotropin-releasing factor receptors,GPCR;Rhodopsin,established,isoprenaline,P07550
2522,0,Class A (Rhodopsin),small molecule,xylometazoline,ada1a_human,ADRA1A,-,-,ASH_Oct2016_404,decongestant,Aminergic ,,approved,Histamine receptors,GPCR;Rhodopsin,established,xylometazoline,P35348
2523,0,Class A (Rhodopsin),small molecule,levonordefrin,ada1a_human,ADRA1A,-,-,ASH_Oct2016_405,decongestant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,levonordefrin,P35348
2524,0,Class A (Rhodopsin),small molecule,xylometazoline,ada2b_human,ADRA2B,-,-,ASH_Oct2016_406,decongestant,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,xylometazoline,P18089
2525,0,Class A (Rhodopsin),small molecule,xylometazoline,ada2a_human,ADRA2A,-,-,ASH_Oct2016_407,decongestant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,xylometazoline,P08913
2526,0,Class A (Rhodopsin),small molecule,protirelin,trfr_human,TRHR,-,-,ASH_Oct2016_408,diagnostic for secondary hypothyroidism and acromegaly,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Rhodopsin,established,protirelin,P34981
2527,0,Class A (Rhodopsin),small molecule,corticorelin ovine triflutate,crfr1_human,CRHR1,-,-,ASH_Oct2016_409,diagnostic in Cushing's syndrome,Aminergic ,,approved,5-Hydroxytryptamine receptors,GPCR;Secretin,established,corticorelin ovine triflutate,P34998
2528,0,Class A (Rhodopsin),small molecule,histamine,hrh2_human,HRH2,-,-,ASH_Oct2016_410,for diagnosis of gastric acid secretory function,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,histamine ,P25021
2529,0,Class B1 (Secretin),small molecule,tetryzoline,ada1a_human,ADRA1A,-,-,ASH_Oct2016_411,"for eye irritation, decongestant",Peptide ,,approved,Calcitonin receptors,GPCR;Rhodopsin,established,tetryzoline,P35348
2530,0,Class A (Rhodopsin),small molecule,ganirelix,gnrhr_human,GNRHR,-,-,ASH_Oct2016_412,for prevention of premature ovulation in fertility treatment,Aminergic ,,approved,Acetylcholine receptors (muscarinic),GPCR;Rhodopsin,established,ganirelix,P30968
2531,1983,Class A (Rhodopsin),small molecule,chenodeoxycholic acid,nr1h4_human,NR1H4,1983,-,ASH_Oct2016_413,for treatment of gall stones,Aminergic ,,approved,Acetylcholine receptors (muscarinic),Nuclear receptor,established,chenodeoxycholic acid,Q96RI1
2532,0,Class A (Rhodopsin),small molecule,cinitapride,5ht2a_human,HTR2A,-,-,ASH_Oct2016_414,for treatment of gastrointestinal disorders,Peptide ,,approved,Vasopressin and oxytocin receptors,GPCR;Rhodopsin,established,cinitapride,P28223
2533,0,Class A (Rhodopsin),small molecule,cinitapride,5ht1a_human,HTR1A,-,-,ASH_Oct2016_415,for treatment of gastrointestinal disorders,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,cinitapride,P08908
2534,0,Class A (Rhodopsin),small molecule,isometheptene,ada1a_human,ADRA1A,-,-,ASH_Oct2016_417,for treatment of migraines,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,isometheptene,P35348
2535,1978,Class A (Rhodopsin),peptide,calcitonin (salmon),calcr_human,CALCR,1978,-,ASH_Oct2016_418,for treatment of Paget's disease,Aminergic ,,approved,Adrenoceptors,GPCR;Secretin,established,calcitonin (salmon),P30988
2536,0,Class A (Rhodopsin),small molecule,methylscopolamine bromide,acm1_human,CHRM1,-,-,ASH_Oct2016_421,Anti-ulcer,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,methylscopolamine bromide,P11229
2537,0,Class A (Rhodopsin),small molecule,methylscopolamine bromide,acm2_human,CHRM2,-,-,ASH_Oct2016_422,Anti-ulcer,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,methylscopolamine bromide,P08172
2538,2013,Class A (Rhodopsin),small molecule,atosiban,oxyr_human,OXTR,,-,ASH_Oct2016_425,labor repressant,Protein ,,approved,Chemokine receptors,GPCR;Rhodopsin,established,atosiban,P30559
2539,0,Class A (Rhodopsin),peptide,buserelin,gnrhr_human,GNRHR,,-,ASH_Oct2016_426,LHRH analogue,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,buserelin,P30968
2540,0,Class A (Rhodopsin),peptide,buserelin,lshr_human,LHCGR,,-,ASH_Oct2016_427,LHRH analogue,Protein ,,approved,Glycoprotein hormone receptors,GPCR;Rhodopsin,established,buserelin,P22888
2541,2003,Class A (Rhodopsin),small molecule,acipimox,hcar2_human,HCAR2,2003,-,ASH_Oct2016_428,lipid-lowering,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,acipimox,Q8TDS4
2542,1988,Class A (Rhodopsin),small molecule,levonordefrin,ada1a_human,ADRA1A,-,-,ASH_Oct2016_429,nasal decongestant,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,alpha-methylnoradrenaline,P35348
2543,2001,Class A (Rhodopsin),small molecule,triptorelin,gnrhr_human,GNRHR,2001,-,ASH_Oct2016_430,palliiative treatment of advanced prostate cancer,Peptide ,,approved,Gonadotrophin-releasing hormone receptors,GPCR;Rhodopsin,established,triptorelin,P30968
2544,1993,Class A (Rhodopsin),small molecule,indoramin,ada1b_human,ADRA1B,1993,-,ASH_Oct2016_431,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,indoramin,P35368
2545,1993,Class A (Rhodopsin),small molecule,indoramin,ada1a_human,ADRA1A,1993,-,ASH_Oct2016_432,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,indoramin,P35348
2546,1993,Class A (Rhodopsin),small molecule,indoramin,ada1d_human,ADRA1D,1993,-,ASH_Oct2016_433,Antihypertensive,Aminergic ,,approved,Adrenoceptors,GPCR;Rhodopsin,established,indoramin,P25100
2547,2008,Class A (Rhodopsin),small molecule,icatibant,bkrb1_human,BDKRB1,2008,2011,ASH_Oct2016_434,hereditary angioedema,Peptide ,,approved,Bradykinin receptors,GPCR;Rhodopsin,established,"firazyr, icatibant, je049",P46663
2548,2004,Class A (Rhodopsin),small molecule,iloprost,pd2r_human,PTGDR,2004,2004,ASH_Oct2016_435,Antihypertensive,Lipid ,,approved,Prostanoid receptors,GPCR;Rhodopsin,established,"iloprost,ventavis",Q13258
2549,2012,Class A (Rhodopsin),antibody,mogamulizumab,ccr4_human,CCR4,2014,-,ASH_Oct2016_436,Antineoplastic,Protein ,,approved,Chemokine receptors,GPCR;Rhodopsin,established,mogamulizumab,P51679
2550,2002,Class A (Rhodopsin),small molecule,gamma hydroxybutyric acid,hcar1_human,HCAR1,2002,-,ASH_Oct2016_437,Hypnotics and Sedatives,Alicarboxylic acid ,,approved,Hydroxycarboxylic acid receptors,GPCR;Rhodopsin,established,sodium oxybate,Q9BXC0
